The synthesis of N-substituted ferrocenes and CH activation towards the synthesis of Organosilanols by Özçubukçu, Salih
The Synthesis of N -Substituted Ferrocenes
and
C–H Activation Towards the Synthesis of
Organosilanols
Salih O¨zc¸ubukc¸u
Dissertation
The Synthesis of N -Substituted Ferrocenes
and
C–H Activation Towards the Synthesis of
Organosilanols
Von der Fakulta¨t fu¨r Mathematik, Informatik und Naturwissenschaften der
Rheinisch-Westfa¨lischen Technischen Hochschule Aachen zur Erlangung des akademischen
Grades eines Doktors der Naturwissenschaften genehmigte Dissertation
vorgelegt von
Master of Science
Salih O¨zc¸ubukc¸u
aus Gaziantep (Tu¨rkei)
Berichter: Universita¨tsprofessor Dr. Carsten Bolm
Universita¨tsprofessor Dr. Dieter Enders
Tag der mu¨ndlichen Pru¨fung: 22 Januar 2007
Diese Dissertation ist auf den Internetseiten der Hochschulbibliothek online verfu¨gbar.
For everybody
The work presented in this thesis was carried out at the Institute of Organic Chemistry of the
RWTH-Aachen University, under the supervision of Prof. Dr. Carsten Bolm between January
2003 and July 2006.
I would like to thank Prof. Dr. Carsten Bolm for giving me the opportunity to work on this
exciting research topic, excellent conditions and support in his research group. I would like to
thank Prof. Dr. Dieter Enders for his kind assumption of the co-reference.
Parts of this work have already been published or submitted:
’Organosilanols as Catalysts in Asymmetric Aryl Transfer Reactions’ O¨zc¸ubukc¸u, S.; Schmidt,
F.; Bolm, C. Org. Lett. 2005, 7, 1407. (This article has been highlighted in Synfact 2005, 0, 41.)
’A General and Efficient Synthesis of Nitrogen-Substituted Ferrocenes’ O¨zc¸ubukc¸u, S.; Scmitt,
E.; Leifert, A.; Bolm, C.; Synthesis 2007, 389.
’Diastereoselective Catalytic C–H Activation of Ferrocenes’ O¨zc¸ubukc¸u, S.; Bolm, C.;Manuscript
in Prep.
viii
Contents
1 Introduction 1
1.1 C–H Activation Reactions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
1.1.1 Stoichiometric C–H Activation Reactions . . . . . . . . . . . . . . . . . . 3
1.1.2 Pioneer Studies on Catalytic C–H Activation Reactions . . . . . . . . . . 4
1.1.3 Murai’s Catalytic C–H Activation . . . . . . . . . . . . . . . . . . . . . . 5
1.1.4 Catalytic Olefin Insertion into the C–H Bond . . . . . . . . . . . . . . . . 12
1.1.5 Catalytic Dehydrogenation of Alkanes . . . . . . . . . . . . . . . . . . . . 14
1.1.6 Catalytic Borylation of C–H Bonds . . . . . . . . . . . . . . . . . . . . . . 15
1.1.7 Catalytic Insertion of Nitrogen into the C–H Bond . . . . . . . . . . . . . 17
1.1.8 Catalytic Insertion of Oxygen into the C–H Bond . . . . . . . . . . . . . . 20
1.2 Objectives of the Research . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
1.3 Results and Discussions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
1.3.1 Diastereoselective C–H Activation of Ferrocenyl Oxazolines . . . . . . . . 23
1.3.2 Application of Different Type of Substrates . . . . . . . . . . . . . . . . . 27
1.4 Summary and Outlook . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
2 Organosilanols 31
2.1 Properties of Organosilanols . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32
2.1.1 Acidity and Basicity of Organosilanols . . . . . . . . . . . . . . . . . . . . 32
2.1.2 Biologically Active Silanols . . . . . . . . . . . . . . . . . . . . . . . . . . 32
2.2 General Synthesis of Organosilanols . . . . . . . . . . . . . . . . . . . . . . . . . 36
2.2.1 Synthesis of Silanols From Si–H Compounds . . . . . . . . . . . . . . . . 37
2.2.2 Synthesis of Silanols by the Hydrolysis of Halosilane . . . . . . . . . . . . 41
2.2.3 Synthesis of Silanols via the Cleavage of Si–O Bond . . . . . . . . . . . . 42
2.2.4 Synthesis of Silanols by the Hydrolysis of Si–N Bond . . . . . . . . . . . . 43
ix
x2.2.5 Synthesis of Silanols by the Cleavage of Si–Ph Bond . . . . . . . . . . . . 43
2.3 Application of Silanols . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
2.3.1 Cross-coupling Reactions of Silanols . . . . . . . . . . . . . . . . . . . . . 44
2.3.2 The Silanol Moiety as a Directing Group . . . . . . . . . . . . . . . . . . 46
2.3.3 Silandiol-Based Anion Receptors . . . . . . . . . . . . . . . . . . . . . . . 47
2.4 Objectives of the Research . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
2.5 Results and Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49
2.5.1 Synthesis of Ferrocene-based Organosilanols . . . . . . . . . . . . . . . . . 49
2.5.2 Application of Organosilanols in Asymmetric Reactions . . . . . . . . . . 51
2.5.3 Organosilanols as Directing Group on Ferrocenes . . . . . . . . . . . . . . 53
2.5.4 Synthesis of Ferrocene-Based Disilanols . . . . . . . . . . . . . . . . . . . 54
2.5.5 Hydrogen Bond Catalyzed Hetero-Diels-Alder Reaction . . . . . . . . . . 56
2.5.6 On the Way to a Silanol Analog of Prolinols . . . . . . . . . . . . . . . . . 58
2.6 Summary and Outlook . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 59
3 N -Substituted Ferrocene Derivatives 61
3.1 Syntheses of Ferrocenyl Amine . . . . . . . . . . . . . . . . . . . . . . . . . . . . 61
3.2 Synthesis of 1,1’-Diamino Ferrocene . . . . . . . . . . . . . . . . . . . . . . . . . 64
3.3 Objectives of the Research . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65
3.4 Results and Discussions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66
3.4.1 A General Synthesis of Ferrocenyl Amines . . . . . . . . . . . . . . . . . . 66
3.4.2 Pyrazole as a Directing Group on Ferrocenes . . . . . . . . . . . . . . . . 70
3.4.3 Bispyrazoles as Potential Ligands . . . . . . . . . . . . . . . . . . . . . . . 73
3.4.4 A Small Extension of Bispyrazoles . . . . . . . . . . . . . . . . . . . . . . 73
3.5 Summary and Outlook . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 75
4 Experimental Section 77
4.1 General Methods and Chemicals . . . . . . . . . . . . . . . . . . . . . . . . . . . 77
4.1.1 Solvents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 77
4.1.2 Determination of the Physical Data . . . . . . . . . . . . . . . . . . . . . 78
4.2 C–H Activation of Ferrocene Compounds . . . . . . . . . . . . . . . . . . . . . . 80
4.2.1 General Procedure A for C–H Activation Reactions . . . . . . . . . . . . . 80
4.2.2 Synthesis of (S,Rp)-2-(triethylsilane)ferrocenyl-5-tert-butyloxazoline (S,Rp)-
75 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 80
xi
4.2.3 Synthesis of (S,Rp)-2-(triethylsilane)ferrocenyl-5-iso-propyloxazoline [(S,Rp)-
79] . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 81
4.2.4 Synthesis of (S,Rp)-2-(triethylsilane)ferrocenyl-5-benzyloxazoline[(S,Rp)-81] 82
4.2.5 Synthesis of (S,Rp)-2-(triethylsilane)ferrocenyl-5-phenyloxazoline[(S,Rp)-80] 83
4.2.6 Synthesis of 2-(triethylsilane)-1-pyrazolyl-ferrocene (94) . . . . . . . . . . 84
4.2.7 Synthesis of 1-[(4S,7R)-7,8,8-trimethyl-4,5,6,7-tetrahydro-4,7-methano-2-
indazolyl]-2-triethylsilyl ferrocene [(4S,7R,Rp)-96] . . . . . . . . . . . . . 85
4.2.8 Synthesis of 1-(α-triethylsilane)ferrocenyl-1-ethanol (91) . . . . . . . . . . 86
4.2.9 Synthesis of (S,Rp)-2-(triethylsilane)cyrhetrenyl-5-tert-butyloxazoline [(S,Rp)-
100] . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87
4.3 Synthesis of Organosilanols . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 88
4.3.1 Synthesis of silanes 152: General Procedure B . . . . . . . . . . . . . . . 88
4.3.2 Synthesis of (S,Rp)-2-(α-dimethylsilane)ferrocenyl-5-tert-butyl-oxazoline [(S,Rp)-
152a] . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 89
4.3.3 Synthesis of (S,Rp)-2-(α-diisopropylsilane)ferrocenyl-5-tert-butyloxazoline
[(S,Rp)-152b] . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 90
4.3.4 Synthesis of (S,Rp)-2-(α-diphenylsilane)ferrocenyl-5-tert-butyloxazoline [(S,Rp)-
152c] . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 91
4.3.5 Synthesis of (S,Rp)-2-(α-diisopropylsilane)ferrocenyl-5-phenyloxazoline [(S,Rp)-
152d] . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 92
4.3.6 Synthesis of (S,Rp)-2-(α-diphenylsilane)ferrocenyl-5-phenyloxazoline [(S,Rp)-
152e] . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 93
4.3.7 Synthesis of (S,Rp)-2-(α-diisopropylsilane)ferrocenyl-5-iso-propyloxazoline
[(S,Rp)-152f ] . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 94
4.3.8 Synthesis of (S,Rp)-2-(α-diphenylsilane)ferrocenyl-5-iso-propyloxazoline [(S,Rp)-
152g] . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 95
4.3.9 Synthesis of (S,Rp)-2-(α-diisopropylsilane)ferrocenyl-5-benzyloxazoline [(S,Rp)-
152h] . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 96
4.3.10 Synthesis of (S,Rp)-2-(α-diphenylsilane)ferrocenyl-5-benzyloxazoline [(S,Rp)-
152i] . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 97
4.4 Synthesis of ferrocenyl silanols 153 . . . . . . . . . . . . . . . . . . . . . . . . . . 98
4.4.1 Synthesis of (S,Rp)-2-(α-dimethylsilanol)ferrocenyl-5-tert-butyloxazoline [(S,Rp)-
153a] . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 98
xii
4.4.2 Synthesis of (S,Rp)-2-(α-diisopropylsilanol)ferrocenyl-5-tert-butyloxazoline
[(S,Rp)-153b] . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 99
4.4.3 Synthesis of (S,Rp)-2-(α-diphenylsilanol)ferrocenyl-5-tert-butyloxazoline [(S,Rp)-
153c] . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 100
4.4.4 Synthesis of (S,Rp)-2-(α-diisopropylsilanol)ferrocenyl-5-phenyloxazoline [(S,Rp)-
153d] . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 101
4.4.5 Synthesis of (S,Rp)-2-(α-diphenylsilanol)ferrocenyl-5-phenyloxazoline [(S,Rp)-
153e] . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 102
4.4.6 Synthesis of (S,Rp)-2-(α-diisopropylsilanol)ferrocenyl-5-iso-propyloxazoline
[(S,Rp)-153f ] . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103
4.4.7 Synthesis of (S,Rp)-2-(α-diphenylsilanol)ferrocenyl-5-iso-propyloxazoline [(S,Rp)-
153g] . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 104
4.4.8 Synthesis of (S,Rp)-2-(α-diisopropylsilanol)ferrocenyl-5-benzyloxazoline [(S,Rp)-
153h] . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 105
4.4.9 Synthesis of (S,Rp)-2-(α-diphenylsilanol)ferrocenyl-5-benzyloxazoline [(S,Rp)-
153i] . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 106
4.4.10 Synthesis of 1,1’-bis(dimethylsilyl)ferrocene (158) . . . . . . . . . . . . . 107
4.4.11 Synthesis of 1,1’-bis(tetramethylsiloxane)ferrocene (159) . . . . . . . . . . 108
4.4.12 Synthesis of ferrocenyldimethylsilanol (156) . . . . . . . . . . . . . . . . . 109
4.4.13 Synthesis of 1,1’-bis(dimethylsilanol)ferrocene (160) . . . . . . . . . . . . 110
4.4.14 Synthesis of rac-1,1’-bis(phenylmethylsilanol)ferrocene (161) . . . . . . . 111
4.5 Synthesis of N -Substituted Ferrocenes . . . . . . . . . . . . . . . . . . . . . . . . 112
4.5.1 Synthesis of Iodoferrocene (193) . . . . . . . . . . . . . . . . . . . . . . . 112
4.5.2 Synthesis of 1,1’-diiodoferrocene (196) . . . . . . . . . . . . . . . . . . . . 113
4.5.3 Synthesis of (S,Rp)-α-iodo-ferrocenyl-5-benzyloxazoline [(S,Rp)-211] . . . 114
4.5.4 Synthesis of N -substituted ferrocenes; General Procedure D . . . . . . . . 115
4.5.5 Synthesis of N -ferrocenyl pyrazole (93) . . . . . . . . . . . . . . . . . . . 115
4.5.6 Synthesis ofN -ferrocenyl-(4S,7R)-7,8,8-trimethyl-4,5,6,7-tetrahydro-4,7-methano-
2-indazole (95) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 116
4.5.7 Synthesis of N -ferrocenyl indole (199) . . . . . . . . . . . . . . . . . . . . 117
4.5.8 Synthesis of N -ferrocenyl pyrrole (200) . . . . . . . . . . . . . . . . . . . 117
4.5.9 Synthsis of N -ferrocenyl imidazole . . . . . . . . . . . . . . . . . . . . . . 118
4.5.10 Synthesis of 1-ferrocenyl-1,2,4-triazole (202) . . . . . . . . . . . . . . . . . 119
xiii
4.5.11 Synthesis of N -ferrocenyl-methyl phenyl sulfoximine (203) . . . . . . . . 119
4.5.12 Synthesis of N -ferrocenyl-benzamide (205) . . . . . . . . . . . . . . . . . 120
4.5.13 Synthesis of 1,1’-bis(N -pyrazolyl) ferrocene (208) . . . . . . . . . . . . . . 121
4.5.14 Synthesis of 1,1’-bis[(4S,7R)-7,8,8-trimethyl-4,5,6,7-tetrahydro-4,7-methano-
2-indazolyl] ferrocene (209) . . . . . . . . . . . . . . . . . . . . . . . . . . 122
4.5.15 Synthesis of 2,6-bis(N -pyrazolyl)pyridine (220) . . . . . . . . . . . . . . . 123
4.5.16 Synthesis of 2,6-bis[(4S,7R)-7,8,8-trimethyl-4,5,6,7-tetrahydro-4,7-metha-
no-2-indazolyl]pyridine (221) . . . . . . . . . . . . . . . . . . . . . . . . . 123
Bibliography 125
5 Appendix 137
5.1 Acknowledgement . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 137
5.2 Curriculum Vitae . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 141
List of Tables
1.1 Screening of different metal complexes for diastereoselective ortho-silylation of
ferrocenyl oxazoline 74 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
1.2 Screening of different silanes for diastereoselective ortho-silylation of ferrocenyl
oxazoline 74 by using Ru(H)2(CO)(PPh3)3 as catalyst. . . . . . . . . . . . . . . . 24
1.3 Optimization of solvent and hydrogen scavenger for diastereoselective ortho-silylation
of ferrocenyl oxazoline 74 by using Ru(H)2(CO)(PPh3)3 as catalyst. . . . . . . . 25
1.4 Catalytic diastereoselective ortho-silylation of ferrocenyl oxazolines 77 . . . . . . 26
2.1 Synthesis of organosilanes 152 via ortho-lithiation and subsequent quenching with
chloro silanes. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50
2.2 Synthesis of organosilanol 153 via oxidation of Si–H bond with Ir catalyst. . . . 51
2.3 Asymmetric phenyl transfer reaction to substituted benzaldehydes 154 using
organosilanol-based catalysts and various zinc reagents. . . . . . . . . . . . . . . 52
3.1 Products of the coupling of iodoferocene (193) and 1-1’-diiodoferrocene (196)
with coupling components. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67
3.2 Complexation study of bispyrazol 208 and 209 with various copper salts in dif-
ferent solvents. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 73
xiv
List of Figures
1.1 Ibuprofen . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
1.2 Products formed using various directing groups to effect Ru-catalyzed ortho-
silylation. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
1.3 Ferrocenyl oxazoline 153 having silanol moeity. . . . . . . . . . . . . . . . . . . . 22
1.4 Different ferrocene derivatives having different directing groups which have been
tested under Murai’s conditions for ortho-silylation with Et3SiH. . . . . . . . . . 27
1.5 C–H activation on ferrocenes. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
2.1 Some silanols having anti-muscarinic activity. . . . . . . . . . . . . . . . . . . . . 33
2.2 Hydrated form of Almquist’s ketone. . . . . . . . . . . . . . . . . . . . . . . . . . 34
2.3 Silicon analogs of Almquist’s ketone as ACE inhibitors. . . . . . . . . . . . . . . 34
2.4 The structure of haloperidal and sila-haloperidal. . . . . . . . . . . . . . . . . . . 35
2.5 The structure of rac-venlafaxine and rac-sila-venlafaxine. . . . . . . . . . . . . . 35
2.6 The structure of α-terpineol and its sila-derivative. . . . . . . . . . . . . . . . . . 36
2.7 The structure of rac-linalool and its sila-derivative. . . . . . . . . . . . . . . . . . 36
2.8 Carbinol 150 which is used as ligand in asymmetric aryl transfer reactions and
its silanol analog 153. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
2.9 Prolinol 170 and sila-prolinol 171. . . . . . . . . . . . . . . . . . . . . . . . . . . 58
3.1 Potential ligands having P,O--, P,N--, and N,N-- coordinations which could be
synthesized from chiral pyrazole 197. . . . . . . . . . . . . . . . . . . . . . . . . . 71
3.2 Structure of imidazole 201 and triazole 202. . . . . . . . . . . . . . . . . . . . . 75
3.3 ortho-Lithiated chiral pyrazole 95 . . . . . . . . . . . . . . . . . . . . . . . . . . 76
xv
List of Schemes
1.1 Pioneer studies in C–H activation . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
1.2 Zr-catalyzed functionalization of α-picoline (6) via C–H activation. . . . . . . . . 5
1.3 Ru-catalyzed acylation of pyridine with CO and 1-hexene . . . . . . . . . . . . . 5
1.4 Murai’s Ru-catalyzed ortho-functionalization of an aromatic ketone via C–H ac-
tivation with different olefins. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
1.5 Ru-catalyzed activation of olefinic C–H bonds with olefin 13. . . . . . . . . . . . 6
1.6 Rh-catalyzed asymmetric intramolecular C–H activation with chiral phosphine
ligand. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
1.7 Murai’s proposed mechanism for Ru-catalyzed C–H activation. . . . . . . . . . . 8
1.8 Two plausible mechanism for the reductive elimination step of the proposed cat-
alytic cycle. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
1.9 Ru-catalyzed silylation of the ortho C–H bond of phenyl oxazoline 23. . . . . . . 9
1.10 Silylation of a benzylic C–H bond of arylpryidine 29 via Ru-catalyzed C–H acti-
vation. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
1.11 Catalytic carbonylation of phenyl ring using a pyridine moiety as a directing group. 11
1.12 Ru-catalyzed carbonylation of an aromatic ring using an oxazoline as a directing
group. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
1.13 Carbonylation of an sp3-hybridized C–H bond adjacent to a nitrogen atom in
alkylamines catalyzed by a rhodium complex. . . . . . . . . . . . . . . . . . . . . 12
1.14 Rh-catalyzed intramolecular C–H activation of benzimidazole derivative 37. . . . 12
1.15 Rh-catalyzed C–H activation of aromatic rings using an imine as a directing group. 13
1.16 Application of Rh-catalyzed C–H activation method in the synthesis of mescaline
derivative 43. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
1.17 Rh-catalyzed intermolecular alkene insertion to the C–H bond of benzimidazole
(44). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
xvi
xvii
1.18 First catalytic dehydrogenation of alkanes with rhenium as catalyst. . . . . . . . 14
1.19 Dehydrogenation of alkanes with H2. . . . . . . . . . . . . . . . . . . . . . . . . . 15
1.20 First stoichiometric alkane borylation mediated by a rhenium complex. . . . . . . 16
1.21 Rh-catalyzed borylation of octane without photo-irradition. . . . . . . . . . . . . 16
1.22 Ir-catalyzed borylation of 1,3-dibromobenzene (56) without photo-irradition. . . 17
1.23 Mn-catalyzed C–H amination of alkanes 58 with in situ prepared nitrenes from
PhI(OAc)2 and amines 59 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
1.24 Rh-catalyzed intramolecular amination of C–H bond of carbamates 61. . . . . . 18
1.25 Rh-catalyzed intramolecular amination of C–H bond of sulfamates 63. . . . . . . 19
1.26 Total synthesis of manzaicidin A via C–H insertion as a key step. . . . . . . . . . 19
1.27 Ru-catalyzed intramolecular asymmetric C–H amidation of sulfamate 67. . . . . 20
1.28 Sanford’s Pd-catalyzed oxidation of sp3 hydridized C–H bonds. . . . . . . . . . . 20
1.29 Sanford’s Pd-catalyzed oxidation of sp3 hydridized C–H bonds with different di-
recting groups. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
1.30 Yu’s Pd-catalyzed diastereoselective iodination of sp3 hydridized C–H bond. . . . 21
1.31 Catalytic diastereoselective ortho-silylation of ferrocenyl oxazoline 74 under Mu-
rai’s conditions. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
1.32 Catalytic diastereoselective ortho-silylation of ferrocenyl oxazolines 77. . . . . . . 25
1.33 Catalytic diastereoselective ortho-silylation of ferrocenyl oxazolines 77. . . . . . . 26
1.34 Unsuccesful attempt to synthesize chlorosilane 82 via C–H activation. . . . . . . 27
1.35 Ru-catalyzed ortho-silylation of ferrocenyl alcohol 91 via C–H activation. . . . . 28
1.36 Ru-catalyzed ortho-silylation of ferrocenyl pyrazole 93 via C–H activation. . . . 28
1.37 Ru-catalyzed ortho-silylation of ferrocenyl chiral pyrazole 95 via C–H activation. 28
1.38 Ru-catalyzed C–H activation of paracyclophanyl oxazoline 97 via C–H activation. 29
1.39 Ru-catalyzed double silylation of cyrhetrenes oxazoline 99 via C–H activation. . 29
2.1 Oxidation of trisubstituted silanes 108 to corresponding silanols 109 with ozone. 37
2.2 Oxidation of trisubstituted silanes to corresponding silanols with dioxiranes 116. 38
2.3 Oxidation of trisubstituted silanes to corresponding silanols with peroxybenzoic
acid. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
2.4 Ultrasound-assisted oxidation of triphenylsilane (119) triphenylsilanol (120) with
KMnO4. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
2.5 MTO-catalyzed oxidation of silane 121 to silanol 122 with UHP at room tem-
perature. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
xviii
2.6 Ru-catalyzed oxidation of phenyldimethylsilane (111) to phenyldimethylsilanol
(114) under mild conditions. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40
2.7 Ir-catalyzed oxidation of triethylsilane to triethylsilanol under mild conditions. . 40
2.8 Synthesis of Fc3SiOH by the hydrolysis of Fc3SiCl. . . . . . . . . . . . . . . . . . 42
2.9 Synthesis of silanols via the ring opening of siloxanes with organolithium reagents. 43
2.10 The hydrolysis of Si–Ph bond to synthesize silanediol 128. . . . . . . . . . . . . . 43
2.11 Pd-catalyzed Mizoroki-Heck type reaction of silanol 129 with PhI. . . . . . . . . 44
2.12 Pd-catalyzed cross coupling of alkenyl silanol 131 with PhI. . . . . . . . . . . . . 44
2.13 Fluoride free cross-coupling of alkenyl silanol 131 with PhI in the presence of base. 45
2.14 Rh-catalyzed Mizoroki-Heck type reaction and/or conjugate addition of silanols
133 with carbonyl substrate 134 and 137. . . . . . . . . . . . . . . . . . . . . . 45
2.15 The synthesis of tri-substituted isoxazole 143 via cross-coupling of silanol 142. . 46
2.16 The utilization of silanol 145 as a directing group in aromatic metalation. . . . . 47
2.17 Silanediol 149 as an anion receptor. . . . . . . . . . . . . . . . . . . . . . . . . . 47
2.18 Failed reaction of dimethyldichlorosilane in the synthesis of chlorosilan 151. . . . 49
2.19 Synthesis of organosilanes 152 via ortho-lithiation and subsequent quenching with
electrophiles. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50
2.20 Synthesis of organosilanols 153 via oxidation of Si–H bond with Ir catalyst. . . . 51
2.21 Asymmetric phenyl transfer reaction to substituted benzaldehydes 154 using
organosilanol-based catalysts and various zinc reagents. . . . . . . . . . . . . . . 52
2.22 Utilization of silanol 156 in the synthesis of 1,3-disubstituted ferrocenes. . . . . . 53
2.23 Synthesis of silanol 156 from ferrocenyl tin 157. . . . . . . . . . . . . . . . . . . 53
2.24 Unexpected result after ortho-lithiation of silanol 156. . . . . . . . . . . . . . . . 54
2.25 Unsuccesful attempt through the synthesis of disilanol 160 with an Ir-catalyst. . 54
2.26 Unsuccesful attempt through the synthesis of disilanol 160 with a Ru-catalyst. . 55
2.27 One-pot synthesis of disilanol 160. . . . . . . . . . . . . . . . . . . . . . . . . . . 55
2.28 Synthesis of disilanol 161. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56
2.29 Hydrogen bond catalyzed Hetero-Diels-Alder reaction of Rawal and Yamamoto. . 56
2.30 The possible mechanism of hydrogen bond activation of aldehydes. . . . . . . . . 57
2.31 Disilanol 160 catalyzed hetero-Diels-Alder reaction. . . . . . . . . . . . . . . . . 57
2.32 (–)-Spartein assisted asymmetric functionalization of N -Boc-pyrrolidine with TM-
SCl. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58
xix
2.33 (–)-Spartein assisted asymmetric functionalization of N -Boc-pyrrolidine with di-
phenylchlorosilane. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 59
2.34 Asymmetric phenyl transfer reaction to substituted benzaldehydes 154 using
organosilanol-based catalysts and various zinc reagents. . . . . . . . . . . . . . . 59
2.35 Outlook and future plan for the synthesis of sila-prolinol 171. . . . . . . . . . . . 60
3.1 Nesmeyanov’s two-step synthesis of ferrocenyl amine (177) by copper mediated
sodium azide coupling and subsequent reduction with LiAlH4. . . . . . . . . . . . 62
3.2 Cu(I)-mediated condensation of bromoferrocene with phthalimide by Sato . . . . 62
3.3 Herberhold’s method of the synthesis of ferrocenyl amine (177). . . . . . . . . . 63
3.4 Hessen’s synthesis of ferrocenyl amine (177) via the reaction of lithiated ferrocene
with azidostyrene. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 63
3.5 Richard’s synthesis of ferrocenyl amine (177) via Curtius rearrangement. . . . . 64
3.6 Nesmeyanov’s two-step synthesis of 1,1’-diamino ferrocene(187) via copper me-
diated sodium azide coupling and subsequent reduction with LiAlH4. . . . . . . . 64
3.7 CuI-mediated phenylation of sulfoximine 191 by Bolm. . . . . . . . . . . . . . . . 65
3.8 Cu-catalyzed synthesis of ferrocenyl aryl ether 195 by Plenio. . . . . . . . . . . . 66
3.9 General synthesis of N -substituted ferrocenes . . . . . . . . . . . . . . . . . . . . 66
3.10 Bildstein’s synthesis of N,N ’-diferrocenyl-N -heterocyclic carbene precursor 210
starting from iodoferrocene (193). . . . . . . . . . . . . . . . . . . . . . . . . . . 69
3.11 Copper-mediated coupling of iodooxazoline 211 with sulfoximine 191 or pyrazole
or imidazole. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 69
3.12 The first step in the synthesis of chiral pyrazole 197. . . . . . . . . . . . . . . . . 70
3.13 The second step in the synthesis of chiral pyrazole 197. . . . . . . . . . . . . . . 70
3.14 Lithiation of pyrazole with tert-BuLi in THF at 0 ◦C. . . . . . . . . . . . . . . . 72
3.15 Lithiation of chiral pyrazole 197 with different BuLi species in THF or Et2O at
0 ◦C. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 72
3.16 The first synthesis of bpp by double substitution reaction. . . . . . . . . . . . . . 73
3.17 Copper-mediated synthesis of bpp under milder conditions. . . . . . . . . . . . . 74
3.18 Copper-mediated synthesis of bpp under milder conditions. . . . . . . . . . . . . 74
3.19 General synthesis of N -substituted ferrocenes . . . . . . . . . . . . . . . . . . . . 75
xx
Chapter 1
Introduction
Since the first milestone in organic chemistry was established by Woehler [1] in 1828 with
the synthesis of urea from various cyanates and ammonium salts, there has been an explosive
proliferation of synthetic methods by which to make organic molecules that indicates their
importance and application in today’s world. This is perhaps best reflected in the fact that over
the last 30 years, there has been an exponential increase in the number of compounds which is
registered by the Chemical Abstract Service (CAS). Whereas in 1965, there was a total of only
212.000 compounds registered, by 1996, there were 15.8 million compounds listed. Currently,
new compounds are registered by CAS at a rate of around 1 million per year or, in other words,
at a rate of approximately 2 compounds per minute. [2] The unprecedented rate of discovery of
new compounds is a consequence of new synthetic approaches to novel organic molecules being
continually sought and developed.
In the pharmaceutical industry, there is a siginificant demand for one particular group of com-
pounds, namely chiral organic molecules, and the development of more efficient synthetic meth-
ods by which to produce them. Although chiral organic molecules have long been known, the
pharmaceutical implications of racemic drugs have, however, only been extensively recognized in
the last 20 years, [3,4] since each enantiomer of a drug may have similar or different pharmacoki-
netic responses. [5,6] For example, it has been known for many years that opiate [7] enantiomers
can interact with different receptors, leading to different effects in the metabolism. [8] Indeed,
the (–)-enantiomers of opiates are potent narcotic analgesics, whereas their (+)-enantiomers
are useful anti-tussive agent. Beside the fact that two enantiomers may have different phar-
macological properties, some enantiomers have equipotent properties (e.g. flecainide [9]) or one
enantiomer may possess all or most of the activity (e.g. β-blockers [10]). In the latter case, there
1
2are some advantages to using the single enantiomer, since this exposes the patient to a lower
body load and thus minimizes unwanted drug interactions. Pharmacodynamic side and drug
co-administration effects can also be easily assessed if a single enantiomer is used and, likewise,
enantiomer-enantiomer drug interactions and bio-inversion can be avoided. Such awareness of
the influence of the chirality upon biological activity has led to an increase in the use of single
enantiomers in the drug market. [11] As a result of this trend, in 1994, eight of the top ten chiral
drugs were marketed as single enantiomers [12] and according to a 2005 ranking by IMS Health
based on US Sales, six of the ten top selling prescription drugs are sold in the form of single
enantiomers.1
To overcome the increased demand for chiral molecules and/or single enantiomers, intensive
research is being carried out in both the academic and industrial realms. Meanwhile, recent
developments like the advent of green chemistry and high raw material prices increasingly de-
mand atom economy. The concept of atom economy was first enunciated by Trost [14, 15] at
the beginning of 1990s and describes the efficiency of a chemical process in terms of all of the
atoms involved. In a 100% atom economic reaction the amount of all starting materials and/or
reagents equals the amount of the desired products formed: that is, no atom is wasted. One of
the nicest examples to illustrate the importance of atom economy in industry is the production
of ibuprofen.
COOH
CH3
H3C
CH3
1
Figure 1.1: Ibuprofen
Ibuprofen (1) is the active ingredient of one of the world’s top selling drugs commercialized
as an analgesics under varios brand names (i.e. Act-3, Advil, Brufen, Motrin, Nuprin, Nurofen),
but which is also effective as a non steroidal anti-inflammatory drug (Figure 1.1). The current
world production of ibuprofen (1) exceeds 15 million kilograms per year. The first synthesis
of ibuprofen (1), patented by Alliance Boots,2 and which has been used for the preparation
for many years, had an atom economy of 40% over 6 steps. After this patent expired, other
1For e review about the importance of chirality in drugs, see: [13]
2U.S. Patent 3,385,886 Boots Pure Drug Co. Ltd. May 28, 1968.
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companies started to produce ibuprofen and a three-step synthesis with an atom economy of
77% was developed. Considering the annual, global production of ibuprofen, this increase in
atom economy is very dramatic and an industrial success.
The Diels-Alder, hydrogenation, cycloaddition and C–H activation reactions are several ex-
amples of transformation having high atom economy. Click chemistry which is a novel con-
cept [16] introduced by Sharpless, also, by the virtue of its definition requires high atom econ-
omy. Condensation reactions, in which small molecules like water, hydrogen or CO2 are formed,
also rank considerably high in terms of atom economy. In contrast, however, conventional sub-
stitution reactions exhibit poor atom economy, not only due to their tendency to generate large
amounts of waste (e.g. in the form of salts from leaving group), but also because additional
steps are often required to synthesize substrates bearing an appropriate leaving group. As a
result, the direct activation of (normally unreactive) C–H bonds has found increasing favour
as an alternative to conventional substitution reactions because it dispenses with the need of
pre-functionalization and has a high atom economy.
1.1 C–H Activation Reactions
1.1.1 Stoichiometric C–H Activation Reactions
The development of methods for the functionalization of C–H bonds is currently one of
the most attractive research subjects in the fields of organic and organometallic chemistry.
[17] C–H activation reaction include the cleavage of a carbon-hydrogen bond and subsequent
functionalization of carbon atom with useful chemical groups. A variety of metal complexes,
consisting of a metal (M) and its associated ligands, are capable to react with a C–H bond
via metal insertion to give an intermediate that has C–M bond which can undergo reductive
elimination of metal to afford functionalized product.
Although bond dissociation energy of C–H is usually quite large, e.g. 105 kcal/mol for H–
CH3, and 110 kcal/mol for H–C6H5, [18] transition metal complexes are able to break unactivated
C–H bonds. Pioneering research in C–H activation was initiated in 1963 by Kleiman and Dubeck,
[19] who reported that the Cp2Ni complex can cleave the ortho-C–H bond of azobenzene 2,
thereby forming an ortho-nickelated complex 3 (Scheme 1.1).
4N
N + Cp2Ni
Ni
N
N
RuMe2P
PMe2
Me2P
PMe2
RuMe2P
PMe2
Me2P
PMe2
2 3
4 5
Scheme 1.1: Pioneer studies in C–H activation
Two years later, Chatt and Davidson reported [20] that the first oxidative addition of naph-
thalene to Ru(0) afforded complex 4, which is in equilibrium with the pi-coordinated napthalene
ruthenium complex 5 (Scheme 1.1).
Subsequent to these pioneering studies, many other groups [21] have also extensively studied
C–H activation reactions but almost all of them involved C–H cleavage by the stoichiometric
amounts of transition metal complexes. [22] [23] The development of a catalytic version has
progressed only very slow and, in many cases the use of an excess of one of the reactants and/or
photo-irradiation is required to attain a reasonable catalyst turnover.
1.1.2 Pioneer Studies on Catalytic C–H Activation Reactions
Notable developments of catalytic C–H activation reactions were made as recently as the
late 1980s. In 1989, Jordan reported [24] a Zr-catalyzed coupling of propene and α-picoline (6)
which involves sequential aryl C–H activation to afford 6-Me,2-i -Pr-pyridine (7). The reaction
proceeds under 1 atm of H2, at 150
◦C and conversion of α-picoline (6) to compound 7 was
complete after 25 h. Although it is very selective and efficient, a drawback of this reaction is
that hydrogenation of propene and the formation of unreactive Zr-pyridine species occur as side
reactions (Scheme 1.2).
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N
+
H2 1 atm
CH2Cl2, 23 °C, 25 h
N
N
Cp2Zr
4 mol%
1.5 atm
6 7
Scheme 1.2: Zr-catalyzed functionalization of α-picoline (6) via C–H activation.
In 1992, Moore published, the catalytic acylation of pyridine using CO and an olefin, em-
ploying Ru3(CO)12 as the catalyst. [25] This process requires harsh reaction conditions over a
long reaction time (16 h) including high temperature (150 ◦C), and high pressure of CO (150
psi). Without CO, the acylation product cannot be observed using either thermal (180 ◦C) or
photochemical initiation. The regioselectivities of the reactions are relatively high, but mod-
erate conversions and turnover frequencies are obtained. In a typical reaction, pyridine (8) is
employed as solvent and the reaction is conducted at 150 ◦C under 150 psi of carbon monoxide,
and 1-hexene is converted to pyridyl ketone 9 with a yield of 65% after 16 h (Scheme 1.3).
N
+  CO  + n-Bu
Ru3(CO)12
(1.5 mol%)
150 °C, 16 h N O
n-Bu
65%8 9
Scheme 1.3: Ru-catalyzed acylation of pyridine with CO and 1-hexene
1.1.3 Murai’s Catalytic C–H Activation
Murai has intensively contributed on C–H activation reactions after his breakthrough study
[26] which was a very efficient and selective ortho-substitution of an aromatic ketone 10 with
olefins via C–H activation in the presence of a ruthenium catalyst, forming new C–C bond
to afford product 11 (Scheme 1.4).3 The high regioselectivity of this process is considered to
be a result of the ketone functionality acting as directing group towards ortho-C–H activation
through its ability to coordinate the ruthenium catalyst and bring the metal centre into close
proximity to the ortho-C–H bond. In subsequent reports of Murai, many other functional groups,
3For a review about the contributions of Murai and Kakiuchi on C–H activation, see: [27]
6such as esters, [28] aldehydes, [29] aldimines, [30] amidinates, [31] hydrazones, [32] nitriles, [33]
oxazolines, [34] amines, [35] pyrazoles [35] and pyridines [35] were used as directing groups.4
O
CH3
CH3
+
toluene, 135 °C
Y
Y = H, t-Bu, o-tol, SiMe2(OEt), CH2SiMe3
93 − 100%
Ru(H)2(CO)(PPh3)3 (4 mol%)
O
CH3
CH3
Y
10 11
Scheme 1.4: Murai’s Ru-catalyzed ortho-functionalization of an aromatic ketone via C–H
activation with different olefins.
In addition to aromatic C–H bonds, olefinic C–H bonds can also be activated towards C–C
bond formation with the aid of an appropriate catalysts. A useful example is that of the reaction
between the olefinic ketone 12 and 15, and the vinyl silane 13 which, under ruthenium-catalyzed
conditions, afforded the substituted cyclohexene 14 and 16, respectively. [37] Interestingly, the
more bulky ketone 15 reacted much faster and product 16 was obtained in almost quantitative
yield, compared with its less sterically-hindered counterpart (Scheme 1.5). 5,6
O
R
+ Si(OEt)3
Ru(H)2(CO)(PPh3)3 (12 mol%) 
toluene, 135 °C
O
R
Si(OEt)3
: R = CH3
: R = t-Bu
48 h
0.5 h
50%
96%
: R = CH3
: R = t-Bu
12
13
14
15 16
Scheme 1.5: Ru-catalyzed activation of olefinic C–H bonds with olefin 13.
The intramolecular addition of vinylic C–H bonds to olefins was reported by Murai [40] to give
5-membered carbocycles when catalyzed by ruthenium or rhodium complexes. An asymmetric
version of this reaction has been also performed by the same group, [41] in which a mono-dentate
chiral ferrocenyl phophine ligand and a rhodium complex were employed as a catalyst. In the
4Woodgate has utilized the ruthenium catalyzed reaction of aromatic ketones with olefin for the synthesis of
natural products. [36]
5Trost has also reported very similar results with esters (instead of ketones) by using the same catalytic
system. [38]
6Alkylation of 2-iso-propenylpyridine with 1-hexene via Rh catalyzed olefinic C–H activation has been done
by Kim [39]
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reaction of imidazolyl diene 17, at 50 ◦C, the product 18 is obtained in 75% yield with 82% ee
(Scheme 1.6).
N
N
Fe
OMe
PPh2
[RhCl(cyclooctene)2]2 (5 mol%)/ L*
THF, 50 °C
20 h
L* =
N
N
*
75% yield
82% ee
17 18
Scheme 1.6: Rh-catalyzed asymmetric intramolecular C–H activation with chiral phosphine
ligand.
Mechanistic studies of Murai’s olefin insertion to C–H bond
Preliminary studies into the mechanism of ruthenium catalyzed olefin insertion to C–H bond
have been performed by Murai [42, 43] and several other groups [44, 45]. According to these
results, the most reactive pre-catalyst was Ru(H)2(CO)(PPh3)3, whereas Ru(CO)2(PPh3)3,
Ru(H)2(PPh3)4, Ru(CO)3(PPh3)2 were modestly effective with decreasing activity in this order,
and Ru3(CO)12 was not active. This suggests that neither H nor CO is the necessary ligand and
according to NMR studies, [43] it is believed that the when pre-catalyst Ru(H)2(CO)(PPh3)3 is
used, hydrogenation of olefin occurs to give a zerovalent ruthenium species such as Ru(CO)(PPh3)3
which is thought to be the active catalyst.
Since the C–H bond energy is quite high, it is easy to speculate that the rate-determining
step involves C–H cleavage but deuterium labeling experiments shows that this assumption is
not correct. When a non-reactive deuterated substrate (methyl benzoate) was treated under
Murai’s conditions (shown in Scheme 1.4), as expected, no conversion was observed as shown
by GC study. However, 1H NMR experiment showed that complete H/D scrambling of the two
ortho and three olefinic protons occured. This studies proves the existence of a pre-equilibrium
process prior to the reductive elimination step which indicates that the C–H bond cleavage
step is quite facial and that the reductive elimination step of the catalytic cycle is, in fact, the
rate-determining step. [46]
8RuLn OMe
O
H RuLn
OMe
O
RuLn-1
H
OMe
O
RuLn-2H
Y
OMe
O
RuLn-1H
Y
OMe
O
RuLn-1
Y
OMe
O
H
L
L
Y
OMe
O
Y
L
L = PPh3 or CO
Y = Si(OEt)3
L
Scheme 1.7: Murai’s proposed mechanism for Ru-catalyzed C–H activation.
Based on these preliminary experimental studies, Murai proposed the reaction mechanism
shown in Scheme 1.7.
Murai also claimed that although the reductive elimination of ruthenium and the C-C bond
formation steps, shown in Scheme 1.7, can occur in a sequential fashion (route I), it is also
possible that they may also occur via a not yet fully-understood mechanism in which both
processes occur simultaneously (route II), as described in Scheme 1.8. [43].
EWG [Ru]
MeO O
EWG [Ru]
MeO O
EWG
MeO O
Y
[Ru]
EWG [Ru]
MeO O
Y
Y
Y
σ−σ
σ−pi
Y = Si(OEt)3
route I
route II
EWG = electron withdrawing
             group
19
20
21
22
Scheme 1.8: Two plausible mechanism for the reductive elimination step of the proposed
catalytic cycle.
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According to the results that suggest that reductive elimination step to be the rate-determi-
ning step, an electron withdrawing group on the aromatic ring would be expected to retard the
rate of the reductive elimination process. However, when aromatic esters that are substituted
with an electron withdrawing group are reacted with an olefin, reductive elimination of inter-
mediate 19 to form intermediate 22 is apparently facilitated [47]. Based on these observations,
Murai proposed that a migration mechanism for the reductive elimination is favored compared
to the usual σ-σ coupling mechanism through the formation of intermediate 20. In the case
of σ-pi, the shift of the alkyl group from ruthenium to the aromatic ring generates a negative
charge which is stabilized by the electron withdrawing group (intermediate 21, Scheme 1.8).
This mechanism is consistent with the observation which suggest that meta-oriented electron
withdrawing groups accelerate the reaction better than the ortho- or para-ones.
Murai’s Catalytic Insertion of Silicon to into the C–H Bond
Murai has also reported [34] ruthenium catalyzed dehydrogenative silylation of aromatic C–
H bonds with triethylsilane, using an olefin (tert-butylethylene or norbornene) which acts as a
hydrogen scavenger and effects the reaction in a catalytic manner. The oxazoline moiety acts
as an ortho-directing group to exclusively furnish the ortho-product in high yields when using
excess amounts of silane and olefin. For example, silylation of oxazoline 23 affords product 24
in 93% yield after reflux in toluene for 20 h (Scheme 1.9). Beside the excessive amounts of
reagent needed to effect the reaction, another limitation of this reaction is that it requires the
use of triethylsilane because other types of silane such as triethoxysilane, triisopropyl silane,
ethoxydimethyl silane or tert-butyldimethylsilane, fail to react sufficiently under the reaction
conditions.
N
O
HSiEt3 t-Bu+ +
N
O
SiEt3
Ru3(CO)12 (6 mol%)
toluene, reflux, 20 h
93%23 24
Scheme 1.9: Ru-catalyzed silylation of the ortho C–H bond of phenyl oxazoline 23.
The use of different directing groups other than oxazoline also furnishes the corresponding
ortho-silylated arenes 25–28 in good to excellent yields (Figure 1.2). [35]
10
N
H
SiEt3 98%
N
SiEt3
100%
NMe2
SiEt3
58% 77%
N
SiEt3
25 26 27 28
Figure 1.2: Products formed using various directing groups to effect Ru-catalyzed ortho-
silylation.
Recently, Kakiuchi has extended this method to the activation of sp3-hybridized C–H bond.
[48] Concretely, the silylation of benzylic C–H bonds of arylpyridines can be successfully per-
formed by employing Ru3(CO)12 as catalyst and norbornene as hydrogen scavenger. This reac-
tion is selective for ortho-CH3 groups rather than ortho-CH2 groups. For example, the primary
carbon at the benzylic position in the arylpyridine 29 is selectively silylated and affords the
product 30 in 53% yield after reflux in toluene for 20 h (Scheme 1.10).
N
Ru3(CO)12 (6mol%)
norbornene
toluene, reflux, 20 h.
+  Et3SiH N
SiEt3
53%29 30
Scheme 1.10: Silylation of a benzylic C–H bond of arylpryidine 29 via Ru-catalyzed C–H
activation.
Murai’s carbonylation at a C–H Bond on aromatic ring
Murai has also reported the first effective ruthenium catalyzed carbonylation at a C–H bond
in a benzene ring, [49] effected in a similar fashion to the olefin insertion to C–H bond, in that a
directing group located at an appropriate position on the aromatic ring was employed to ensure
that catalytic cleavage of the ortho-oriented C–H bond was performed with high regioselectivity
and efficiency. For instance, the reaction of 3-methly-2-phenyl-pyridine (31) with ethylene and
CO proceeds at 160 ◦C, to give aromatic ketone 32 in high yield (94%) (Figure 1.11). Simple
aromatic rings such as benzene, pyridine or anisole did not serve as suitable substrates towards
carbonylation. Instead, the presence of an effective directing group such as pyridine or imine
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moieties, were found to be required for the C–H functionalization to occur.
N
N
O
Ru3(CO)12 (2.5 mol%)
H2C=CH2, CO
toluene
20 atm, 160 °C, 20 h
94%31 32
Scheme 1.11: Catalytic carbonylation of phenyl ring using a pyridine moiety as a directing
group.
Unfortunately, however, the imine moiety is not stable under these carbonylation condi-
tions and whereas the pyridine moiety does so, it is not so easy to remove after the desired
functionalization has been performed. Furthermore, neither of these directing groups are easily
transformed into other functionalities and, as such, these moieties have been superseded by the
much more versatile oxazoline directing group.
Oxazolines can be easily synthesized from carboxylic acids, [50,51] aldehydes [52] or cyanides
[53,54] via different well-established methods. Furthermore, and more importantly, they can be
readily transformed into other functional groups such as carboxylic acids and esters [55] or
aldehydes, [56] and also give better reactivity and site selectivity towards carbonylation of the
ortho-C–H bond in aromatic rings. [57] Other five-membered N-heteroaromatic compounds, such
as pyrazoles, oxazoles, and thiazoles, can also be used for the carbonylation reaction, giving the
same selectivity. For example, Ru-catalyzed carbonylation of aryl oxazoline 33 with ethylene
and carbonmonoxide proceeds at 160 ◦C in toluene affording the desired aromatic ketone 34 in
98% yield after 20 h (Scheme 1.12).
O
Ru3(CO)12 (2.5 mol%)
H2C=CH2, CO
toluene
20 atm, 160 °C, 20 h
98%
N
O
N
O
33 34
Scheme 1.12: Ru-catalyzed carbonylation of an aromatic ring using an oxazoline as a directing
group.
Murai reported that [58] carbonylation of an sp3 hybridized C–H bond adjacent to a nitrogen
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atom can be attained by means of pyridine or phenyl ketone moieties as a directing groups. In
the following example, [RhCl(cod)]2 is the choice of catalyst complex and iso-propanol is used
as solvent. It is a three-component reaction with substrate 35, CO and ethylene. The reaction
is quite selective but long reaction time and high temperature are necessary to obtain ketone 36
in high yield (Scheme 1.13).
N
N
N
N
O
[RhCl(CO)2]2 (4 mol%)
CO, H2C=CH2
i-PrOH, 160 °C, 60 h.
70%35 36
Scheme 1.13: Carbonylation of an sp3-hybridized C–H bond adjacent to a nitrogen atom in
alkylamines catalyzed by a rhodium complex.
1.1.4 Catalytic Olefin Insertion into the C–H Bond
In 2001, Bergman and Ellman reported an intramolecular C–H activation of a range of sub-
strates including mono-, di- and trisubstituted alkenes catalyzed by rhodium to form various
five- and six-membered heterocycles. [59] For instance, intramolecular reaction of benzimidazole
derivative 37 in the presence of rhodium catalyst proceeds at 160 ◦C in tetrahydrofuran to give
cyclized benzimidazole derivative 38 in 79% yield after 20 h (Scheme 1.14).
[RhCl(coe)2]2 (5 mol%)
PCy3 (7.5 mol%)
160 °C, THF, 20 h
79%
N
N
N
N
37 38
Scheme 1.14: Rh-catalyzed intramolecular C–H activation of benzimidazole derivative 37.
A microwave-assisted version of this method was published some years later by Bergman
and Ellman, [60] in which reactions of relatively short duration (15–20 min) were performed to
obtain products in similar yield compared to conventional heating procedures.
Bergman and Ellman also developed a method using Wilkinson’s catalyst for the cyclization
of olefins tethered to aromatic imines 39 in which the latter act as directing groups. [61,62] This
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is a novel method for the synthesis of indane, tetralene, dihydrobenzofuran and dihydroindole
derivatives 40-41 which may be varied by the use of different tether lengths, by incorporation
of heteroatoms into the tether and by use of alkenes with various substitution patterns (Scheme
1.15). 7
X
BnN R1
R2
R3
n
O R1
X
O R1
X
R3
R2
R3R2
n
n
1. (PPh3)3RhCl (5 mol%)
    125 or 150 °C, Toluene
2. 1 mol/L HCl (aq.) or
50 − 85%
X = CH2, O, NR
n = 0,1
R1 = R2 = H, Me;
R3 = H, Me, Ph, CO2Me
39 40 41
Scheme 1.15: Rh-catalyzed C–H activation of aromatic rings using an imine as a directing
group.
These authors also applied this method to the synthesis of a mescaline analog. [64] Starting
from a suitable vinyl ether 42, tricyclic mescaline analog 43 could be obtained through few steps
in which C–H activation reaction was the key step (Scheme 1.16).8
MeO
OMe
OMe
NH2
OMe
NH2 .HCl
OO
mescaline
OMe
N
OO
Bn
42 43
Scheme 1.16: Application of Rh-catalyzed C–H activation method in the synthesis of mescaline
derivative 43.
7In 2003, Bergman and Ellman reported the same reaction in an enantioselective manner by using chiral
phosphoramidite ligands. [63]
8Recently, Sames has showed [65,66] a similar intramolecular cyclization via metal catalyzed C–H bond cleav-
age. In the presence of PtCl4 as catalyst, aromatic propargyl ethers can be inserted to aromatic C–H bond,
forming 6-endo products. Propargyl amines and alkynoate esters can also undergo cyclization reaction in the
same fashion. Various substituents on aromatic ring are generally tolerable and heteroaromatic derivatives can
also be used.
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An intermolecular version of this reaction appeared one year later as the first report on
an intermolecular coupling of alkenes with aromatic heterocycles. [67] Additives such as 2,6-
lutidinium chloride play a significant role in increasing the yield of this reaction. As shown
in Scheme 1.17, benzimidazole (44) and tert-butyl ethylene can react to give the benzimidazol
derivative 45 via C–H activation catalyzed by Rh in the presence of 2,6-lutidinium chloride.
N
H
N
+
5 eq.
[RhCl(coe)2]2 (5 mol%)
PCy3 (7.5 mol%)
2,6-lutidinium chloride
(5 mol %)
150 °C, THF
N
H
N
96%44 45
Scheme 1.17: Rh-catalyzed intermolecular alkene insertion to the C–H bond of benzimidazole
(44).
In addition to imidazoles, insertion of olefinolefins into the C–H bond of various oxazolines is
also possible using a rhodium catalyst. [68] In a similar manner, arylation of other heterocycles
can be attained by using iodobenzene derivatives. [69] 9
1.1.5 Catalytic Dehydrogenation of Alkanes
Converting a saturated carbon chain into an olefin is a highly valuable reaction since a wide
variety of functional groups can be achieved by transformations of C–C double bonds. In 1979,
Crabtree demonstrated that it was possible to dehydrogenate alkanes using a stoichiometric
amount of an iridium phosphine complex. [71] Later, in 1983, Baudry and Ephritikhine reported
[72] the first catalytic tranformation of cyclooctane (46) into cyclooctene (47) with the aid
of rhenium catalyst in the presence of tert-butylethylene as hydrogen scavenger under thermal
conditions with a turnover numbers (TON) of 9 (Scheme 1.18).
+ t-Bu + t-Bu
((p-F-C6H4)3P)2ReH7
80 °C, 10 min
9 TONTON = Turnover number
46 47
Scheme 1.18: First catalytic dehydrogenation of alkanes with rhenium as catalyst.
9Recently, mechanistic studies including a survey of functional group compatibility on both alkene and hete-
rocycles have been reported. [70]
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Following these pioneering studies, numerous catalyst systems for the dehydrogenation of
alkanes have been examined and reported by many other research groups.10 Of these, Goldman
has developed [76] a unique and more efficient catalyst system that paradoxically, utilizes a high
pressure of hydrogen for dehydrogenation. Under 1000 psi of hydrogen at 100 ◦C for 15 min., the
rhodium complex RhCl(CO)(PMe3)2 generates cyclooctene (47) from cyclooctane (46) with a
TON of 950 by using norbornene (48) as hydrogen scavenger to form norbornane (49) (Scheme
1.19).
+ +
H2 (1000 psi)
RhCl(CO)(PMe3)2
100 °C, 10 min
950 TON
48 4946 47
Scheme 1.19: Dehydrogenation of alkanes with H2.
According to the proposed mechanism by Goldman, CO is reductively eliminated from the
rhodium complex and H2 is oxidatively added to the metal to form the catalytically active
species RhCl(PMe3)2H2. Subsequently, H2 is transfered to the hydrogen-scavenger olefin, such
that the active metal center can remove H2 from the alkane and again become ready to repeat
the catalytic cycle.
In 1990, Saito found [77] that instead of using a hydrogen scavenger, high temperature
reflux condition was sufficient for continuous removal of hydrogen using Wilkinson catalyst.
The disadvantages of this method are that long reaction times (24 h) are required and that
occurs in low turnover numbers (14 TON). 11
1.1.6 Catalytic Borylation of C–H Bonds
Organoborons are highly versatile compounds in organic synthesis, because they can be easily
converted to other functional groups. By way of example, organoboranes have found particular
application as powerful reagents in the Suzuki-Miyaura cross-coupling with organohalides. [80]
There are many methods by which to make organoboranes but particular interest has recently
been focused on the use of C–H activation reactions for the direct borylation of arenes and
alkanes using transition metal complexes. In 1995, Hartwig described [81] the first example of
10For some representative examples, see: [73–75]
11This simple dehydrogenation system has been improved by Crabtree [78] and some others [79].
16
this transformation using a stoichiometric amount of a cyrhetrenes complex under irradiative
conditions to give an aryl borane compound in high yield and selectivity. Following this method,
for example, using photo-irradiation and CO atmosphere, reaction of n-pentane (50) with B2pin2
(51) regioselectively affords n-pentyl borane 52 (Scheme 1.20).
O
B
O
B
O
O
B O
OCp*Re(CO)3
hν, CO
25 °C, 56 h
95%
+
50 51 52
Scheme 1.20: First stoichiometric alkane borylation mediated by a rhenium complex.
Several years later, Hartwig reported [82] alkane borylation using a vanadium complex and,
more recently, developed [83] the first catalytic version of a borylation using rhodium complex
to achieve C–H activation in high yield and regioselectivity. A remarkable improvement to this
reaction was achieved in 2000, again by Hartwig. [84] Alkane borylation could be effected using
a rhodium complex as a catalyst without the necessity of photo-irradiation or a CO atmophere.
For example, the reaction of n-octane (53) with pinacol borane 54 proceeds at 150 ◦C, to
regioselectively afford n-octyl borane 55 in good yield (Scheme 1.21).
H B
O
O
B O
OCp*Rh(C6Me6)
150 °C, 14 h
+
65%
53 54 55
Scheme 1.21: Rh-catalyzed borylation of octane without photo-irradition.
Furthermore, borylation of aromatic compound is also possible under these conditions.
Although, however, the borylation of mono-substituted benzenes faces some regioselective is-
sue, [85] 1,3-disubstituted benzenes shows nice regioselectivity at the 5-position and very high
yields. Five- and six-membered heteroaromatic compounds are also applicable to the borylation
reaction. [85, 86] For instance, neat 1,3-dibromo benzene (56) reacts with pinacolborane 54, at
100 ◦C, to regioselectively afford boryl arene 57 in high yield (Figure 1.22).
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Br
Br
+ H B
O
O (Ind)Ir(COD) (2 mol%)
neat, 100 °C, 17 h
Br
Br B
O
O
92%
56 5754
Scheme 1.22: Ir-catalyzed borylation of 1,3-dibromobenzene (56) without photo-irradition.
Very recently, Smith reported the Ir-catalyzed borylation of 2-substituted indoles at the
7-position in good yields. [87]
1.1.7 Catalytic Insertion of Nitrogen into the C–H Bond
Research into the catalytic insertion of nitrogen into C–H bonds was pioneered by Breslow
who reported the amination of a saturated C–H bond with a pre-formed nitrene source, namely,
PhI=NR, formed from PhI(OAc)2 and the corresponding primary amine 59, in the presence of
iron or manganese porphyrins. [88] Although several contributions followed this initial work, the
first real breakthrough came upon appearance of a paper by Che, [89] describing the amination
of saturated C–H bonds catalyzed by electron-deficient ruthenium and manganese porphyrins
using a nitrogen source, that is prepared in situ from sulfonamides and iodosobenzene diacetate.
The in situ formation of nitrenes is a significant improvement, even allowing the direct amination
of, for example, indane with trifluoroacetamide, to occur. Typical substrates for amination are
ethyl benzene, indane, adamantane, THF and cyclohexene, and can be effected using a number
of amines such as tosyl and mesyl amine for in situ nitrene formation to afford amine products
60 (Scheme 1.23).
C H + PhI(OAc)2 + H2N-R C NHR
[Mn(TPFPP)Cl] (1 mol%)
CH2Cl2, 40 °C, 2 h
R = Ts, Ns, SO2Me 72 − 92%
58 59 60
Scheme 1.23: Mn-catalyzed C–H amination of alkanes 58 with in situ prepared nitrenes from
PhI(OAc)2 and amines 59
In 2001, Du Bois reported [90] a further notable advance in this area. He prepared a variety
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of oxazolidinones 62 from simple carbamates 61 via regioselective, intramolecular rhodium cat-
alyzed C–H insertion mediated with PhI(OAc)2 and a base. The latter is a necessary additive
for this transformation in order to scavenge the acetic acid generated during the nitrene forma-
tion. The products obtained are precursors of 1,2-amino alcohols. Significantly, when nitrogen
is inserted in the C–H bond of a chiral, enantippure substrate, only one enantiomer is formed,
demonstrating that the reaction is stereospecific and occurs via a concerted insertion process
(Scheme 1.24).
R
O NH2
O
OHN
O
R
Rh-catalyst (5 mol%)
PhI(OAc)2, MgO
CH2Cl2, 40 °C
OHN
O
H3C CH3
[Rh2(tpa)4]
O
H
N O
[Rh2(tpa)4]
O
O
H
N OOHN
O
Ph
O
HN
O
[Rh2(tpa)4] [Rh2(tpa)4]
74%
[Rh2(OAc)4]
83% 77% 79% 84%
61 62
Scheme 1.24: Rh-catalyzed intramolecular amination of C–H bond of carbamates 61.
Du Bois also showed [91] sulfamate esters to be applicable in the same reaction. The main
advantage conferred upon the reaction with the use of sulfamate esters is preferential formation
of six-membered heterocycles. As a result, by converting the same simple alcohols into either
the carbamate or the sulfamate products using the appropriate protocol, it is possible to get
either the 1,2- or 1,3-amino alcohols, respectively (Scheme 1.25).12
12Cyclic sulfamate esters posessing an N,O-acetal moeity exhibit properties consistent with an iminium ion
equivalent and, as such, a suitable nucleophile can be added to these molecules for further functionalization.
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Scheme 1.25: Rh-catalyzed intramolecular amination of C–H bond of sulfamates 63.
Given the facility by which a variety of 1,3-difunctionalized compounds 65 (not just amino
alcohols) can be synthesized using this two-step process (of C–H insertion and opening of the
sulfamate ester 63 with a nucleophile), Du Bois has utilized [92] this method in the total synthesis
of manzacidin A and β-amino acids. [93] Starting from an enantiopure alcohol, a 1,3-amino
alcohol moiety 66 was obtained via formation of the sulfamate ester through C–H insertion, and
this was then converted into the natural product manzacidin A (Scheme 1.26).
N
CO2EtMe
O
HN
O
N
H
Br
manzacidin A
O
CO2EtMe
RO
S
HN
R1
O
R2
S
HN
R1
X
R2
CBzHN
X = OH, NR2, SR, N3
O O
O O
63 65
66
Scheme 1.26: Total synthesis of manzaicidin A via C–H insertion as a key step.
Other metals13 such as silver and ruthenium can be also utilized in the intramolecular ami-
nation of C–H bonds.14
13For representative examples, see: [94,95]
14Sames has also contributed on this field, through his discovery of a chelate-directed, intramolecular amination
of C–H bonds catalyzed by platinium. [96]
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Furthermore, the enantioselective version of catalytic C–H amination was first reported by
Mu¨llet [97], as preliminary results, in which a chiral Rh-complex was utilized as catalyst, and
an aminoindane derivative was obtained in 71% yield with 31% ee. Moreover, Che has con-
tributed [98] on this topic expanding the scope of the reaction and increasing the enantiomeric
excesses up to 86% with intramolecular amidation of sulfamate esters. For example, Ru-catalyzed
enantioselective intramolecular C–H amidation of sulfamate ester 67, by means of chiral por-
phyrin ligand, furnished the cyclic sulfamate 68 in moderate yield and good enantiomeric excess
(Scheme 1.27).
O
SH2N
O
O
O
S
H
N
O
O[Ru(por*)(CO)] (10 mol%)
PhI(OAc)2, Al2O3, benzene
80 °C, 2 h
53%
82% eepor* = chiral porphyrin
67 68
Scheme 1.27: Ru-catalyzed intramolecular asymmetric C–H amidation of sulfamate 67.
1.1.8 Catalytic Insertion of Oxygen into the C–H Bond
Recently, Sanford has reported [99] the Pd-catalyzed oxidation of otherwise unreactive sp3
hybridized C–H bonds of oxime or pyridine substrates. However, this process is normally re-
stricted to the directing group effect of the oxime and pyridine moieties results in high regio-
and chemoselectivity for activation of β-C–H bonds, since more highly substituted substrates
which don’t have a β-CH3 group don’t give C–H activation reaction due to steric reasons.
R1
N
R2R3
MeO 5 mol% Pd(OAc)2
1:1 HOAc:Ac2O
100 °C
R1
N
R2R3
MeO Pd
Ac
O
2
PhI(OAc)2
R1
N
R2R3
MeO OAc
N
MeO
74%
NMeO
78%
OAc OAc
NMeO
No reaction
N
OMe
OAc
81%
69 70 71
Scheme 1.28: Sanford’s Pd-catalyzed oxidation of sp3 hydridized C–H bonds.
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The product 71 obtained from oxime substrates 69, through a palladacycle intermediate 70,
is mostly isolated as a mixture of E/Z isomers. Another drawback of this transformation is the
requirement of stoichiometric amount of PhI(OAc)2 as oxidant.
More recently Sanford has shown that a similar method involving the use of various directing
groups including pyridine, pyrazole and azobenzene moieties is applicable to insert oxygen into
the unactivated C–H bonds of aromatic rings (Figure 1.29). [100]
N
OAc
N
NOAc
N
OAc
88% 54% 62%
N
Ph OAc
47%
H
N
Ph
Scheme 1.29: Sanford’s Pd-catalyzed oxidation of sp3 hydridized C–H bonds with different
directing groups.
Pd-catalyzed, chelate-directed acetoxylation of meta-substituted arene substrates exhibits
high regioselectivity for functionalization at the less-substituted ortho-position. Unlike directed
orto-lithiation and Ru-catalyzed C–H activation reactions, substituents such as OMe, OMOM
and F do not exhibit secondary directing effects. [101]
As an extension of this research, Sanford has also reported insertion of halogen atoms into
C–H bonds using the same metal system. Using N -halosuccinamides as halogen sources in ace-
tonitrile, it is possible to halogenate aromatic C–H bonds with the help of pyridine or oxime
moieties as directing groups. More recently, Yu [102, 103] has utilized oxazolines as directing
groups for the halogenation of sp3-hybridized C–H bonds with iodine, using palladium as a cat-
alyst in the presence of PhI(OAc)2. For example, Pd-catalyzed diastereoselective iodination of
oxazolines 72 furnished iodooxazoline 73 in poor to excellent yields with high diastereoselectiv-
ities, depending on R substitutent (Scheme 1.30).
R N
O
MeMe
R N
O
MeI
Pd(OAc)2 (10 mol%)
PhI(OAc)2, I2
CH2Cl2, r.t.
32 − 98%
dr = 91:9 to 99:1R = H, Me, Ph, OTBS
72 73
Scheme 1.30: Yu’s Pd-catalyzed diastereoselective iodination of sp3 hydridized C–H bond.
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1.2 Objectives of the Research
As highlighted in the introduction part, functionalization of otherwise unreactive C–H bonds
with metal catalysts is currently one of the most attractive research topics in the fields of organic
and organometallic chemistry. Although the catalytic C–H activation of different aromatic
compounds is well-established in literature, to the best of our knowledge, there is no report on
catalytic and diastereoselective C–H tranformation of ferrocenes. Since, as it will be described
in Chapter 2, we are particularly interested in ferrocenyl oxazolines 153 having silanol moeity
(Figure 1.3), we aimed to synhtesize such compounds via C–H activation reaction, which is
analog to Murai’s Ru-catalyzed ortho-silylation of aryl oxazolines (see: Scheme 1.9).
O
N
R'Fe Si OH
R R
153
Figure 1.3: Ferrocenyl oxazoline 153 having silanol moeity.
Furthermore, application of catalytic C–H activation on other ferrocene derivatives and some
other planar-chiral compounds such as paracyclophanes and cyrhetrenes were also examined.
1.3 Results and Discussions
1,2-Disubstituted ferrocenes are very useful and versatile compounds due to their potential
to serve as chiral ligands in asymmetric metal catalysis. [104,105] They are commonly prepared
by ortho-lithiation of mono-substituted ferrocenes bearing directing groups such as amines [106]
or oxazolines [107] and subsequent substitution.
In this context, ferrocenyloxazoline derived from tert-leucine has been shown [107] to be
valuable precursor for the asymmetric synthesis of 1,2-disubstituted ferrocenes. Meanwhile due
to the particular interest on ferrocenyl oxazolines, as it will be described in Chapter 2, oxazoline
74 was choosen as model substrate in our study.
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1.3.1 Diastereoselective C–H Activation of Ferrocenyl Oxazolines
Preliminary investigation was done with model substrate 74 under Murai’s conditions (see
Scheme 1.31) which have already been well established for the ortho-silylation of aryl oxazolines
(Scheme 1.31). Expected product 75 was obtained in 15% yield with 79:21 diastereomeric ratio.
O
N
Fe
O
N
Fe
 Ru3(CO)12 (5 mol%)
Et3SiH (5 eq.)
tert-butylethylene 
(5 eq.)
toluene, 135 °C
20 h
SiEt3 +
15% dr = 79 : 21
diastereomer
74 75
Scheme 1.31: Catalytic diastereoselective ortho-silylation of ferrocenyl oxazoline 74 under
Murai’s conditions.
After getting this promising result, different Ru-complexes, with 10 mol% catalyst loading,
have been screened for optimization (Table 1.1).
Table 1.1: Screening of different metal complexes for diastereoselective ortho-silylation of ferro-
cenyl oxazoline 74
Entry Complex Yield (%) Diastereomeric ratio of silane 75
1 Ru3(CO)12 15 79:21
2 Ru(H)2(CO)(PPh3)3 36 90:10
3 RuCl2(CO)(PPh3)3 33 90:10
4 [RuCl2(CO)3]2 16 70:30
5 RuCl2(PPh3)4 – –
6 [RuCl2(η
6-benzene)]2 – –
7 RhCl(PPh3)3 – –
8 [RuCl2(CO)3]2 + PPh3 – –
9 [RuCl2(CO)3]2 + dppe – –
10 Ru(H2)(H)2(PCy3)2 – –
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As it can be seen in Table 1.1, Ru(H)2(CO)(PPh3)3 and RuCl2(CO)(PPh3)3 were found to
be the best catalysts showing same diastereoselectivity and similar efficiency (entry 2 and 3).
It can be concluded that PPh3 and CO are necessary ligands on the pre-catalyst. However, in
situ preparation of the pre-catalyst which possess phosphine ligands failed in giving the desired
product (entry 8 and 9).
Based on the poster presentation of Jenet,15 application of [RuCl2(η
6-benzene)]2, sodium
formate and PPh3 as a pre-catalyst mixture which increased the rate of the Murai’s reaction on
aryl substrates dramatically, did not afford the desired product 75.16
In order to extend the scope of the reaction, various types of silanes and siloxanes have been
screened by using Ru(H)2(CO)(PPh3)3 as catalyst. The results are shown in Table 1.2
Table 1.2: Screening of different silanes for diastereoselective ortho-silylation of ferrocenyl oxa-
zoline 74 by using Ru(H)2(CO)(PPh3)3 as catalyst.
Entry Silanes Source Yield (%) Diastereomeric ratio of silane 75
1 Et3SiH 33 90:10
2 Et2MeSiH 25 87:13
3 Me2SiH-O-SiHMe2 – –
4 CH2 = CH-Si(OEt)3 – –
5 CH2 = CH-Si(Me)3 – –
6 CH2 = CH-CH2Si(Me)3 – –
7 PhSiH3 – –
8 PhMe2SiH – –
9 Et2SiH2 – –
10 (EtO)2MeSiH – –
11 (EtO)Me2SiH – –
As a result of this study, it could be concluded that trialkyl silanes were necessary to succeed
and alkoxy or alkoxy-alkyl silanes do not react at all.
Based on the work by Oi [108] (see Scheme 1.32), Ru-catalyzed ortho-phenylation of oxazoline
15The third Lilly European Distinguished Lectureship, November 24, 2005.
16Triethoxyvinylsilane was also tested under these conditions, but gave no product.
1.3. Results and Discussions 25
74 was also tested. Unfortunately, treatment of oxazoline 74 with bromobenzene in the presence
of 2.5 mol% of [RuCl2(η
6-benzene)]2, 10 mol% of PPh3 and 2 equivalent of K2CO3 in NMP at
120 ◦C did not afford the desired product 76 (Scheme 1.32).
O
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N
Fe
PhBr
[RuCl2(η6−benzene)]2
(2.5 mol%)
PPh3 (10 mol%)
K2CO3
(2 eq.)
NMP, 120 °C
20 h
74 76
Scheme 1.32: Catalytic diastereoselective ortho-silylation of ferrocenyl oxazolines 77.
Additional optimization were performed in regard to the solvent and hydrogen scavenger
(Table 1.3). In agreement with Murai’s results, [34] norbornene and tert-butylethylene showed
very similar activity but norbornene gave lower diastereoselectivity (entry 2). By using o-xylene
as solvent, the reaction did not proceed at all (entry 3). Performing the reaction in the absence
of solvent gave better yield but slightly lower diastereoselectivity (entry 4). Using 15 mol% of
catalyst resulted in an increase of yield up to 60%, but a slight decrease in diastereomeric ratio
to 88:12.
Table 1.3: Optimization of solvent and hydrogen scavenger for diastereoselective ortho-silylation
of ferrocenyl oxazoline 74 by using Ru(H)2(CO)(PPh3)3 as catalyst.
Entry Solvent H-Scavenger Yield (%) Catalyst dr of silane 75
1 toluene tert-butyl ethylene 10 36 90:10
2 toluene norbornene 10 34 78:22
3 o-xylene tert-butyl ethylene 10 – –
4 – tert-butyl ethylene 10 43 87:13
5 toluene tert-butyl ethylene 15 60 88:12
Varying the substituents on oxazoline group gave following results shown in Scheme 1.33 and
Table 1.4
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Scheme 1.33: Catalytic diastereoselective ortho-silylation of ferrocenyl oxazolines 77.
Table 1.4: Catalytic diastereoselective ortho-silylation of ferrocenyl oxazolines 77
Entry R Compound Yield (%) Diastereomeric ratio
1 i -Pr 79 60 62:38
2 Ph 80 65 60:40
3 CH2Ph 81 72 58:42
As seen in Table 1.4, the substituents on oxazolines have a substantial effect on yield and
diastereomeric ratio. iso-Propyl substituent increased the yield of the reaction but decreased
dramatically diastereomeric ratio. Phenyl and benzyl substituents have positive effect on yields
but negative effect on diastereomeric ratio. As a result, having a less bulky group like benzyl
substituent caused an increment in yield, but a dramatic decrease in diastereomeric ratio.
After establishing this result on ortho-silylation of ferrocenyl oxazoline 77 with triethylsilane,
since alkoxysilanes do not react under these reaction conditions, utilization of chlorosilanes could
be an alternative pathway in order synthesize silanols 153. However, neither dimethylchlorosi-
lane nor diphenylchlorosilane gave the desired chlorosilane products 82 but only starting ma-
terial. This might be due to the instability of chlorosilane moeity in the presence of oxazoline
group which might react internally with Si–Cl bond and breaking the C–Si bond to form the
starting material back. These results which are also consistent with those that will be presented
in Scheme 2.18, appearently show that chlorosilanes 82 are sensitive compounds and not so easy
to synthesize (Scheme 1.34).17
17Quenching the reaction mixture after 20 h with a Grignard reagent such as MeMgBr was also not helpful to
isolate any C–H activated product.
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Scheme 1.34: Unsuccesful attempt to synthesize chlorosilane 82 via C–H activation.
1.3.2 Application of Different Type of Substrates
Applying different directing groups than oxazoline was the subsequent target of the project.
For that purpose a series of different ferrocene derivatives was utilized for the ortho-silylation
reaction under optimized conditions (Figure 1.4).
Fe
NMe2
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Fe
NMe2
CN
Fe
CHO
Fe
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Fe
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CN
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Figure 1.4: Different ferrocene derivatives having different directing groups which have been
tested under Murai’s conditions for ortho-silylation with Et3SiH.
However, none of these ferrocene derivative afforded ortho-silylation product under Murai’s
conditions.
On the other hand, when ferrocenyl alcohol 91 was tested under Murai’s conditions, ortho-
silylated product 92 was obtained in moderate yields (Scheme 1.35).
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Scheme 1.35: Ru-catalyzed ortho-silylation of ferrocenyl alcohol 91 via C–H activation.
N -ferrocenyl pyrazole (93) was treated with triethylsilane and tert-butylethylene in the pres-
ence of ruthenium catalyst in toluene to afford ortho-silylated product in low yield (Scheme 1.36).
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N N
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Et3SiH (5 eq.)
tert-butylethylene 
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35%
93 94
Scheme 1.36: Ru-catalyzed ortho-silylation of ferrocenyl pyrazole 93 via C–H activation.
Chiral derivative of ferrocenyl pyrazole 9518 was also tested under the same conditions and
the desired product 96 was obtained in low yield and moderate diastereomeric ratio (Scheme
1.37).
Fe
N N
Fe
N N
Et3Si
Ru(H)2(CO)(PPh3)3 (10 mol%)
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21%
dr = 73:27
95 96
Scheme 1.37: Ru-catalyzed ortho-silylation of ferrocenyl chiral pyrazole 95 via C–H activation.
Apart from ferrocene, some other backbones have also been tested in the Ru-catalyzed ortho-
18For the synthesis of ferrocenyl pyrazoles 93 and 95, see: Table 3.4.1
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silylation reaction. For example, paracyclophanes are difficult compounds to perform ortho-
lithiation by using strong bases such as n-BuLi or sec-BuLi. Lithiation on the benzylic position
was preferred and it is not so easy to perform ortho-substitution reactions on paracyclophanes.
[109] Therefore paracyclophanyl oxazoline 97 was tested for Ru-catalyzed ortho-silylation via
C–H activation under Murai’s conditions. However, the reaction did not take place and the
desired product 98 has not been obtained.
N
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N
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RuH2(CO)(PPh3)3 (10 mol%)
Et3SiH (5 eq.)
tert-butylethylene 
(5 eq.)
toluene, 135 °C
20 h
SiEt3
97 98
Scheme 1.38: Ru-catalyzed C–H activation of paracyclophanyl oxazoline 97 via C–H activa-
tion.
On the other hand, application of cyrhetrenes in C–H activation reaction as another planar-
chiral substrate backbone gave some unexpected results. Ru-catalyzed ortho-silylation of cyrhet-
renyl oxazoline 99 afforded the double silylated product 100 as single product in high yield.
Surprisingly, even when one equivalent of triethylsilane was used, the double silylated product
100 was isolated beside starting material.
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Scheme 1.39: Ru-catalyzed double silylation of cyrhetrenes oxazoline 99 via C–H activation.
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1.4 Summary and Outlook
In the present thesis, a Ru-catalyzed diastereoselective ortho-silylation of ferrocenyl oxazolines
77 was achieved in poor to good yields and moderate to high diastereomeric ratios. To the best
of our knowledge, this is the first catalytic and diastereoselective C–H activation on ferrocenes.
After screening many other directing groups, only ferrocenyl ethanol 91 and pyrazoles 93 and 95
furnished the desired ortho-silylated product. Crythrenyl oxazoline 99 afforded double silylated
product, probably, due to the electron deficiency on Cp ring which activates the ring towards
C–H activation reactions.
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SiEt3 Fe
Me
OHSiEt3 Fe
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Et3Si Fe
N N
Et3Si
dr = 73:27up to dr = 90:10
78 92 94 96
Figure 1.5: C–H activation on ferrocenes.
Unfortunately, utilization of other silane sources, which could be further functionalized easier
that triethylsilyl group, was not possible. Therefore, the synthesis of silanol 153 could not be
achieved via C–H activation rather than conventional method, that is ortho-lithiation.
Chapter 2
Organosilanols
Silicon is the second most abundant element in the earth’s crust and seventh most plentiful
element in the universe. In nature, silicon exists primarily as silicates, aluminosilicates and silica.
The latter of which is the raw material used for the industrial production of silicon compounds.
Such processes tend to be both difficult and expensive, mostly due to the thermodynamic sta-
bility of the Si–O bonds of silica and because there are only a limited number of methods by
which to replace oxygen with another element such as carbon. Somewhat surprisingly, given
its relationship to carbon on the periodic table, organosilicon compounds are rarely found in
nature. This is perhaps reflected in the fact that organosilicon species cannot be formed directly
from silica, but instead are invariably synthesized from the more reactive halosilanes.
Some of the more commonly synthesized organosilicon compounds are the organosilanols.
The most common ones are simple silanols of the type R3SiOH, which are analog to carbinol,
silanediols and silanetriol of the types R2Si(OH)2 and RSi(OH)3, respectively, are also well
known. The silanol moiety is, in fact, ubiquitous in nature because, the aquatic environment
contains very low level of dissolved silicic acid Si(OH)4 and the many varieties of silica, SiO2, and
silicate rocks have surface hydroxyl groups. However, it was not until 1871 that the first proce-
dure for the preparation of an organosilanol was reported by Ladenburg [110], who synthesized
Et3SiOH, by the hydrolysis of Et3SiCl with aqueous ammonia. Since this seminal discovery,
organosilanols have featured widely in chemical synthesis.
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2.1 Properties of Organosilanols
2.1.1 Acidity and Basicity of Organosilanols
On the high reactivity and acidity of silanols was first commented in 1946 when it was found
that Et3SiOH reacted readily with sodium in xylene and that the silanolate, Me3SiONa, was
formed rapidly when the same silanol was treated with 12 mol/L NaOH solution. Triethylsilyl
acetate was also synthesized from the triethylsilanol and acetic anhydride in good yields. These
observations have been summarized by Sommer [111] as following:
’This surprising behaviour of trimethylsilanol as an acid toward alkali, the activity
of both silanols with sodium, and the formation in good yield of triethylsilyl acetate
from the silanol and acetic anhydride, are evidence that the hydrogen of the hydroxyl
in trialkylsilanols is much more reactive than that in tertiary alcohols.’
Many subsequent studies, mainly using IR, NMR spectroscopy and acid-base titration, have
confirmed the relatively high acidity of silanols compared with carbinols. Surprisingly, silanols
are nearly as basic as the alcohols despite the fact that they are much more acidic. That the
silanols are of an amphoteric nature has been rationalized by invoking ppi-dpi bonding between
Si and O, which allows the negative charge of an R3SiO
− ion to be delocalized, thus giving an
enhanced acidity, whilst the lone pairs of electrons on the oxygen atom, afford silanols their
basic properties. In view of the high acidity and the relatively high basicity of silanols, it is to
be expected that they will form strong hydrogen bonds both with themselves and with other
suitable species.
2.1.2 Biologically Active Silanols
Silanols as Drug Candidate Analogs
The replacement of carbon atoms with silicon is a strategy for extending the chemical diversity
in a known series of organic drugs and for providing potential access to new pharmaceuticals,
particularly as the bond between silicon and an sp2- or sp3-hybridized carbon atom is stable
under most physiological conditions. Tacke has reported many articles concerning this topic and
some examples, concerning the interchange of carbinols (R3COH) with silanols (R3SiOH) that
are taken largely from his research, are presented in the following paragraphs.
A substantial series of muscarinic antagonists, perhaps best-illustrates what can be achieved
by this apparently simple carbon/silicon switch. The structure activity relationships (SARs)
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of muscarinic antagonists with the enzyme active sites have been extensively studied, and it is
clear that the central carbinol moiety common to each of the carbon analogs of the compounds
presented in Figure 2.1 is essential for their activity. Changing the carbinol groups with silanols,
which are more acidic, might enhance the receptor binding. Indeed, most of the silanols shown
in Figure 2.1 demonstrate higher affinities for muscarinic receptors than do their carbon analogs.
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Figure 2.1: Some silanols having anti-muscarinic activity.
Some silanols have also been studied for their in vivo properties, and the results obtained
clearly demonstrate their efficacy. For example, in vivo studies of the peripheral and central
anticholinergic effects of orally administered sila-procyclidine (101) and sila-tricyclamol iodide
(102) upon mice showed that the silicon analog had a greated physiological effect than its
carbon counterpart. In addition to demonstrating greater potency, silaprocyclidine has a longer
duration of action at equivalent dose. [112] However, silanols having chirality on silicon were,
unfortunately, not able to be developed as single enantiomer drug candidates because, unlike
the parent carbon compounds, the analog silanols undergo a relatively rapid racemization under
physiological conditions. However, enantiomers of (hydroxymethyl)silanes have been showen to
demonstrate configurational stability under physiological conditions1.
1For a book about organosilicon chemistry including chirality in bioorganosilicon chemistry, see: ref. [113]
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Figure 2.2: Hydrated form of Almquist’s ketone.
Silanediols are isosteric with the unstable hydrated carbonyl group. Sieburth reported [114]
the first use of silanediols as a transition state analog, which were found to emulate the hydrated
form of Almquist’s ketone. Almquist’s ketone, when in its energetically disfavored hydrate form
103 (Figure 2.2) serves to inhibit ACE (angiotensin converting enzyme) with an IC50 value of
1.0 nM, presumably through chelation of zinc at the active site of this metal metalloproteas
inhibitor. Enzyme assay studies demonstrated that silanediols 104 and 105 are capable of
chelating the zinc ion at the active site of ACE, with IC50 values of 14 and 57 nM, respectively.
Two years later, Sieburth additionally reported [115] that the silanediol derivatives 106 and 107
of Almquist’s ketone also show activity as ACE inhibitors with IC50 values of 3.8 and 19 nM,
respectively. These results show that the silanediols moiety can serve as an effective functional
group with which to mimic the transition state of metalloprotease inhibitors (Figure 2.3).2
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Figure 2.3: Silicon analogs of Almquist’s ketone as ACE inhibitors.
Recently, Tacke reported [117] the synthesis of the silicon analog of the dopamine (D2)
receptor antagonist, haloperidal. In radioligand binding studies, carbon and silicon analogs
2Very recently, Sieburth reviewed [116] his contributions on this topic
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showed similar potencies at recombinant human dopamine hD1, hD4 and hD5 receptors, whereas
the silicon analog, sila-haloperidal, was found to be 4.7-fold more potent at hD2 receptors than
the corresponding carbon analog (Figure 2.4).
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Si NHO (CH2)3
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haloperidal sila-haloperidal
Cl Cl
Figure 2.4: The structure of haloperidal and sila-haloperidal.
Very recently, Tacke published [118] another example in which a silicon analog of a bio-
logically active carbinol rac-venlafaxine, was synthesized in order to compare its pharmaco-
logical efficacy with that of its carbon counterpart (Figure 2.5). rac-Venlafaxine is a sero-
tonin/noradrenaline reuptake inhibitor which was found clinical use as antidepressant. Its sil-
icon analog rac-sila-venlafaxine, was produced in multistep synthesis, and tested as racemic
and enantiomerically pure form of its hydrochloride salts for their efficacy in serotonin, nora-
drenaline and dopamine reuptake inhibition assays (Figure 2.5). These pharmacological studies
of the enantiomerically pure compounds showed that while activity of the noradrenaline and
dopamine transporters is essentially unaffected by sila-substitution, the potency at serotonin
transporters is reduced by two orders of magnitude. Similar activities were observed against
different transporters, when the racemates of venlafaxine and sila-venlafaxine were tested.
C
NMe2
HO Si
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rac-venlafaxine rac-sila-venlafaxine
Figure 2.5: The structure of rac-venlafaxine and rac-sila-venlafaxine.
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Silanols as Perfumes
α-Terpineol is a component of many ethereal oils with the fragrance of lilac. Wannagat
reported [119] the synthesis of sila-derivative of α-terpineol and found that the intensity of the
fragrance of sila-α-terpineol is comparable with the natural product. (Figure 2.6).
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Me Me Si
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Me
Me
α−terpineol sila−α−terpineol
Figure 2.6: The structure of α-terpineol and its sila-derivative.
Linalool is a widespread natural product with a muguet-like fragrance, and (S )-(+)-enan-
tiomer of which a sex pheremone acting upon males of the vernal solitary bee species Colletes
cunicularius. Tacke also synthesized [120] the sila-derivative of rac-linalool and demonstrated
that there is no big difference between the activity of the natural pheromone and its sila-analog
(Figure 2.7).3
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Figure 2.7: The structure of rac-linalool and its sila-derivative.
2.2 General Synthesis of Organosilanols
Silanols are generally sensitive to acid, base and heat because they may undergo dimerization
to form siloxanes via self-condensation. This point should be considered when planning the
synthesis and isolation of a silanol. The use of dilute solutions for the synthesis might be helpful
to prevent the dimerization. In the reaction mixture for the synthesis of silanols, formation
of an acid or base should be avoided, otherwise precautions, such as in situ neutralization by
adding a weak acid or base, must be taken. The reactions should not be carried out at high
temperatures. Bulky substituents on silicon reduce the tendency of dimerization due to the
3In the analysis of activity, antennae of males of the bee species C. cunicularius were used as detectors.
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steric factors. However, these substituents also cause the lower reactivity of the silicon atom
towards hydrolysis or oxidation and may require harsh conditions to be reacted.
2.2.1 Synthesis of Silanols From Si–H Compounds
Organosilanes containing small substituents and several Si–H bonds such as RSiH3 (R = Me,
Et, n-Bu) species are very reactive towards oxygen. They may spontaneously ignite in air, in
the presence of a metal or under pressure. On the other hand, organosilanes possessing bulkier
substituents or fewer Si–H bonds are more stable and may be distilled in air.
Compounds containing Si–H bonds can be rapidly oxidized by ozone at low temperatures
to afford the corresponding silanols (and oxygen) in good yields. Ozonolysis of the sterically
hindered silane t-Bu3SiH gave t-Bu3SiOH as the only detectable product. As shown in Scheme
2.1, many other trisubstituted organosilanes 108 having the phenyl or ethoxy groups can also
be readily converted to silanols 109 easily.4
R3Si H O3+
CH2Cl2
< 0 °C
R3Si OH O2+
R3 = t-Bu3, Et3, (c-C6H11)3, PhMe2, Ph3, (EtO)3
108 109
Scheme 2.1: Oxidation of trisubstituted silanes 108 to corresponding silanols 109 with ozone.
Interestingly, oxidation of triethylsilane with ozone afforded singlet dioxygen in addition
to the triethylsilanol, presumably via formation of the intermediate triethylsilyl hydrotrioxide,
Et3SiOOOH. This reaction has been investigated by Corey [122] since it seemed that oxidation of
triethylsilane with ozone could be exploited as a chemical source of singlet oxygen at sufficiently
low temperatures as to allow the synthesis of endoperoxides.
Another method for the oxidation of the Si–H bond employs highly reactive dioxiranes. This
method has the advantages of relatively short reaction times and high yields whilst additionally
producing fewer producing less by-products, and has found greatest application in synthesis
where low temperatures and the absence of acids or bases are required for the formation of
otherwise sensitive compounds. Adam reported [123] a very efficient oxidation of silanes to
silanols with dioxirane at low temperatures, in which, for example, dioxirane 116a reacts with
Et3SiH (110) and PhMe2SiH (111) in less than one minute at between −20
◦C and 0 ◦C, to
4For a mechanistic study on this topic, see: ref. [121]
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afford the correspondins silanols 113 and 114 in almost quantitative yields. The optically active
silane (+)(α-naphthyl)PhMeSiH ((+)-112) may be transformed with a high degree of retention
to the corresponding silanol (+)-115 (Scheme 2.2), and as a result, a concerted spiro-type
transition structure has been proposed for this Si–H bond oxidation.
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Scheme 2.2: Oxidation of trisubstituted silanes to corresponding silanols with dioxiranes 116.
In 1967, Nagai reported [124] a novel method for the oxidation of silanes to silanols with per-
oxybenzoic acid to afford corresponding silanols. By way of example, Et3SiH (110), PhMe2SiH
(111) and Ph2MeSiH (117) each react with peroxybenzoic acid in benzene to afford the corre-
sponding silanols 113, 114 and 118 in 70, 60 and 58% yields, respectively (Scheme 2.3). This
kind of oxidation has been shown to proceed with retention of configuration at silicon. [125]
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Scheme 2.3: Oxidation of trisubstituted silanes to corresponding silanols with peroxybenzoic
acid.
Oxidation of Si–H bonds may also be carried out by use of the strong oxidizing agent,
KMnO4. Lickiss reported [126] that the use of ultrasound in experiments employing KMnO4
for the oxidation of silanes increased the solubility of the oxidant in organic solvents, thereby
improving the yield and decreasing the reaction time, particularly for the oxidation of sterically
hindered Si–H bonds. For instance, conventional stirring of Ph3SiH (119) with KMnO4 in THF
furnished the corresponding silanol 120 in 88% yield after 22 h, whereas utilization of ultrasound
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for only one hour gave the same product in up to 92% yield (Scheme 2.4). it should be noted,
however, that when the steric hindrance is too great, as, for example, in (Me3Si)3CPh3SiH, no
reaction occurs.
Ph3SiH Ph3SiOH
KMnO4
ultrasound
THF, r.t., 1 h
92%119 120
Scheme 2.4: Ultrasound-assisted oxidation of triphenylsilane (119) triphenylsilanol (120) with
KMnO4.
Although, regarded as relatively expensive, silver salts such as AgNO3 and Ag2O can also
be used in stoichiometric amounts for the otherwise clean and generally high yielding oxidation
of silane. [127]
In recent years, research into the oxidation of silanes to silanols has increasingly focused
on metal catalyzed processes, such that many new methods have been developed. One of the
earliest examples of metal catalyzed silane oxidation to be reported was developed by Adam
who discovered that the methyltrioxoruthenium (MTO) effects the oxidation of silanes in high
conversions and excellent selectivities in favor of the silanols without the formation of disiloxane
by-products) when the urea/hydrogen peroxide adduct (UHP) is used as oxygen source instead
of aqueous H2O2. It is proposed that the urea acts as a host, forming channels, inside which the
MTO-catalyzed Si–H oxidation reaction takes place. [128] Under these heterogeneous conditions,
the catalyst is not inly stabilized but the self-condensation of silanols is also prevented for steric
reasons, meaning that a bulky silane such as t-BuMe2SiH (122) can be converted into the
corresponding silanol 122 at room temperature in very high yield after 18 h (Scheme 2.5). This
type of oxidation proceeds with retention of stereochemistry at silicon.
Si H
t-Bu
Me
Me Si OH
t-Bu
Me
Me
1 mol % MTO, UHP
CH2Cl2, 20 °C, 18 h
98%
121 122
Scheme 2.5: MTO-catalyzed oxidation of silane 121 to silanol 122 with UHP at room tem-
perature.
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In 2000, Chang reported [129] a further notable advance in this area through his discovery
of a practical, highly selective hydrolytic and catalytic oxidation method that is applicable to a
wide variety of silane substrates. With a low catalyst loading (2 mol%) of [RuCl2(p-cymen)]2,
in the presence of two equivalents of water at room temperature under air, phenyldimethylsilane
(111) can be oxidized to phenyldimethylsilanol (114) in 95% yield after only 10 minutes at room
temperature (Scheme 2.6). Although the exact role of oxygen is not known at this stage, the
reaction rates were moderately increased under an oxygen atmosphere especially in cases of slow-
reacting substrates. Without water, less than 5% conversion was observed under these reaction
conditions. The oxidation of an optically active silane proceeds with inversion of configuration
at silicon.
Si H
Ph
Me
Me Si OH
Ph
Me
Me
2 mol% [RuCl2(p-cymen)]2
CH3CN, r.t., 10 min
95%
111 114
Scheme 2.6: Ru-catalyzed oxidation of phenyldimethylsilane (111) to phenyldimethylsilanol
(114) under mild conditions.
Very recently, Chang has improved his procedure with a catalyst system of [IrCl(C8H12)]2 un-
der essentially-neutral and mild conditions, and a wide variety of silanols have been synthesized
in good to excellent yields. [130] For example, when a solution of triethylsilane in acetonitrile is
treated at room temperature with 2 equivalents of water and 1 mol% [IrCl(C8H12)]2, triethylsi-
lanol is produced in 80% yield after 1 h (Scheme 2.7).
Et3SiH
1 mol% [IrCl(C8H12)]2
CH3CN, r.t., 1 h
80%
Et3SiOH
Scheme 2.7: Ir-catalyzed oxidation of triethylsilane to triethylsilanol under mild conditions.
Although the mechanism of the oxidation of silanes to silanols in the presence of [IrCl(C8H12)]2/H2O
or [RuCl2(p-cymen)]2/H2O system is not definitely declared by the author but it is assumed that
the Ir or Ru metals activate the Si–H bond to give a silylmetal hydride intermediate because
peaks at –8.51 ppm and at –10.00 ppm were observed in separate 1H-NMR spectroscopy ex-
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periments upon mixing the triethylsilane with stoichiometric amounts of [IrCl(C8H12)]2 and
[RuCl2(p-cymen)]2 (in CD3CN), respectively. The oxidation of an optically active silane pro-
ceeds with racemization at the silicon centre.
2.2.2 Synthesis of Silanols by the Hydrolysis of Halosilane
Si–X bonds are generally labile and sensitive to hydrolysis. Therefore, one of the easy and
common way to obtain silanols is the hydrolysis of Si–X bond under various conditions depending
on the substrate.
Synthesis of silanols by the hydrolysis of Si–F bond
The hydrolysis of fluorosilanes is not a commonly used method for the synthesis of silanols.
It requires alkaline conditions; thus, i -Pr3SiF and i -Pr2SiF2 may react with aqueous ethanolic
sodium or potassium hydroxide solutions to afford the corresponding silanols i -Pr3SiOH and i -
Pr2Si(OH)2 in 65 and 50% yields, respectively. [131] Although not a hydrolysis reaction, a similar
protocol has been used for the formation of sterically hindered silanols in which for example,
t-Bu2SiMeF reacted with KOH in refluxing hexane to give t-Bu2MeSiOH in 78% yield. [132]
Synthesis of silanols by the hydrolysis of Si–Cl bond
In contrast, chlorosilanes are perhaps, one of the most commonly employed substrates for the
synthesis of silanols due to their ready availability and susceptibility towards hydrolysis, however,
some precautions should be taken to prevent the dimerization of silanols in aqueous media by
the addition of inorganic or organic bases to the reaction mixture in order to neutralize any
hydrochloric acid formed. This procedure is nicely illustrated for the hydrolysis of Et2SiCl2 with
aqueous NaOH, which produces Et2Si(OH)2 in good yields (65%). [133] Chlorosilanes with bulky
substituents like ferrocene can also be hydrolyzed in this manner, such that, for example, when a
solution of triferrocenylchlorosilane (123) in diethylether was reacted with H2O in the presence
of Et3N at 40
◦C, triferrocenylsilanol (124) was afforded in 80% yield (Scheme 2.8). [134]
42
Et3N, H2O
Et2O, 40 °C, 30 min
Si
Cl
80%
Fe Fe
Fe
Si
HO
Fe Fe
Fe
123 124
Scheme 2.8: Synthesis of Fc3SiOH by the hydrolysis of Fc3SiCl.
Synthesis of silanols by the hydrolysis of Si–Br and Si–I bonds
The hydrolysis of bromosilanes is rarely used for the synthesis of silanols, but such substrates
may be hydrolyzed in similar ways to chlorosilanes. For example, the hydrolysis of i -Pr2SiBr2
with aqueous ammonia gives i -Pr2Si(OH)2 in 90% yield. [135]
Although, the hyrolysis of iodosilanes is generally relatively fast, the presence of bulky groups
on silicon atom may hamper silanol formation, such that, lengthy reaction times are sometimes
necessary to attain hydrolysis. For instance, (Me3Si)3SiPh2I requires 60 days under reflux in
H2O/MeCN (1:19) to be hydrolyzed. [136, 137] whereas, the less sterically hindered dimethyl
derivative, (Me3Si)3SiMe2I, has a half-life of 19 minutes in H2O/DMF (1:49) at 60
◦C. The
hydrolysis of (Me3Si)3SiHFI with H2O/acetone (1:1) affords (Me3Si)3SiHFOH in 2 h at room
temperature in 88% yield, and demonstrates the relative ease of hydrolysis of Si–I compared
with both Si–H and Si–F bonds.
2.2.3 Synthesis of Silanols via the Cleavage of Si–O Bond
The hydrolysis of alkoxysilanes provides an alternative approach to synthesis of silanols that
allows for the formation of products (such as those containing non-bulky functional groups)
which would otherwise be susceptible to dimerization. For example, shaking of Me2Si(OEt)2
with H2O at 25
◦C for 48 h affords crystalline Me2Si(OH)2, which is very sensitive towards both
acids and bases and may undergo condensation to give dimethyl disiloxane. [138]
An analogous approach to the formation of silanols from alkoxy silanes is illustrated by the
cleavage of the Si–O bond of cyclic siloxanes, e.g.(R2SiO)3, with organolithium reagents. For
example, the reaction of MeLi and (Ph2SiO)3 (125) in hexane at room temperature afford a
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93% yield of Ph2MeSiOH (114) upon acidic work-up, while t-BuLi and (Me2SiO)3 (126) in
diethylether at between 0 ◦C and room temperature furnish t-BuMe2SiOH (122) in 98% yield
(Scheme 2.9). [139]
(R2SiO)3
1. R'Li 
2. H+ (aq)
: R = Ph, R' = Me   
: R = Me, R' = t-Bu
93 − 98%
R'R2SiOH
: R = Ph, R' = Me   
: R = Me, R' = t-Bu
125
126
114
122
Scheme 2.9: Synthesis of silanols via the ring opening of siloxanes with organolithium reagents.
2.2.4 Synthesis of Silanols by the Hydrolysis of Si–N Bond
Silanols have also, on occasion, been prepared by the hydrolysis of silanes that posses Si–N
bond. For example, trimethylsilanol was obtained in 73% yield by the hydrolysis of Me3SiNHAc
in ice-cold water after 30 min. [140] It would appear that aminosilanes are more susceptible
to hydrolysis that are alkoxysilanes, since Miner found that it is possible to remove the NH2
groups, but not the tert-alkoxy groups of (t-BuO)2Si(NH2)2 and afford white needle-like crystals
of (t-BuO)2Si(OH)2 in 56% yield after shaking in ice water over 5 min. [141]
2.2.5 Synthesis of Silanols by the Cleavage of Si–Ph Bond
The cleavage of Si–Ph bond can also be used to generate silanols. As shown in Scheme 2.10,
Sieburth reported [114] that the hydrolysis reaction of diphenylsilane 127 to silanediol 128
were performed using triflic acid at 0 ◦C for 10 min, followed by addition of aqueous ammonia
solution.
SiBzHN NHBn
O
Ph Ph
SiBzHN NHBn
O
HO OH1. TfOH
    CH2Cl2, 0 °C, 10 min
2. NH3(aq)
127 128
Scheme 2.10: The hydrolysis of Si–Ph bond to synthesize silanediol 128.
As represented in this section, silanols can be synthesized by many various methods which
are also a consequence of their varied applications in organic chemistry.
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2.3 Application of Silanols
2.3.1 Cross-coupling Reactions of Silanols
Since silanols are inexpensive, readily prepared and environmentally benign, they have also
found application as coupling components in cross-coupling reactions. In 1999, Mori reported
[142] that aryl- and alkenylsilanols can undergo Mizoroki-Heck type reaction with an olefin as
the first example of a C–C bond-forming reaction using silanols. For example, treatment of
aromatic silanol 129 with iodobenzene in the presence of Pd(PPh3)4 as a catalyst and Ag2O
as an additive in tetrahydrofuran at 60 ◦C affords the coupling product 130 in 80% yield after
36 h (Scheme 2.11). Subsequently, Mori reported the usage of silandiol and silantriols in the
cross-coupling reactions. [143]
Si
MeO
OH
Me Me
+ PhI
Ph
MeO
Pd(PPh3)4 (5 mol%)
Ag2O
THF, 60 °C, 36 h
80%
129 130
Scheme 2.11: Pd-catalyzed Mizoroki-Heck type reaction of silanol 129 with PhI.
Subsequently, one year later, Denmark also demonstrated [144] the facility with which
alkenylsilanols undergo the Pd-catalyzed cross-coupling reactions with aryl or vinyl iodides in
the presence of tetrabutylammonium fluoride (TBAF) or tetrabutylammonium hydroxide. The
advantages of Denmark’s conditions over Mori’s are that reactions can proceed at room tem-
perature without the necessity for stoichiometric amounts of silver oxide and that the reaction
proceed rapidly. As an example, alkenyl silanol 131 was reported to undergo Pd-catalyzed
cross-coupling with iodobenzene in tetrahydrofuran in the presence of two equivalents of TBAF
at room temperature and, after 10 min, olefin 132 was afforded in 82% yield with a very high
E/Z ratio (99.2/0.8)(Scheme 2.12).
+ PhI
5 mol% Pd(dba)2
2 eq. TBAF
THF, r.t., 10 min
91%
n-C5H11
Si OH
Me Me
n-C5H11
Ph
131 132
Scheme 2.12: Pd-catalyzed cross coupling of alkenyl silanol 131 with PhI.
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The use of the fluoride ion in such a complex molecule synthesis has several advantages, not
least of which is the fact that it demonstrates a marked affinity for silicon (the Si–F bond is one
of the shortest known bonds). Furthermore, TBAF is not inexpensive and, as such Denmark
released an analog fluoride-free cross-coupling using stoichiometric amounts of base (rather than
TBAF) the following year. This improved catalysis is demonstrated by the reaction of alkenyl
silanol 131 with iodobenzene in DME at room temperature, which affords the olefin 132 after
15 min in 91% yield with a very high E/Z ratio (99.3/0.7) (Scheme 2.13).
+ PhI
Pd(dba)2 (5 mol%)
2 eq.. KOSiMe3
DME, r.t., 15 min
91%
n-C5H11
Si OH
Me Me
n-C5H11
Ph
131 132
Scheme 2.13: Fluoride free cross-coupling of alkenyl silanol 131 with PhI in the presence of
base.
In 2001, Mori also reported [145] that the Rh-catalyzed reaction of silanediols with α,β-
unsaturated esters can be directed toward either the Mizoroki-Heck (MH) type reaction or
conjugate addition depending on the solvent system and the electronic nature of the carbonyl
substrate. For example, the [Rh(OH)(COD)]2 catalyzed reaction of silanediol 133 with acrolein
(134) in tetrahydrofuran at 70 ◦C afforded conjugate addition product 136 in 56%, whereas
the reaction of ethyl acrylate (137) under the same conditions afforded the product of MH-type
reaction 138 in 74% yield, along with only trace amounts of conjugate adduct 139. When
water–THF (2:1) was instead used as a solvent mixture with this latter reaction systems, the
conjugate adduct 139 was afforded as the main product in 53% yield along with a 5% yield of
the product of MH-type reaction 138 (Scheme 2.14).
[Rh(OH)(COD)]2 (3 mol%)
H2O and/or THF, 70 °C, 24 h
5 − 74%
R
OSi OH
Et OH
+
R
O
R
O
Ph Ph
+
: R = Me
: R = OEt
0 − 53%
: R = Me
: R = OEt
: R = Me
: R = OEt
133 134 135 136
137 138 139
Scheme 2.14: Rh-catalyzed Mizoroki-Heck type reaction and/or conjugate addition of silanols
133 with carbonyl substrate 134 and 137.
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In 2005, Denmark applied [146] his silanol-based cross-coupling reaction to the synthesis
of 3,4,5-trisubstituted isoxazoles. A [3+2] cycloaddition reaction between silyl ether 140 and
chlorooxime 141 afforded silanol 142 in 52% yield after hydrolysis. This silanol was subsequently
subjected to a Pd-catalyzed cross-coupling reaction with 4-iodotoluene (144) at 80 ◦C in dioxane
in the presence of 2.5 equivalents of KOt-Bu and 1 equivalent of Cu(OAc)2, to afford 3,4,5-
trisubstituted isoxazole 143 in 69% yield (Scheme 2.15).
Ph Si
Me
Me
OMe +
N
ClPh
OH N
OPh
PhSi
HO
Me
Me
1. KHCO3, dioxane
    reflux, 5 h
2. 1.0 mol/L HOAc
    CH3CN
N
OPh
PhSi
HO
Me
Me
I
Me
+
52%
N
OPh
Ph
Me
69%
5 mol% Pd(dba)2 CHCl3
NaOt-Bu
dioxane, 80 °C, 4 h
.
140 141
142
142
143144
Scheme 2.15: The synthesis of tri-substituted isoxazole 143 via cross-coupling of silanol 142.
2.3.2 The Silanol Moiety as a Directing Group
The directed ortho-metalation reaction is comprised of the deprotonation of an aromatic
compound at a site that is located ortho to a heteroatom-containing directing group by a strong
base, normally an alkyllithium reagent, leading to an ortho-metalated species. Silanols could be
also used for this purpose, however, that the use of these compounds is only illustrated by the
following example.
In 1993, Sieburth investigated [147] the possibility to use silanols as a new form of direct-
ing group for the ortho-metalation in aromatic compounds. However, rather than effecting
solely ortho-metalation, the substituted aromatic products were observed as a mixture of iso-
mers. For example, the treatment of silanol 145 first with KH in hexane, then with n-BuLi
in THF at room temperature, followed by quenching with CO2 and subsequent treatment with
(trimethylsilyl)diazomethane, afforded several products, which were found to be the three car-
boxylated silanols 146, 147 and 148, which the first of resulted from intramolecular esterifica-
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tion. Starting material was isolated in 42% yield. Although this method requires optimization,
it demonstrates the application of silanols as directing groups in metalation reactions (Scheme
2.16).
Si OH
t-Bu t-Bu 1. KH, hexane
2. n-BuLi, THF, r.t., 15 h
3. CO2
4. TMSCHN2, hexane, r.t., 2 h
Si
O
t-Bu t-Bu
1%
Si OH
t-Bu t-Bu
28%
Si OH
t-Bu t-Bu
16%
CO2Me
MeO2C
+
+
O
145
146 147
148
Scheme 2.16: The utilization of silanol 145 as a directing group in aromatic metalation.
2.3.3 Silandiol-Based Anion Receptors
Very recently, Kondo demonstrated [148] the first example of silandiol as an anion receptor.
As seen in Scheme 2.17, silanediol 149 is possible to be associated with anions such as chloride
and acetate.
O
Si
O H
H
Anion
O
Si
O H
H
Anion
149
Scheme 2.17: Silanediol 149 as an anion receptor.
In order to discriminate whether the process is a hydrogen bond complexation or a proton
transfer of a Bronsted-type acid-base equilibrium, they performed 1H NMR dilution experiments
of a 1:1 mixture of silanediol 149 and acetate, which resulted in a shift of CH protons of naphthyl
groups to the direction of dissociation by dilution, which clearly showed that it is a hydrogen
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bond complexation rather than the proton transfer.5 Moreover, x-ray analysis of the complex
of silanediol 149 with chloride, whereas tetrabutylammonium as a counterion, clearly indicated
the hydrogen bond formation between chloride and hydrogen of Si–OH moieties.
2.4 Objectives of the Research
As presented in the introduction part, organosilanols have found important applications in
various fields. Although it is not mentioned, they also play important roles in the production of
silicon-based polymeric materials. [149] However, to the best of our knowledge, they have never
been utilized as chiral ligands in catalytic asymmetric reactions.6 Therefore, the application of
silanols in asymmetric catalysis had caught our attention.
Recently, it was demonstrated that ortho-substituted ferrocene 150 with oxazolinyl- and
diphenylhydroxy methyl groups is an effective catalyst for the asymmetric aryl transfer reaction
to aldehydes leading to products with up to 99% ee. Motivated by these results, We wondered
about the applicability of structurally analog organosilanols 153, which have the same oxazolinyl-
substituted ferrocene backbone, but differ in the hydroxyl-bearing side chain. The resulting steric
and electronic modification was expected to have an impact on the examined catalyst system
and alter its activity and selectivity.
O
N
R'Fe C OH
R R
O
N
R'Fe Si OH
R R
150 153
Figure 2.8: Carbinol 150 which is used as ligand in asymmetric aryl transfer reactions and its
silanol analog 153.
As the second part of the present work, application of organosilanols as directing groups on
ferrocenes was explored. Having unexpected products from this study changed the direction of
the project towards the synthesis of ferrocene-based silanediols and their application in hetero-
Diels-Alder reaction.
5If the process would be a proton transfer, the equilibrium is independent of the concentration of the species,
because the equilibrium constant is dimensionless.
6For examples of silanols in achiral metal complexes, see: [150] and references therein
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Enhanced acidity of silanols compared to carbon analog could be utilized in asymmetric
catalysis in terms of increased reactivity. The synthesis and application of silicon analog of
diphenylprolinol was the aim of the last project. The synthesis part is an ongoing project, which
some of its preliminary results are briefly discussed.
N
H
Si
OH
Ph
Ph
2.5 Results and Discussion
2.5.1 Synthesis of Ferrocene-based Organosilanols
The first attempt for the synthesis of organosilanols using chlorosilane 151 as a key inter-
mediate failed in the first step. Diastereoselective ortho-lithiations of ferrocenyl oxazolines 74,
with sec-BuLi at −78 ◦C in THF, followed by electrophilic attack with dichlorodimethyl silane
gave only starting material. This might be due to the instability of chlorosilane moeity in the
presence of oxazoline group which might react internally with Si–Cl bond and breaking the C–Si
bond to form the starting material back. Ferrocenyl oxazolines 77 are readily available from
ferrocene carboxylic acid following a known literature protocol. [151]
O
N
Fe Si Cl
R R
O
N
Fe
1. sec-BuLi, −78 °C, THF
    5 h
2. R2SiCl2, r.t., overnight
genelSi-Cl
R = Me, Ph
74
Scheme 2.18: Failed reaction of dimethyldichlorosilane in the synthesis of chlorosilan 151.
Therefore, an alternative pathway has been tried in the synthesis of organosilanols 153, using
silanes 152 as key intermediates. A series of organosilanes has been prepared through following
synthetic pathway. Diastereoselective ortho-lithiations of ferrocenyl oxazoline 77 with sec-BuLi
at −78 ◦C in THF, followed by electrophilic attack with various chlorosilanes gave diastereomer-
ically enriched 1,2-disubstituted ferrocenes 152 in good yields (60-85%) (Scheme 2.19) (Table
2.1). Since the diastereomers of silanes 152 were inseparable by simple flash chromatography,
they have been used in the next step as diastereomeric mixtures. It has been also tried to prepare
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organosilanes with tert-butyl groups at the silicon atom. Those attempts, however, remained
unsuccessful, since lithiated oxazolines 77 did not react with di-tert-butylchlorosilane.
O
N
R'Fe
O
N
R'Fe
1. sec-BuLi, −78 °C, THF, 5 h
2. R2SiHCl, r.t., 14 h
    R = i-Pr, Ph, Me
Si
60 − 85%
R R
H
R = t-Bu, i-Pr, Ph, Ch2Ph
a-i77 152
Scheme 2.19: Synthesis of organosilanes 152 via ortho-lithiation and subsequent quenching
with electrophiles.
Table 2.1: Synthesis of organosilanes 152 via ortho-lithiation and subsequent quenching with
chloro silanes.
Entry Compound R’ R Yield (%)
1 152a t-Bu CH3 64
2 152b t-Bu i -Pr 64
3 152c t-Bu Ph 91
4 152d Ph i -Pr 70
5 152e Ph Ph 68
6 152f i -Pr i -Pr 81
7 152g i -Pr Ph 85
8 152h CH2Ph i -Pr 82
9 152i CH2Ph Ph 60
Using a method recently introduced by Chang, [130] the silyl group of silanes 152 was
oxidized in air with [IrCl(C8H12)]2 as catalyst giving ferrocenyl organosilanols 153. After column
chromatography and isolation of the major diastereomer, stereochemically homogeneous samples
of organosilanols 153 were obtained in 43-91% yield (Scheme 2.20)(Table 2.2).
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O
N
R'Fe Si OH
R R
43 − 91%
[IrCl(C8H12)]2 (1 mol%)
H2O, air, r.t., CH3CN
O
N
R'Fe Si H
R R
a-i a-i152 153
Scheme 2.20: Synthesis of organosilanols 153 via oxidation of Si–H bond with Ir catalyst.
Table 2.2: Synthesis of organosilanol 153 via oxidation of Si–H bond with Ir catalyst.
Entry Compound R’ R Yield (%)
1 153a t-Bu CH3 91
2 153b t-Bu i -Pr 75
3 153c t-Bu Ph 77
4 153d Ph i -Pr 57
5 153e Ph Ph 53
6 153f i -Pr i -Pr 65
7 153g i -Pr Ph 72
8 153h CH2Ph i -Pr 45
9 153i CH2Ph Ph 43
2.5.2 Application of Organosilanols in Asymmetric Reactions
The catalytic properties of organosilanols 153 were explored in asymmetric phenyl transfer
reactions from organozinc reagents7 to benzaldehydes 154 giving diarylmethanols 155. The
results are summarized in Table 2.3 in order to give the whole picture of the project.8
7A colloborations with Frank Schmidt had been done for this project. All reactions were run on a 0.25 mmol
scale using 10 mol% of silanol 153. Method A: use of Ph2Zn (0.65 equiv) and Et2Zn (1.3 equiv) in toluene at
10 ◦C for 12 h. Method B: use of Ph3B (1.0 equiv) and Et2Zn (3.0 equiv) at 10
◦C for 12 h. Method C: use
of PhB(OH)2 (2.4 equiv) and Et2Zn (7.2 equiv) and DiMPEG (10 mol%; MW = 2000 g/mol) in toluene (first
at 60 ◦C for 12 h, then 10 ◦C for 12 h). Enantiomeric ratios were determined by HPLC analysis using a chiral
column. The major product had R configuration
8For further details, please see Frank Schmidt’s Dr. rer. nat. thesis. There results has been also published [152]
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OH
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1. Phenyl source, ZnEt2
    Organolsilanol         (10 mol%)
2. work-up
a: R = 4-Cl     
c: R = 2-Br
b: R = 4-OMe
d: R = 4-Me154 155
153
Scheme 2.21: Asymmetric phenyl transfer reaction to substituted benzaldehydes 154 using
organosilanol-based catalysts and various zinc reagents.
Table 2.3: Asymmetric phenyl transfer reaction to substituted benzaldehydes 154 using
organosilanol-based catalysts and various zinc reagents.
Entry Substrate Organosilanol Method (Product) Yield (%) e.e.(%)
1 154a 153a A (155a) 40 30
2 154a 153b A (155a) 82 91
3 154a 153c A (155a) 84 89
4 154a 153d A (155a) 82 87
5 154a 153e A (155a) 76 85
6 154a 153f A (155a) 87 78
7 154a 153g A (155a) 73 76
8 154a 153h A (155a) 85 63
9 154a 153i A (155a) nd9 58
10 154a 153c B (155a) 73 88
11 154a 153c C (155a) 67 83
12 154b 153c A (155b) 81 87
13 154c 153c A (155c) 70 84
14 154d 153c A (155d) 84 83
Although the observed enantioselecitivities are slightly lower than those of the corresponding
carbinols, [153–155] the method certainly demonstrates a possibility to use silanols as a ligand
for enantioselective metal catalysts.
As a result, the use of silanols in catalysis has promising prospectives as analog to carbon-
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based alcohols, due to changes in bond length, proton acidity and atomic radius.
2.5.3 Organosilanols as Directing Group on Ferrocenes
Inspired by the work of Sieburth, summarized in Scheme 2.16, silanols could be used as a
directing group in ferrocenes. Since the removal of silanols could be relatively easy, double
functionalization of ortho-position of silanols was aimed for the synthesis of 1,3-disubstituted
ferrocenes (Scheme 2.22).
Si
Fe
OH
MeMe
1. ortho-metalation
2. Electrophile-1
Si
Fe
OH
MeMe
E
1. ortho-metalation
2. Elecrophile-2
3. Desilylation
Fe E
E'
156
Scheme 2.22: Utilization of silanol 156 in the synthesis of 1,3-disubstituted ferrocenes.
Dimethylferrocenylsilanol 156 could be synthesized in one step starting from ferrocenyl tin
compound 157 which is readily available from ferrocene following known literature protocols
(Scheme 2.23). [156]10 Interestingly, using one equivalent of hexamethyltrisiloxane did not afford
the desired product 156 at all.
Sn(n-Bu)3
Fe
Si
Fe
OH
MeMe
1. n-BuLi (1.3 equiv)
    THF,−78 °C
2.
O
Si O Si
OSi
Me Me
Me
Me
Me
Me
(0.33 equiv)
44%
156157
Scheme 2.23: Synthesis of silanol 156 from ferrocenyl tin 157.
Following a modified procedure of Sieburth [147] for the metalation reaction, silanol 156 has
been treated with n-BuLi, refluxed in THF and quenched with Et3SiCl. After work up, beside
starting material, unexpected products 160 were obtained in poor yield. Changing the lithium
10An alternative synthesis could be done in two-step using dimethylchlorosilane and subsequent oxidation of
Si–H to Si–OH, but one-step synthesis was prefered due to higher yields.
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species to tert-BuLi afforded the same product 160 with a better yield.
Si
Fe
OH
1. RLi
    THF, reflux, 18 h
2. Et3SiCl
MeMe
Si
Fe
OH
MeMe
Si
Me
OH
Me
R = n-Bu                               10%
R = t-Bu                                19%
Fe+
156 160
Scheme 2.24: Unexpected result after ortho-lithiation of silanol 156.
This results showed that instead of ortho-lithiation, 1’-lithiation occured and intramolecular
reaction furnished disilanol 160 and ferrocene.
2.5.4 Synthesis of Ferrocene-Based Disilanols
Although the desired synthetic method for the synthesis of 1,3-disubstituted ferrocenes had
failed, disilanol 160 has caught attention for further studies. Disilanol could be used as a ligand
or organocatalyst for many reactions. For that reason, the synthesis of disilanol has been tried
starting from ferrocene. The formation of 1,1’-lithiated ferrocene with n-BuLi and TMEDA
and quenching with dimethylchlorosilane afforded the corresponding disilane 158 in 27% yield
(Scheme 2.25). However, the oxidation of disilane with Ir-catalyst did not afford the desired
product but a cyclized disilanol 159 (a siloxane).
Fe
1. n-BuLi, TMEDA
    hexane, 18 h
2. Me2SiClH (2.2 equiv)
    r.t., overnight
Si
Fe
H
MeMe
Si
Me
H
Me
[IrCl(COD)]2 (1 mol%)
H2O, CH3CN, 2 h
Si
Fe
MeMe
Si
MeMe
O
49% 94%158 159
Scheme 2.25: Unsuccesful attempt through the synthesis of disilanol 160 with an Ir-catalyst.
There are two possible pathways for the formation of this unexpected product 159. The
first one is that, under reaction conditions, disilanols 160, cyclized to give siloxane 159. The
second possibility is that after the oxidation of one Si–H bond, the oxidation of second Si–H
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bond occurs by means of Si–OH moiety by intermolecular reaction, rather than water.
Using [RuCl2(η
6-benzene)]2 as catalyst for the oxidation, gave the same siloxane and monosi-
lanol in good yields (Scheme 2.26). The formation of monosilanol 156 could not be understood
without a knowledge of the mechanism.
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[RuCl2(η6-C6H6)]2 (1 mol%)
H2O, CH3CN, r.t., 4 h
Si
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MeMe
48% 47%
158 159 156
Scheme 2.26: Unsuccesful attempt through the synthesis of disilanol 160 with a Ru-catalyst.
Nevertheless, instead of searching for alternative oxidation methods, the synthetic pathway
was changed to one-step procedure as for in the synthesis of silanol 156. For this purpose,
1,1’-lithiated ferrocene was quenched with hexamethyltrisiloxane to afford the desired disilanol
160 in 23% yield (Scheme 2.27).
Fe
Si
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OH
MeMe
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Me
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1. n-BuLi, TMEDA 
    hexane, r.t., 5 h
2.
O
Si O Si
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Me Me
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Me
Me
Me
(0.66 eq.)
23%
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Scheme 2.27: One-pot synthesis of disilanol 160.
Since 1,1’-disubstituted ferrocenes are achiral, in order to synthesize a chiral version of disi-
lanol, 1,1’-dilithiated ferrocene has been reacted with 1,3,5-trimethyl-1,3,5-triphenyl-trisiloxane
to give a mixture of racemic and meso form of disilanol 161 and monosilanol 162 as a side-
product (Scheme 2.28).
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Scheme 2.28: Synthesis of disilanol 161.
Racemic and meso mixture of disilanols 161 were separated by preparative HPLC using
chiral stationary columns. However, in agreement with Tacke’s results [120], chiral silicon center
of disilanol 161 can easily racemize in the presence of water and alcohol. Since an iso-propanol-
hexane mixture was used as an eluent in the preparative HPLC, after separation and removal
of the solvent, disilanol 161 was found to be already epimerized in the solution.
2.5.5 Hydrogen Bond Catalyzed Hetero-Diels-Alder Reaction
Recently, Rawal and Yamamoto [157,158] showed a highly enantioselective hetero-Diels-Alder
(HDA) reaction using chiral diols as catalysts. This was one of the major breakthrough in
hydrogen bond catalyzed reactions. Chiral diols were acting as a Lewis acid by activating the
carbonyl group of the aldehyde through double hydrogen bonding. For example, he reported
that diene 163 could undergo a hetero-Diels-Alder reaction with aryl aldehyde 164 at −80 ◦C in
toluene and BAMOL 165 as catalyst to afford the intermediate 164 which could be converted
to 1,2-dihydropyran 164 upon reacting with acetylchloride at −78 ◦C in CH2Cl2-toluene for 30
min (Scheme 2.29).
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Scheme 2.29: Hydrogen bond catalyzed Hetero-Diels-Alder reaction of Rawal and Yamamoto.
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X-ray structure analysis of the complex of 2,2’-bis-(diphenylhydroxymethyl)binaphthylene
(as a simple family of BAMOL 165) with benzaldehyde showed that there is an intramolecular
hydrogen bond between two hydroxyls and an intermolecular hydrogen bond to the carbonyl
oxygen of benzaldehyde. [158] This indicates that the reaction was probably catalyzed through
the single-point rather than two-point activation (Scheme 2.30).
O O O O
HH
R H
O
H H
R H
O
Single-point
activation
Two-point
activation
Scheme 2.30: The possible mechanism of hydrogen bond activation of aldehydes.
Taking into account the higher acidity of silanols compared to that of carbon analog, disilanol
160 was selected to be tested as an organocatalyst in hydrogen bond catalyzed HDA reaction
following the Rawal’s procedure and moderate activity was observed. Since, an enantiopure
disilanol could not be isolated, the enantioselective version of HDA was not possible to test. 11
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Scheme 2.31: Disilanol 160 catalyzed hetero-Diels-Alder reaction.
11Christine Beemelmans performed a kinetic study using reactIR in which the ratio of the HDA reaction,
when catalyzed by disilanol 160 was found to be comparable with that obtained when the structurally analogous
paracyclophanyl disilanols were used as catalysts. For further details, see: Beemelman’s Diploma Thesis, RWTH
– Aachen University, 2006.
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2.5.6 On the Way to a Silanol Analog of Prolinols
(S )-Diphenylprolinol (170) is a well known amino alcohol that has found many applications
in asymmetric catalysis. For example, it is the precursor of a series of chiral oxazoborolidines
known as CBS-catalyst which is particularly used in the reduction of carbonyl compounds [159]
beside many other reactions such as Diels-Alder [160] or Michael reactions. [161]
N
H
C
OH
Ph
Ph
N
H
Si
OH
Ph
Ph
170 171
Figure 2.9: Prolinol 170 and sila-prolinol 171.
Enhanced acidity of silanols compared to carbon analogs could be utilized in asymmet-
ric catalysis in terms of increased reactivity. The silicon analog of diphenylprolinol (Figure
2.9) was aimed to be synthesized via (–)-sparteine assisted asymmetric lithiation12 of N -Boc-
pyrrolidine. [164, 165] It is a method which was initially introduced by Beak [164]and further
developed by many other groups.13 For example, N -Boc-pyrrolidine (172) could be enantiose-
lectively deprotonated with (–)-sparteine/sec-BuLi system and quenched with TMSCl to afford
pyrrolidine 172 in good yield and high enantioselectivity (Scheme 2.32).
N
Boc
1. sec-BuLi/(−)-sparteine
    Et2O, −78 °C, 5 h
2. TMSCl, −78 °C −> r.t., 3 h
N
Boc
TMS
71%
94% e.e.
172 173
Scheme 2.32: (–)-Spartein assisted asymmetric functionalization of N -Boc-pyrrolidine with
TMSCl.
Using this well-known method, the synthesis of sila-prolinol 171 became a target of the
project. Initially, in order to established a suitable synthetic method, the racemic synthesis of
desired silanol 171 was tested using achiral amine such as N,N,N’,N’ -tetrametylethylenediamine
(TMEDA) but deprotonation of N -Boc-pyrrolidine (172) could not be achieved. Therefore,
12For review about enantioselective synthesis with lithium/(–)-spartein carbanion pairs: see refs. [162] and [163]
13For representative examples: see ref. [165–168]
2.6. Summary and Outlook 59
it was decided to perform the enantioselective synthesis using (–)-sparteine. Enantioselective
deprotonation of N -Boc-pyrrolidine with (–)-sparteine/sec-BuLi, and subsequent treatment with
hexaphenyltrisiloxane did not afford the desired N -Boc-silane 174. When diphenylchlorosilane
was used instead of using hexaphenyltrisiloxane, reaction proceeded well and gave the desired
silane 174 in moderate yield. Enantiomeric excess of the product could not be determined yet.
N
Boc
1. sec-BuLi/(−)-sparteine
    Et2O, −78 °C, 5 h
2. Ph2SiClH
N
Boc
Si
Ph
Ph
H
60%172 174
Scheme 2.33: (–)-Spartein assisted asymmetric functionalization of N -Boc-pyrrolidine with
diphenylchlorosilane.
2.6 Summary and Outlook
In the present chapter, the synthesis of planar-chiral ferrocene-based organosilanols 153 was
described. High enantioselectivities and yields of up to 91 and 87%, respectively, have been
achieved in a colloboration with Frank Schmidt using both zinc and boron-based aryl sources.
Although silanols 153 gave lower yields and enantiomeric excesses compared to carbinol ana-
log 150, to the best of our knowledge this is the first application of chiral organosilanols in
asymmetric catalysis (Scheme 2.34).
H
O
R
OH
R
1. Phenyl source, ZnEt2
    Organolsilanol         (10 mol%)
2. work-up
a: R = 4-Cl     
c: R = 2-Br
b: R = 4-OMe
d: R = 4-Me154 155
153
Scheme 2.34: Asymmetric phenyl transfer reaction to substituted benzaldehydes 154 using
organosilanol-based catalysts and various zinc reagents.
Application of silanols as directing group on ferrocenes is still an ongoing project. They can
be further investigated for their utilization as the directing group to 1’-position on ferrocenes.
Synthesis of a disilanol having a chiral silicon atom was tried, however, due to the racemization
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in the alcoholic solution, no optically active silanol was obtained. Achiral disilanol 160 was
tested as organocatalyst in a hetero-Diels-Alder reaction and moderate activity was observed.
On this work, although the synthesis of sila-prolinol 171 could not be completed, the pre-
liminary result towards the synthesis of it was presented.
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Scheme 2.35: Outlook and future plan for the synthesis of sila-prolinol 171.
Chapter 3
N -Substituted Ferrocene Derivatives
Following the discovery of the ferrocenes in the 1950’s, [169,170] over the decades, ferrocene
and its derivatives have been in the focus of a large number of investigations, that have revealed
an enormous potential for the use of such materials in applied organometallic chemistry [171]
and material science. [172] The interest in ferrocenes stems largely from the fact that although
these organometallics are classical aromatic compounds, they can have rather unique properties
due to their particular electronic and geometric features. As a consequence, standard methods
for the functionalization of aromatic compound often prove unsuitable for the synthesis and
modification of ferrocene derivatives and, hence, novel approaches to the formation of compounds
such as ferrocenyl amines have been, and actually, are being, developed.
3.1 Syntheses of Ferrocenyl Amine
The synthesis of ferrocenyl amine (177) was first achieved by Nesmeyanov in 1955 by the
reaction of O-derivative of hydroxylamine with ferrocenelithium. [173] In 1963, Nesmeyanov
published [174] a second, improved protocol for the preparation of ferrocenyl amine (177) by
the reduction of ferrocenyl azide (176). As shown in Scheme 3.1 ferrocenyl azide (176) was
synthesized in very high yield (98%) by the reaction of bromoferrocene with sodium azide in the
presence of CuBr in DMF/H2O, in the dark, at room temperature for 2 days. Upon reduction
of azide 176 with LiAlH4 in diethyl ether, ferrocenyl amine was obtained in 72% yield.
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Fe
Br CuBr, NaN3
DMF/H2O 
r.t., 2 days
Fe
N3
98%
LiAlH4
Et2O, rt
72%
Fe
NH2
175 176 177
Scheme 3.1: Nesmeyanov’s two-step synthesis of ferrocenyl amine (177) by copper mediated
sodium azide coupling and subsequent reduction with LiAlH4.
In 1981, Sato reported [175] that copper(I) oxide in pyridine was an effective promotor for the
initial nucleophilic substitution step in a modified Ullmann coupling to furnish ferrocenyl amine
(177) after reflux with hydrazine. Specifically, bromoferrocene (175) reacts with phthalimide
(178) in the presence of Cu2O in 4-picoline to afford N -ferrocenyl phthalimide (179) in 71%
yield after 24 hours at reflux. Phthalimide 179 was reduced to afford ferrocenyl amine (177) in
good yield (82%) upon treatment with hydrazine in ethanol when held under reflux conditions
for 40 minutes (Scheme 3.2).1
Fe
Br
HN
O
O
+
Cu2O
4-picoline 
reflux, 24 h
Fe
NHPht
71%
NH2NH2
EtOH, reflux
40 min
82%
Fe
NH2
175 178 179 177
Scheme 3.2: Cu(I)-mediated condensation of bromoferrocene with phthalimide by Sato
In 1999, Bildstein reported [177,178] an optimized, high-yielding version of this synthesis for
the large scale (≤20 g) preparation of ferrocenyl amine (177) from ferrocene and, later applied
this method to the synthesis of N,N -diferrocenyl-N -heterocyclic carbenes.
The discovery by Herberhold [179] in 1983, shows that ferrocenyl amine (177) can be ob-
tained from ferrocenyl bromide (175) with sodium amides in the presence of copper(I) bromide.
This two-step procedure, described in Scheme 3.3, involves the reaction between bromo ferrocene
(175) and the sodium salt of acetamide in the presence of CuBr at 120 ◦C to afford N -ferrocenyl
acetamide (180) in less than 40% yield in addition to 1,1-biferrocene as a side product.2 Hydrol-
ysis of amide 180 in refluxing aquoues KOH gave ferrocenyl amine (177) in 90% yield (Scheme
1The reduction step has been previously described by Nesmeyanov [176]
2The procedure was adapted from early work of Nesmeyanov. See: [180]
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3.3).
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NaNHAc
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aq. KOH
reflux, 6 h Fe
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175 180 177
Scheme 3.3: Herberhold’s method of the synthesis of ferrocenyl amine (177).
Recently, Hessen reported [181] a synthesis which is adapted from an early work of Hass-
ner [182] for the synthesis of anilines and heteroaromatic amines, using α-azidostyrene (181) as
a nitrogen source. As shown in Scheme 3.4, ferrocene was lithiated with t-BuLi in tetrahydro-
furan, and the resulting reaction mixture was subsequently reacted with α-azidostyrene (181)
at −70 ◦C, prior to being subjected to acidic work-up, to afford ferrocenyl amine (177) in 50%
yield. The disadvantage of this method is that it involves the use of an azide 1813 which can
be dangereous for macro-scale synthesis of ferrocenyl amine (177).
Fe Fe
NH2
1. t-BuLi, THF, −70 °C
2.
3. aq. HCl
Ph
N3
50%
182
181
177
Scheme 3.4: Hessen’s synthesis of ferrocenyl amine (177) via the reaction of lithiated ferrocene
with azidostyrene.
In 2002, Richards provided [184] an alternative method for the formation of ferrocenyl amine
(177) using an optimized version of the synthesis reported by Arimoto [185] in which the amine
moiety was installed via Curtius rearrangement. Azide 1834 undergoes Curtius rearrangement
upon heating to 105 ◦C and, in the presence of 2-trimethylsilylethanol, the resulting isocyanate
3For its synthesis from styrene in three steps, see: [183]
4Ferrocene carboxylic azide can be easily synthesized from ferrocene carboxylic acid through one-pot two-step
synthesis. [184]
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reacts to afford the corresponding carbamate 184 which can be deprotected on treatment with
excess TBAF to furnish ferrocenyl amine (177) in 80% overall yield (Scheme 3.5).5
Fe
CON3
toluene
105 °C, 3 h
Fe
NH
O(CH2)2TMS
O
TBAF
THF, 50 °C
15 min
Fe
NH2
80% over
two steps
TMS OH
185 184 177
Scheme 3.5: Richard’s synthesis of ferrocenyl amine (177) via Curtius rearrangement.
3.2 Synthesis of 1,1’-Diamino Ferrocene
1,1’-Diamino ferrocene has been synthesized and converted into corresponding carbamate
derivative by Nesmeyanov [174] but could not be isolated due to its propensity to oxidize in
air. As shown in Scheme 3.6, an ethanolic solution of 1,1’-dibromo ferrocene (186) was treated
with aqeuous solution of sodium azide in the presence of CuBr on a steam-bath for 6 minutes to
afford 1,1’-diazido ferrocene (189) in 31% yield. LiAlH4 reduction of diazide 189 in dry diethyl
ether gave diamine 187 which was immediately converted to carbamate 188 upon treatment
with methylchloroformate, in the presence of triethylamine in 50% yield.
Fe
Br CuBr, NaN3
EtOH/H2O 
steam bath,
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Fe
N3
31%
LiAlH4
Et2O, r.t.
50%
Fe
NH2
Br N3 NH2
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NHCO2Me
NHCO2Me
ClCO2Me
Et3N
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r.t., 30 min
186 189 188187
Scheme 3.6: Nesmeyanov’s two-step synthesis of 1,1’-diamino ferrocene(187) via copper me-
diated sodium azide coupling and subsequent reduction with LiAlH4.
For a long time, the synthesis of 1,1’-diamino ferrocene (187) was not further examined until
a report by Arnold [188] about an improved high-yield synthesis of 1,1’-diamino ferrocene (187)
5Togni [186] and Shabat [187] also reported the synthesis of ferrocenyl amine (177) via similar method with
small modifications.
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via modified Nesmeyanov synthesis. Arnold showed that when the same reaction was performed
over 48 hours at room temperature using CuCl (instead of the conditions specified above) in
the initial step of the Nesmeyenov sequence, the yield of 1,1’-diazido ferrocene (189) could be
improved to 59%. The reduction of diazide 189 with H2/Pd in methanol (instead of LiAlH4 in
diethyl ether) provided 1,1’-diamino ferrocene (187) as a yellow crystalline substance after 6 h.
3.3 Objectives of the Research
Presumably due to synthetic problems, nitrogen-substituted ferrocenes are relatively unex-
plored. The most common way for their preparation is the derivatization of amino- (Fc-NH2) and
diaminoferrocene which are readily available by several well-established synthetic routes some
of them being described in the introduction part. This dependence of the synthesis different N -
substituted ferrocenes from ferrocenyl amine (177), restrains the diversity of the synthesis these
type of compounds. For this purpose, we were interested in a general synthesis of N -substituted
ferrocenes, especially, through C–N bond formation.
Recently, Bolm developed [189] the copper(I) iodide catalyzed cross-coupling reactions af-
fording N -arylated sulfoximines in high yields. This approach represented an alternative method
for the well-established palladium-catalyzed coupling reaction. For example, N -arylation of sul-
foximine 191 with phenyl iodide 190 as an aryl source and Cs2CO3 as a base, in the presence of
CuI at 90 ◦C in DMSO, afforded N -phenyl sulfoximine 192 in high yield (Scheme 3.7). Catalytic
version of this reaction was also published by Bolm. [190,191]
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I
+
CuI, Cs2CO3
DMSO, 90 °C, 12 h
94%
O
S
N
Me
Ph
Ph
190 191191
Scheme 3.7: CuI-mediated phenylation of sulfoximine 191 by Bolm.
The same copper salt was used in catalytic amount by Plenio, [192] who prepared ferrocenyl
aryl ethers in good yields starting from iodoferrocene. For example, ferrocenyl aryl ether 195
could be synthesized in high yield by CuI/PPh3 catalyzed coupling reaction from iodoferrocene
(193) and phenol 194 (Scheme 3.8).
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Scheme 3.8: Cu-catalyzed synthesis of ferrocenyl aryl ether 195 by Plenio.
3.4 Results and Discussions
3.4.1 A General Synthesis of Ferrocenyl Amines
In the light of the results mentioned above, iodoferrocene or 1,1’-diiodoferrocene was chosen
as coupling component in combination with cheap and readily available copper(I) iodide for the
development of a direct synthesis of N -substituted ferrocenes by C–N cross-coupling.
I
Fe
X
+  R-[N]-H
CuI
K2CO3 or KOtBu
DMSO, 90 °C
[N]-R
Fe
X'
X = H
X = I X' = H, [N]-R
193
196
Scheme 3.9: General synthesis of N -substituted ferrocenes
The reactions were performed at 0 ◦C using DMSO as solvent and K2CO3 or KOt-Bu as
base. Different solvents such as DMF or CH3CN were also tested but they did not improve the
yields. Using other carbonate bases than K2CO3 such as Cs2CO3 or Na2CO3 also did not have
any positive effect on the yield of the reaction.
Generally, less nucleophilic nitrogen derivatives having electron-withdrawing groups gave the
best results. For example, high yields were obtained in couplings with methyl phenyl sulfox-
imine (191), pyrazole and its chiral derivative 197. Since ferrocenyl is an electron rich group,
when nitrogen is directly attached to the ferrocene, it becomes very electron rich and reactive.
Therefore, electron-withdrawing groups on nitrogen are mostly required in order to to obtain
high stability of the products. There is a rough correlation between the pKb of Fc-N-H and the
yield of its product. Yields are increasing when nitrogen compounds are possesing higher pKb
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Entry Coupling Component Product Yield (%)
1 N
H
N
Fe
N
N
93
84
2 N NH
197
Fe
N N
198
70
3
N
H
Fe
N
199
73
4 N
H
Fe
N
200
62
5
N
H
N
Fe
N
N
201
31
6 N N
H
N
Fe
N
N
N
202
30
7
Me
S Ph
HN O
N
Fe
S
O
Ph
Me
203
80
8
Me NH2
O
Fe
H
N
O
Me
204
70
Table 3.1: Products of the coupling of iodoferocene (193) and 1-1’-diiodoferrocene (196) with
coupling components.
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(contn’d Table 3.4.1)
Entry Coupling Component Product Yield (%)
9
Ph NH2
O
Fe
H
N
O
Ph
205
57
10 N
H
PhPh
Fe
N
Ph
Ph
207
43
11 N
H
N
Fe
N
N
N
N
208
50
12 N NH
197
Fe
N N
N N
209
31
values. This could imply that the rate determining step of the reaction is the removal of the
hydrogen attached to nitrogen with a base and as a result of this nitrogen compound having low
pKb do not react or react with low yields and forming relatively less stable products. This may
also explain why aniline and diphenylamine resulted in only poor conversions and low yields and,
aliphatic amines such as morpholine, n-butyl amine and diphenylprolinol (170) did not react at
all.
On the other hand, unexpected lower yielding reaction of imidazole and triazole could not
be accounted for these explanations. This shows that reactivity of nitrogen compounds could
be also dependent on the stereoelectronic properties of other intermediates in the reaction.
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Although reactions with imidazole and triazole gave lower yields, they were of synthetic inter-
est, since they led to products such as imidazole 201 and triazole 202, which could be valuable
compounds in N -heterocyclic carbene chemistry. Similar ferrocenes were commonly prepared
by derivatization of ferrocenyl amine (177) over several steps. For example, Bildstein [177] has
synthesized N,N ’-diferrocenyl-N -heterocyclic carbene precursor 210 starting from iodoferrocene
(193) over 4 steps and around 10% overall yield (Scheme 3.10).
Fe
I
Fe
NH22 steps 2 steps
Fe
N N
FeTfO
79% 13%
193 177 210
Scheme 3.10: Bildstein’s synthesis of N,N ’-diferrocenyl-N -heterocyclic carbene precursor 210
starting from iodoferrocene (193).
The coupling of amides such as acetamide and benzamide required the use of the stronger
base KOt-Bu to achieve better yields. Surprisingly, N -Cbz-proline amide did not afford the
desired chiral ferrocene derivative even in the presence of KOt-Bu. Acetylhydrazide was also
tested in the coupling with iodoferrocene (193), however, it did not afford the desired product.
The coupling of o-iodo-ferrocenyl oxazoline 211 with either pyrazole or methyl phenyl sulfox-
imine (191) produced only deiodinated product 74. This can be attributed to steric crowdening
and a negative effect of another coordination site for the metal, which is also consistent with the
low yield of the bis-coupling products (Scheme 3.11).
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Me
Ph
CuI, K2CO3 or KOtBu
90 °C, DMSO, 16 h
O
N
Fe H
pyrazole,
imidazole
211 74
191
Scheme 3.11: Copper-mediated coupling of iodooxazoline 211 with sulfoximine 191 or pyrazole
or imidazole.
Double cross-couplings using 1,1’-diiodoferrocene were only successful with pyrazole deriva-
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tives. The low yields were due to the formation of mono-coupling and mono-deiodination
by-products. The attempt to use methyl phenyl sulfoximine led to a mixture of bis- and
mono-coupled product together with the mono-coupled/mono-deiodinated ferrocene in low yield.
Amides such as acetamide and N -Cbz-prolinamide did not react.
Chiral pyrazole was prepared from (+)-camphor (212) following a known literature protocol
through a two-step synthesis. (+)-Camphor (212) was first refluxed with excess amount of KH6
in THF for 15 min, quenched with ethyl formate and stirred at room temperature overnight to
give α-carbaldehyde keton 2137 in moderate yields (Scheme 3.12).
O
1. KH, THF
    reflux, 15 min
2. HCOOEt, r.t.
    16 h O
H
O
O
H
OH
64%212 213 214
Scheme 3.12: The first step in the synthesis of chiral pyrazole 197.
In the second step, α-carbaldehyde keton 213 was treated with hydrazine hydrate and re-
fluxed for 4 h in methanol to obtain chiral pyrazole 197 as a pale yellow solid in good yield after
recyrstalization (Scheme 3.13).
O
H
O
N2H4 . H2O
MeOH, reflux
4 h
77%
N NH
213 197
Scheme 3.13: The second step in the synthesis of chiral pyrazole 197.
3.4.2 Pyrazole as a Directing Group on Ferrocenes
It is well-established that 1,2- and 1,1’-disubstituted ferrocenes are very useful as versatile chiral
ligands in asymmetric metal catalysis. [104, 105, 171, 193, 194] Following Ugi’s pioneering work
in 1970, [106] they are commonly prepared starting from monosubstituted ferrocenes by ortho-
6Using NaH, instead of KH leaded mainly starting material and unknown side products.
7It is in equilibrium with its keto-enol tautomer 214
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lithiation8 with directing groups such as amines and hydrazones, [196]9 sulfoxides, [198] acetals,
[199] or oxazolines [107,152,200] and subsequent trapping of the resulting lithium reagent with
an appropriate electrophile. However, no pyrazole was utilized for this purpose. Therefore,
studies were then focused on the applicability of pyrazole as ortho-directing group on ferrocenes
and the synthesis of potential ligands such as shown in Figure 3.1.
Fe
N N
HO
PhPh
Fe
N N
Ph2P Fe
N N
N
R
215 216 217
Figure 3.1: Potential ligands having P,O--, P,N--, and N,N-- coordinations which could be
synthesized from chiral pyrazole 197.
Pyrazole was choosen as a model substrate for ortho-directing reaction and triethylchlorosi-
lane was the electrophile of choice for quenching the lithiated species. Pyrazole 93 was treated
with sec-BuLi in tetrahydrofuran at 0 ◦C and after 6 h, triethylchlorosilan was added and the
mixture was stirred for 14 h at room temperature. After acidic work-up, only starting material
was obtained. Changing the butyllithium species to tert-BuLi gave a product, whose NMR
analysis showed that lithiation occured on pyrazole ring but not on ferrocene (Scheme 3.14).
8For a recent review illustrating the major advances in directed lithiations (by complex induced proximity
effects), see: [195]
9For a review about the use of chiral hydrazones, see: [197]
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Fe
N N 1. t-BuLi, THF
    0 °C, 6 h
2. Et3SiCl, 14 h
Fe
N N
Fe
N N
Et3Si
SiEt3
93
94
218
Scheme 3.14: Lithiation of pyrazole with tert-BuLi in THF at 0 ◦C.
This results showed that achiral pyrazole 93 was not a good model substrate since it has
also some other positions which could be lithiated with tert-BuLi. Therefore, chiral pyrazole
95 was used for further test reaction. It was treated with tert-BuLi at 0 ◦C in tetrahydrofuran
and after 3 h, triethylchlorosilan was added and the mixture was stirred at room temperature
for 16 h. Unfortunately no product was obtained. Changing the solvent to the diethylether and
applying the same conditions did not afford the desired product and only starting material was
recovered. Using sec-BuLi and n-BuLi in diethylether had no positive effect on the reaction and
only starting material was recovered after acidic work-up (Scheme 3.15).
Fe
N N
Fe
N N
Et3Si
1. RLi, 0 °C
    THF or Et2O
2. Et3SiCl, r.t.
    overnight
R = t-Bu, sec-Bu, n-Bu
95 96
Scheme 3.15: Lithiation of chiral pyrazole 197 with different BuLi species in THF or Et2O at
0 ◦C.
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3.4.3 Bispyrazoles as Potential Ligands
As a subsequent study, complexation of bispyrazoles 208 and 209 with Cu (II) salts was
studied. Unfortunately, no complexes was obtained with the copper salts shown in Table 3.2.
Table 3.2: Complexation study of bispyrazol 208 and 209 with various copper salts in different
solvents.
Entry Bispyrazole Cu-salt Solvent Co-ligand Product
1 208 Cu(SO4)2 CH3OH – –
2 208 CuCl2 CH3OH – –
3 208 Cu(OTf)2 CH3CN KBr –
4 208 Cu(ClO4)2.6H2O CH3CN KBr –
5 208 CuI CH3CN – –
6 209 Cu(OTf)2 CH3OH – –
7 209 Cu(ClO4)2.6H2O CH3CN KBr –
3.4.4 A Small Extension of Bispyrazoles
After the discovery of 2,6-bis(N -pyrazolyl)pyridine (bpp) by Jameson and Goldsby, [201]
much work has been carried out in the past decades with various transition metals and the bpp
because of its potential in binding to metal atoms.10
Since, 2-position of pyridine is labile to the nucleophilic substitution reaction, the synthesis
of bpp (220) could be achieved by nucleophilic substitution reaction of 2,6-dibromopyridine
(219) with potassium salt of pyrazole under long reactiong time (4 days) and harsch conditions
(110− 130 ◦C) (Scheme 3.16). [201]
NBr Br
N
N K
diglyme, 110−130 °C
4 days
NN N
NN
85%
219 220
Scheme 3.16: The first synthesis of bpp by double substitution reaction.
10For a representative examples, see: [202]
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Interestingly, the metal-mediated or catalyzed coupling reaction has not been reported yet.
Therefore, the project was slightly extended to the synthesis of bpp via copper-mediated coupling
reaction.
For this purpose, dibromopyridine 219 was treated with pyrazole in the presence of CuI as
a coupling mediator and K2CO3 as a base in DMSO at 90
◦C for 16 h and bpp was obtained in
72% yield (Scheme 3.17).
NBr Br
N
NH
CuI, K2CO3
DMSO, 90 °C, 16 h
NN N
NN
72%219 221
Scheme 3.17: Copper-mediated synthesis of bpp under milder conditions.
Synthesis of chiral bpp 221 was previously reported by Steel [203] by using classical nu-
clophilic substitution reaction of dibromopyridine 219 with excess amount (four equivalents) of
in situ prepared potassium salt of chiral pyrazole 197 in diglyme at 120 ◦C–130 ◦C in 70% yield
after 3-4 days. Using coupling reaction method, chiral bpp 221 was obtained in 57% yield upon
the reaction of dibromopyridine 219 with chiral pyrazole 197 in the presence of CuI and K2CO3
at 90 ◦C in DMSO after 30 h (Scheme 3.18).
NBr Br
CuI, K2CO3
DMSO, 90 °C, 30 h
N
chiralbpp
57%
chiralpyrazole
N NH
N
N
N
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Scheme 3.18: Copper-mediated synthesis of bpp under milder conditions.
As a result, the syntheses of bpp (220) and chiral bpp 221 were achieved in good yields at
milder temperature with shorter reaction time, using mild bases and a cheap metal-mediator.
As a subsequent study, complexation of chiral bpp 221 with Cu (II) salts was studied. Neither
Cu(ClO4)2 nor Cu(OTf)2 in the presence of KBr as a co-ligand in CH3CN and subsequent
evaporation afford the Cu (II) complex of chiral bpp 221.
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3.5 Summary and Outlook
In this part of the thesis, a simple and efficient method for the preparation of various N -
substituted ferrocene by Ullmann type coupling reaction mediated by copper(I) iodide was pre-
sented. Attractive features of this protocol are the direct synthesis of such valuable compounds
by C–N bond formation and the use of simple and cheap reagents (metal salt and base).
I
Fe
X
+  R-[N]-H
CuI
K2CO3 or KOtBu
DMSO, 90 °C
[N]-R
Fe
X'
X = H
X = I X' = H, [N]-R
193
196
Scheme 3.19: General synthesis of N -substituted ferrocenes
Moreover, pincer-type bispyrazolylpyridine 220 and 221 were also synthesized by means of
this method in good yield at milder temperature with shorter reaction time, using mild bases
and a cheap metal-mediator, compared to literature protocols. [201,203]
Ferrocenyl imidazole 201 and triazole 202 are interesting compound which could be valuable
precursors in N -heterocyclic carbene chemistry (Figure 3.2).
N
Fe
N N
Fe
N
N
201 202
Figure 3.2: Structure of imidazole 201 and triazole 202.
Unfortunately, ortho-lithiation of pyrazole 95 was not achieved so far, but after further
investigation, a route to new-type of chiral ferrocenyl potential ligands could be opened.
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Figure 3.3: ortho-Lithiated chiral pyrazole 95
Although no metal complex of 1,1’-bispyrazolyl ferrocene 208, its chiral derivative 209 and
chiral bpp 221 with Cu(I) and Cu(II) salts was obtained, By means of further investigations,
they could serve as achiral and chiral ligands for various transition metals.
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Chapter 4
Experimental Section
4.1 General Methods and Chemicals
All reactions involving air- or moisture-sensitive compounds were carried out under argon using
standard Schlenk and vacuum line techniques. [204] Glassware were heated under vacuum with a
heat gun and flushed with argon. Addition of all reagents as well as solvents was carried out with
glass or polypropylene syringes equipped with V2A steel needles under argon steam. Chemicals
which are labile to air were kept in a glove-box or refrigerator and stored under argon.
4.1.1 Solvents
The solvents were dried and distilled under argon according to standard procedures: [205]
Acetone: was purchased from Fluka and used as received. Acetonitrile: was purchased from
Sigma-Aldrich and used as supplied. CCl4: was purchased from Merck and used as received.
CH2Cl2: was distilled from CaH2 under Ar. Diethyl ether: was predried over KOH distilled
from sodium benzophenone ketyl radical under argon. DMF: was purchased from Merck and
used as received. DMSO: was purchased from Merck and used as received and stored over
4 A˚ molecular sieves. Methanol: analytically pure MeOH required for the desymmetrization
was purchased from Fluka or Merck and used as supplied. THF: was predried over KOH and
distilled from sodium benzophenone ketyl radical under argon. Toluene: was distilled from
sodium benzophenone ketyl radical under argon and stored over 4 A˚ molecular sieves.
Unless otherwise specified, all reagents were purchased from commercial suppliers (Acros, Aldrich,
Fisher-Scientific, Fluka, Lancaster, Merck, Strem) and used without further purification. All the
amino acids employed in practice were received from Degussa.
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4.1.2 Determination of the Physical Data
1H NMR Spectra
1H NMR spectra were recorded at room temperature on a Varian VXR 300 (300 MHz), Varian
Gemini 300 (300 MHz) or Inova 400 (400 MHz) spectrometer. The chemical shifts are given
in ppm using tetramethylsilane (δ = 0.00 ppm) as internal standard, and in the absence of
tetramethylsilane, they are based on the deuterated solvent peak (Chloroform δ = 7.25 ppm).
The coupling constants J are given in Hertz. The following abbreviations are used in order
to describe the signals observed in the 1H NMR-spectra: s (singlet), d (doublet), t (triplet), q
(quartet), quin (quintet), m (multiplet), bs (broad signal). The diastereomeric ratio (dr) was
determined by analysis of the 1H NMR-spectra of the crude reaction product.
13C NMR Spectra
13C NMR spectra were 13C-broad band-decoupled and measured with a Varian VXR 300 (75
MHz), Varian Gemini 300 (75 MHz) or Inova 400 (100 MHz) spectrometer. The chemical shifts
are given in ppm using tetramethylsilane (δ = 0.00 ppm) or the deuterated solvent peak as
internal standard.
Mass spectrometry
Mass spectra were recorded on a Varian MAT 212 and a Finnigan MAT 95 spectrometer. All
values are given in atomic units of mass per elemental charge (m/z). The intensity is given as a
percentage of the base peak.
IR-spectroscopy
Infrared spectra were recorded on a Perkin-Elmer PE-1760 FT apparatus. All bands are given
in cm−1. Only the strongest bands (50-100%) are listed.
Optical rotation
Optical rotations were determined on a Perkin Elmer PE-241 instrument at room temperature
(ca. 20 ◦C) using solvents of Merck UVASOL-quality. The measurements were carried out using
a light frequency of 589 nm (D-line of a sodium vapour lamp) in a cuvette (length d = 10 cm;
concentration c is given in g/100 mL).
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Melting point
Melting Points were measured in open glass capillaries with a Bu¨chi B-540 apparatus and are
uncorrected.
Elemental analysis
All microanalyses were conducted on a Heraeus CHN RAPID instrument. All values are given
as mass percentages.
Chromatography
Thin layer chromatography (TLC):
TLC was performed using precoated aluminium backed sheets (Merck silica gel 60 F254). De-
tection was performed by using UV radiation (254 nm).
Column chromatography:
Separations by column chromatography were conducted according to the suggestion of Still.
[206] Silica gel 60 (Merk, mesh 40-63 µm) was employed as stationary phase. All solvents have
been distilled prior to use.
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4.2 C–H Activation of Ferrocene Compounds
4.2.1 General Procedure A for C–H Activation Reactions
To a solution of substrate (0.2 mmol) in toluene (0.2 mL) was added the catalyst (0.02 mmol),
triethylsilane (0.16 mL, 1 mmol) and tert-butyl ethylene (0.12 mL, 1 mmol) under argon atmo-
sphere. The reaction mixture was heated up to 135 ◦C in a closed vessel and maintained for 20
h with stirring. After cooling, the reaction mixture was separated by column chromatography
using pentane/diethyl ether mixture as eluent.
4.2.2 Synthesis of (S,Rp)-2-(triethylsilane)ferrocenyl-5-tert-butyloxazoline -
(S,Rp)-75
O
N
Fe
SiEt3
It was synthesized according to general procedure A, starting from ferrocenyl-5-tert-butyl-
oxazoline (0.2 mmol, 62 mg) using 10 mol% of Ru(H)2(CO)(PPh3)3 as catalyst in 33% yield as
an orange oil (28 mg, diastereomeric ratio = 90:10). Eluent: pentane/diethyl ether = 90/10.
1H NMR (300 MHz, CDCl3): δ 0.87–0.95 (m, 24H, -Si(CH2CH3)3, -C(CH3)3), 3.79 (dd, J
= 8.2 Hz, 10.1 Hz, 1H, -CHN), 4.00 (t, J = 8.2 Hz, 1H, -CH2O), 4.09 (s, 5H, C5H5), 4.11 (s,
5H, C5H5) (due to diastereomer) 4.14 (dd, J = 8.4 Hz, 10.1 Hz, 1H, -CH2O), 4.17 (t, J = 2.5
Hz, 1H, -C5H3), 4.38 (t, J = 2.5 Hz, 1H, -C5H3), 4.82 (dd, J = 1.5 Hz, 2.5 Hz, -C5H3) (due to
diastereomer), 4.84 (dd, J = 1.5 Hz, 2.5 Hz, -C5H3).
13C NMR (75 MHz, CDCl3): δ 4.4 (CH2) (due to diastereomer), 4.8 (CH2), 6.7 (CH3) (due
to diastereomer), 8.1 (CH3), 26.1 (CH3), 33.6 (C), 68.1 (CH2), 69.5(CH), 71.6 (CH), 72.9 (CH),
76.3 (CH), 77.3 (CH), 165.8 (C).
MS (EI, 70 eV): m/z (%) 425 (M+, 100), 396 (46), 368 (11), 296 (20), 268 (10).
[α]D
25 –28.1 (c 2.1, CHCl3).
HRMS for C23H35FeNOSi: calcd. 425.1837, found 425.1838.
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4.2.3 Synthesis of (S,Rp)-2-(triethylsilane)ferrocenyl-5-iso-propyloxazoline -
[(S,Rp)-79]
O
N
Fe
SiEt3
It was synthesized according to general procedure A, starting from ferrocenyl-5-iso-propyl-
oxazoline (0.2 mmol, 60 mg) using 10 mol% of Ru(H)2(CO)(PPh3)3 as catalyst in 60% yield as
an orange oil (49 mg, diastereomeric ratio = 62:38). Eluent: pentane/diethyl ether = 90/10.
1H NMR (300 MHz, CDCl3): δ 0.70–0.95 (m, 15H, -Si(CH2CH3)3 + diastereomer), 0.91
(d, J = 6.0 Hz, 3H, -CH(CH3)2), 0.95 (d, J = 6.7 Hz, 3H, -CH(CH3)2), 1.66–1.77 (m, 1H,
-CH(CH3)2), 1.67–1.78 (m, 1H, -CH(CH3)2)(due to diasetereomer), 3.82–3.95 (m, 1H, -NCH +
diasteromer), 4.09 (s, 5H, C5H5), 4.10 (s, 5H, C5H5) (due to diastereomer), 4.16–4.21 (m, 1H,
-CH2O + diastereomer), 4.38 (t, J = 2.5 Hz, 1H, -C5H3) (due to diastereomer), 4.39 (t, J =
2.5 Hz, 1H, -C5H3), 4.84 (dd, J = 1.2 Hz, 2.5 Hz, 1H, -C5H3) (due to diastereomer), 4.86 (dd,
J = 1.5 Hz, 2.5 Hz, 1H, -C5H3).
13C NMR (75 MHz, CDCl3): δ 4.5 (CH2) (due to diastereomer), 4.7 (CH2), 7.1 (CH3) (due
to diastereomer), 8.8 (CH3), 20.2 (CH3), 22.2 (CH3), 32.4 (CH), 32.5 (CH) (due to diastereomer),
68.2 (CH2), 68.3 (due to diastereomer), 69.0(CH), 69.1 (CH) (due to diastereomer), 70.2 (CH),
70.5 (C), 70.6 (CH) (due to diastereomer), 72.3 (CH), 72.5 (CH) (due to diastereomer), 165.7 (C).
MS (EI, 70 eV): m/z (%) 411 (M+ , 95), 382 (100), 296 (30), 268 (19).
[α]D
25 –70.0 (c 0.7, CHCl3).
HRMS for C22H33FeNOSi: calcd. 411.1681, found 411.1680.
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4.2.4 Synthesis of (S,Rp)-2-(triethylsilane)ferrocenyl-5-benzyloxazoline[(S,Rp)-
81]
O
N
CH2PhFe SiEt3
It was synthesized according to general procedure A, starting from ferrocenyl-5-benzyloxa-
zoline (0.2 mmol, 69 mg) using 10 mol% of Ru(H)2(CO)(PPh3)3 as catalyst in 72% yield as an
orange oil (66 mg, diastereomeric ratio = 58:42). Eluent: pentane/diethyl ether = 90/10.
1H NMR (400 MHz, CDCl3): δ 0.69–0.95 (m, 15H, -Si(CH2CH3)3 + diastereomer), 2.56
(dd, J = 9.3 Hz, 13.7 Hz, 1H, -CH2Ph), 2.67 (dd, J = 8.0 Hz, 13.7 Hz, 1H, -CH2Ph) (due to
diastereomer), 3.06 (dd, J = 5.5 Hz, 13.7 Hz, 1H, -CH2Ph) (due to diastereomer), 3.16 (dd, J
= 4.7 Hz, 13.7 Hz, 1H, -CH2Ph), 3.91–3.97 (m, 1H, -NCH + diasteromer), 4.08 (s, 5H, C5H5)
(due to diastereomer), 4.11 (s, 5H, C5H5), 4.12–4.21 (m, 2H, -CH2O + diastereomer), 4.29–4.39
(m, 1H, -C5H3 + diastereomer), 4.42 (dt, J = 2.5 Hz, 5.0 Hz, 1H, -C5H3 + diastereomer), 4.90
(dt, J = 1.4 Hz, 2.5 Hz, 1H, -C5H3 + diastereomer), 7.13–7.28 (m, 5H, -Ph).
13C NMR (100 MHz, CDCl3): δ 5.0 (CH2), 8.2 (CH3), 41.9 (CH2), 67.7 (C), 67.8 (C) (due
to diastereomer), 69.8 (CH), 71.4 (CH2), 72.1 (CH), 73.2 (CH), 73.2 (CH) (due to diastereomer),
77.6 (CH), 77.7 (CH) (due to diastereomer), 126.4 (CH), 128.5 (CH), 128.5 (CH) (due to di-
astereomer), 129.2 (CH), 129.4 (CH)(diastereomer), 138.2(C).
IR (KBr): ν 2951, 1652, 1455, 1237, 1138 cm−1.
MS (EI, 70 eV): m/z (%) 459 (M+, 93), 430 (100), 296 (18), 268 (14).
[α]D
25 +22.2 (c 1.0, CDCl3).
HRMS for C22H33FeNOSi: calcd. 459.1681, found 459.1681.
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4.2.5 Synthesis of (S,Rp)-2-(triethylsilane)ferrocenyl-5-phenyloxazoline[(S,Rp)-
80]
O
N
PhFe
SiEt3
It was synthesized according to general procedure A, starting from ferrocenyl-5-phenyloxa-
zoline (0.2 mmol, 66 mg) using 10 mol% of Ru(H)2(CO)(PPh3)3 as catalyst in 65% yield as an
orange oil (58 mg, diastereomeric ratio = 60:40). Eluent: pentane/diethyl ether = 90/10.
1H NMR (400 MHz, CDCl3): δ 0.69–0.95 (m, 15H, -Si(CH2CH3)3 + diastereomer), 4.08
(t, J = 8.0 Hz, 1H, -NCH), 4.08 (t, J = 8.0 Hz, 1H, -NCH) (due to diastereomer), 4.14 (s, 5H,
C5H5) (due to diastereomer), 4.15 (s, 5H, C5H5), 4.21–4.24 (m, 1H, -CH2O + diastereomer),
4.43 (t, J = 3.5 Hz, 1H, -C5H3), 4.45 (t, J = 3.5 Hz, 1H, -C5H3) (due to diastereomer), 4.58
(dt, J = 8.2 Hz, 9.9 Hz, 1H, -CH2O), 4.95 (dd, J = 1.4 Hz, 2.5 Hz, 1H -C5H3), 5.00 (dd, J
= 1.4 Hz, 2.5 Hz, 1H -C5H3), 5.14 (ddd, J = 3.3 Hz, 8.0 Hz, 9.9 Hz, 1H, -CH2O + diastereomer).
13C NMR (100 MHz, CDCl3): δ 5.1 (CH2), 5.1 (CH2) (due to diastereomer), 8.2 (CH3), 8.3
(CH3) (due to diastereomer), 69.8 (CH), 69.8 (CH) (due to diastereomer) 71.5 (C), 72.1 (CH),
72.2 (CH) (due to diastereomer), 73.3 (CH), 73.4 (CH) (due to diastereomer), 74.2 (CH2), 74.4
(CH2) (due to diastereomer), 77.7 (CH), 77.8 (CH) (due to diastereomer), 126.6 (CH) (due to
diastereomer), 126.8 (CH), 127.4 (CH), 128.6 (CH), 128.7 (CH) (due to diastereomer), 142.6(C),
143.0 (C), 167.8 (C).
IR (KBr): ν 2952, 1649, 1456, 1236, 1136 cm−1 .
MS (EI, 70 eV): m/z (%) 445 (M+, 63), 416 (100), 299 (12), 268 (10).
[α]D
25 +92.6 (c 0.5, CHCl3)
HRMS for C21H31FeNOSi: calcd. 445.1524, found 459.1525.
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4.2.6 Synthesis of 2-(triethylsilane)-1-pyrazolyl-ferrocene (94)
Fe
N N
Et3Si
It was synthesized according to general procedure A starting from N -ferrocenyl pyrazole (93)
(0.2 mmol, 50 mg), using 10 mol% of Ru(H)2(CO)(PPh3)3 as catalyst in 35% yield as an orange
oil (26 mg). Eluent: pentane/diethyl ether = 95/5.
1H NMR (400 MHz, CDCl3): δ 0.63–0.78 (m, 6H, -Si(CH2CH3)3), 0.94 (t, J = 8.0 Hz, 9H,
-Si(CH2CH3)3), 4.10 (dd, J = 1.4 Hz, 2.2 Hz, 1H, -C5H3), 4.27 (s, 5H, -C5H5), 4.32 (t, J = 2.2
Hz, 1H, -C5H3), 4.59 (dd, J = 1.4 Hz, 2.2 Hz, 1H, -C5H3), 6.29 (t, J = 2.2 Hz, 1H, -CH), 7.52
(d, J = 1.6 Hz, 1H, -NCH), 7.73 (d, J = 2.20 Hz, 1H, -CHN).
13C NMR (100 MHz, CDCl3): δ 4.7 (CH2), 8.0 (CH3), 67.4 (CH), 67.5 (CH), 69.9 (CH),
72.7 (CH), 105.7 (CH), 131.5 (CH), 139.5 (CH).
IR (KBr): ν 2952, 1520, 1410, 1110 cm−1.
MS (EI, 70 eV): m/z (%) 366 (M+, 40), 337 (100).
Anal. Calcd. for C19H26FeN2OSi: C, 62.29; H, 7.15; N, 7.65. Found: C, 62.11; H, 7.34; N,
7.61.
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4.2.7 Synthesis of 1-[(4S,7R)-7,8,8-trimethyl-4,5,6,7-tetrahydro-4,7-methano-
2-indazolyl]-2-triethylsilyl ferrocene [(4S,7R,Rp)-96]
Fe
N N
Et3Si
It was synthesized according to general procedure A, starting from 1-[(4S,7R)-7,8,8-trimethyl-
4,5,6,7-tetrahydro-4,7-methano-2-indazolyl]-ferrocene (197) (0.2 mmol, 72 mg) using 10 mol%
of Ru(H)2(CO)(PPh3)3 as catalyst in 21% yield as an orange oil (20 mg, diastereomeric ratio =
73:27). Eluent: pentane/diethyl ether = 95/5.
1H NMR (400 MHz, CDCl3): δ 0.67–0.78 (m, 6H, -Si(CH2CH3)3 + diasteromer), 0.71 (s,
3H, -C(CH3)2 + diastereomer), 0.92–0.98 (m, 9H, -Si(CH2CH3)3 + diastereomer), 0.94 (s, 3H,
-C(CH3)2 + diastereomer), 1.14–1.21 (m, 1H, -CH2 + diastereomer), 1.26 (s, 3H, -CH3 + di-
astereomer), 1.27–1.37 (m, 1H, -CH2 + diastereomer), 1.78–1.87 (m, 1H, -CH2 + diastereomer),
2.03–2.13 (m, 1H, -CH2 + diastereomer), 2.77 (d, J = 3.8 Hz, 1H, -CH + diastereomer), 4.02–
4.04 (m, 1H, -C5H3 + diastereomer), 4.20 (s, 5H, -C5H5) (due to diastereomer), 4.21 (s, 5H,
-C5H5), 4.25–4.27 (m, 1H, -C5H3 + diastereomer), 4.48–4.49 (m, 1H, -C5H3) (due to diastere-
omer), 4.49 (dd, J = 1.4 Hz, 2.5 Hz, 1H, -C5H3), 7.32 (s, 1H, -CH), 7.32 (s, 1H, -CH) (due to
diastereomer).
13C NMR (100 MHz, CDCl3): δ 4.7 (CH2), 4.8 (CH2) (due to diastereomer), 8.1 (CH3), 8.2
(CH3) (due to diastereomer), 10.9 (CH3), 19.3 (CH3), 20.5 (CH3) (due to diastereomer), 20.8
(CH3), 28.0 (CH2) (due to diastereomer), 28.3 (CH2), 33.8 (CH2) (due to diastereomer), 33.9
(CH2), 47.4 (CH) (due to diastereomer), 47.5 (CH), 50.2 (C), 66.1 (C), 66.5 (CH), 67.8 (CH),
69.7 (CH), 72.3 (CH), 122.7 (CH) (due to diastereomer), 123.1 (CH).
IR (KBr): ν 2952, 1946, 1506, 1405, 1004 cm−1.
MS (EI, 70 eV): m/z (%) 474 (M+, 85), 445 (100).
[α]D
25 +2.5 (c 1.6, CDCl3).
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Anal. Calcd. for C27H38FeN2Si: C, 68.34; H, 8.07; N, 5.90. Found: C, 68.56; H, 7.99; N,
6.12.
4.2.8 Synthesis of 1-(α-triethylsilane)ferrocenyl-1-ethanol (91)
Fe
OH
Me
SiEt3
It was synthesized according to general procedure A, starting from (1-ethanol)-ferrocene (0.2
mmol, 46 mg) using 10 mol% of Ru(H)2(CO)(PPh3)3 as catalyst in 65% yield as an orange oil
(45 mg). Eluent: pentane/diethyl ether = 95/5.
1H NMR (400 MHz, CDCl3): δ 0.54 (q, J = 8.0 Hz, 9H, -Si(CH2CH3)3), 0.90 (t, J = 8.0
Hz, 6H, -Si(CH2CH3)3), 1.42 (d, J = 6.3 Hz, 3H, -CH3), 3.99–4.02 (m, 1H, -C5H3), 4.03–4.05
(m, 1H, -C5H3), 4.06 (s, 5H, -C5H5), , 4.12–4.14 (m, 1H, -C5H3), 4.63 (q, J = 6.3 Hz, 1H,
-CHOH).
13C NMR (100 MHz, CDCl3): δ 5.3 (CH2), 7.2 (CH3), 24.2 (CH3), 65.8 (CH), 66.4 (CH),
67.4 (CH), 67.5 (C), 67.7 (CH), 68.6 (CH).
MS (EI, 70 eV): m/z (%) 344 (M+, 100), 326 (31), 223 (29), 213 (18).
Anal. Calcd. for C18H28FeOSi: C, 62.78; H, 8.20. Found: C, 62.60; H, 8.16.
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4.2.9 Synthesis of (S,Rp)-2-(triethylsilane)cyrhetrenyl-5-tert-butyloxazoline
[(S,Rp)-100]
O
N
Re
COOC
OC
SiEt3
SiEt3
It was synthesized according to general procedure A, starting from cyrhetrenyl-5-tert-oxa-
zoline (0.2 mmol, 93 mg) using 10 mol% of Ru(H)2(CO)(PPh3)3 as catalyst in 72% yield as an
orange oil (100 mg). Eluent: pentane/diethyl ether = 95/5.
1H NMR (300 MHz, CDCl3): δ 0.69–0.95 (m, 15H, -Si(CH2CH3)3), 3.82 (m, 2H, -NCH +
-CH2O), 4.21 (dd, J = 7.4 Hz, 9.1 Hz, 1H, -CH2O), 5.26 (d, J = 2.7 Hz, 1H, -CH), 5.36 (d, J
= 2.7 Hz, 1H, -CH).
13C NMR (75 MHz, CDCl3): δ 4.9 (CH2), 5.1 (CH2), 7.8 (CH3), 7.9 (CH3), 26.1 (CH3),
33.5 (C), 68.5 (CH2), 76.9 (CH), 92.7 (C), 94.6 (CH), 96.0 (CH), 194.4 (C).
IR (KBr): ν 3436, 2020, 1918 cm−1 .
MS (EI, 70 eV): m/z (%) 689 (M+-3, 8), 660 (100), 560 (15), 83 (13).
Anal. Calcd. for C27H47NO4ReSi2: C, 46.86; H, 6.85; N, 2.02. Found: C, 46.77; H, 6.91;
N, 1.77.
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4.3 Synthesis of Organosilanols
4.3.1 Synthesis of silanes 152: General Procedure B
Ferrocenyl silanes 152 have been synthesized according to the following general procedure, which
had previously been applied in slightly different form for the synthesis of diastereomerically pure
ortho-substituted ferrocenyl oxazolines. [151]
A solution of ferrocenyl oxazoline 77 (1 mmol) in dry THF (20 mL) was prepared at room
temperature under argon atmosphere and cooled to −78 ◦C (by using a dry ice/acetone mixture).
After being treated dropwise with sec-BuLi (1.0 mL, 1.3 mmol, 1.3 M in cyclohexane), the
mixture was stirred for 2 hours at the same temperature. The addition of sec-BuLi changed
the color of the solution from orange to red. The respective chlorosilane (1.5 mmol) was added
dropwise, and the solution was allowed to warm to room temperature overnight. After washing
with water (20 mL) and phase separation, the aqueous phase was extracted with CH2Cl2 (10
mL) until the aqueous phase became colorless. The combined organic phases were dried over
Na2SO4, filtered and concentrated under reduced pressure. Flash column chromatography with
a suitable solvent system (pentane/diethyl ether) was used for the purification of the resulting
ferrocenyl silanes 152. The products proved to be rather unstable, and commonly samples with
purities of ca. 90% were obtained.
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4.3.2 Synthesis of (S,Rp)-2-(α-dimethylsilane)ferrocenyl-5-tert-butyl-oxazo-
line [(S,Rp)-152a]
O
N
Fe Si H
MeMe
It was synthesized according to general procedure B, starting from ferrocenyl-5-tert-butyl-
oxazoline and dimethyl-chlorosilane, in 64% yield as an orange oil. Eluent: pentane/diethyl
ether = 85/15.
1H NMR (300 MHz, CDCl3): δ 0.29 (d, J = 3.5 Hz, 3H, -SiH(CH3)2), 0.31 (d, J = 3.7
Hz, 3H, -SiH(CH3)), 0.89 (s, 9H, -C(CH3)), 3.81 (dd, J = 7.4 Hz, 8.7 Hz, 1H, -CHN), 4.04–4.10
(m, 1H, -CH2O), 4.08 (s, 5H, C5H5), 4.15 (dd, J = 8.7 Hz, 9.3 Hz, 1H, -CH2O), 4.21 (dd, J =
1.2 Hz, 1.9 Hz, 1H, -C5H3), 4.36 (t, J = 2.5 Hz, 1H, -C5H3), 4.57 (dq, J = 3.5 Hz, 3.7 Hz, 1H,
-SiH(CH3)2), 4.76–4.80 (m, 1H, -C5H3).
13C NMR (75 MHz, CDCl3): δ -3.2 (CH3), -1.7 (CH3), 36.0 (CH3), 33.7 (C), 68.3 (CH3),
69.5(C), 69.9 (CH), 72.0 (CH), 73.0 (CH), 76.4 (CH).
IR (KBr): ν 2957, 2140, 1657 cm−1 .
MS (EI, 70 eV): m/z(%) 369 (M+, 100), 354 (28), 312 (30), 195 (21), 121 (12).
[α]D
25 –126.7 (c 3.0, CDCl3).
HRMS for C19H19FeNOSi: calcd. 369.1211, found 369.1212.
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4.3.3 Synthesis of (S,Rp)-2-(α-diisopropylsilane)ferrocenyl-5-tert-butyloxazo-
line [(S,Rp)-152b]
O
N
Fe Si H
It was synthesized according to general procedure B, starting from ferrocenyl-5-tert-butyl-
oxazoline and diisopropylchlorosilane, in 64% yield as an orange oil. Eluent: pentane/diethyl
ether = 85/15.
1HNMR (400 MHz, CDCl3): δ 0.95 (s, 9H, -C(CH3)3), 0.97 (d, J = 7.7 Hz, 3H, -CH(CH3)2),
1.01 (d, J = 7.7 Hz, 1H, -CH(CH3)2), 1.20 (d, J =6.9 Hz, 3H, -CH(CH3)2), 1.25 (d, J = 6.6 Hz,
3H, -CH(CH 3)2), 1.30-1.40 (m, 2H, -CH(CH3)2), 3.88 (dd, 1H, J = 8.0 Hz, 10.0 Hz, -CHN),
4.09 (t, J = 8.2 Hz, 1H, -CH2O), 4.15 (s, 5H, C5H5), 4.23 (dd, J = 8.5 Hz, 10.1 Hz, 1H, -CH2O),
4.29 (dd, J = 1.4 Hz, 2.4 Hz, 1H, -C5H3), 4.31 (t, J = 1.6 Hz, 1H, -SiH(CH(CH3)2)2), 4.47 (t,
J = 2.20 Hz, 1H, -C5H3), 4.92 (dd, J = 1.4 Hz, 2.4 Hz, 1H, -C5H3).
13C NMR (100 MHz, CDCl3): δ 11.8 (CH), 12.3 (CH), 18.8 (CH3), 19.3 (CH3), 19.6 (CH3),
20.7 (CH3), 26.0 (CH3), 33.5 (C), 68.0 (CH2), 68.1 (C), 69.7 (C), 70.0 (CH), 72.0 (CH), 72.3
(CH), 76.2 (CH), 77.3 (CH), 165.4 (C).
IR (KBr): ν 2951, 2125, 1657 cm−1.
MS (EI, 70 eV): m/z(%) 425 (M+, 41), 382 (100), 282 (22).
[α]D
25 +36.0 (c 0.5, CHCl3).
HRMS for C23H35FeNOSi: calcd. 425.1837, found 425.1837.
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4.3.4 Synthesis of (S,Rp)-2-(α-diphenylsilane)ferrocenyl-5-tert-butyloxazoline
[(S,Rp)-152c]
O
N
Fe Si H
Ph Ph
It was synthesized according to general procedure B, starting from ferrocenyl-5-tert-butyl-
oxazoline and diphenylchlorosilane, in 91% yield as a dark orange solid. Eluent: pentane/diethyl
ether = 85/15.
mp. 118− 120 ◦C.
1H NMR (300 MHz, CDCl3): δ 0.82 (s, 9H, -C(CH3)3), 3.72 (dd, J = 8.2 Hz, 9.7 Hz, 1H,
-CHN), 4.09 (t, J = 8.2 Hz, 1H, -CH2O), 4.02–4.05 (m, 1H, -CH2O), 4.10–4.15 (m, 1H, -C5H3),
4.14 (s, 5H, C5H5), 4.44 (t, J = 2.20 Hz, 1H, -C5H3), 5.00 (bs, 1H, -C5H3). 5.74 (s,1H, -SiHPh2),
7.21–7.72 (m, 10H, -SiHPh2).
13C NMR (75 MHz, CDCl3): δ 25.7 (CH3), 33.4 (C), 66.2 (C), 68.3 (CH2), 70.2 (CH), 72.7
(CH), 72.8 (CH), 75.8 (C), 76.1 (CH), 78.8 (CH), 127.4 (CH), 127.8 (CH), 128.8 (CH), 129.3
(CH), 135.0 (CH), 135.7 (CH), 135.8 (C), 136.0 (C), 165.3 (C).
IR (KBr): ν 2955, 2152, 1659, 1145, 1113 cm−1.
MS (EI, 70 eV): m/z(%) 493 (M+, 100), 416 (39), 409 (32).
[α]D
25 –52.6 (c 1.09, CHCl3).
HRMS for C29H21FeNOSi: calcd. 493.1524, found 493.1525.
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4.3.5 Synthesis of (S,Rp)-2-(α-diisopropylsilane)ferrocenyl-5-phenyloxazoline
[(S,Rp)-152d]
O
N
PhFe Si H
It was synthesized according to general procedure B, starting from ferrocenyl-5-phenyloxazo-
line and diisopropylchlorosilane, in 70% yield as dark orange oil. Eluent: pentane/diethyl ether
= 80/20.
1H NMR (300 MHz, CDCl3): δ 0.99 (d, J = 7.2 Hz, 3H, -Si(CH(CH3)2)2), 0.99 (d, J = 7.4
Hz, 3H, -Si(CH(CH 3)2)2), 1.20 (d, J = 6.7 Hz, 3H, -Si(CH(CH3)2)2), 1.24 (d, J = 5.9 Hz, 3H,
-Si(CH(CH3)2)2), 1.26-1.40 (m, 2H, -Si(CH(CH3)2)2), 4.09 (t, J = 8.4 Hz, 1H, -CH2O), 4.20 (s,
5H, C5H5), 4.21 (s, 5H, C5H5) (due to diastereomer), 4.30 (t, J = 2.1 Hz, 1H, -SiH(CH(CH3)2)2),
4.34 (dd, J = 1.5 Hz, 2.5 Hz, 1H, -C5H3), 4.53 (t, J = 2.5 Hz, 1H, -C5H3), 4.62 (dd, J = 8.2
Hz, 9.9 Hz, 1H, -CH2O) (due to diastereomer), 4.72 (dd, J = 8.2 Hz, 9.9 Hz, 1H, -CH2O), 5.05
(dd, J = 1.2 Hz, 2.5 Hz, -C5H3), 5.11 (dd, J = 1.2 Hz, 2.5 Hz, 1H, -C5H3), 5.18-5.28 (m, 1H,
-CHN-), 7.23–7.40 (m, 5H, -Ph).
13C NMR (75 MHz, CDCl3): δ 11.7 (CH), 12.36 (CH), 12.43 (CH) (due to diastereomer),
18.9 (CH3) (due to the diastereomer), 19.0 (CH3), 19.4 (CH3), 19.5 (CH3), 20.5 (CH3), 68.3
(CH), 68.4 (CH) (due to the diastereomer), 69.7 (CH), 70.0 (CH) (due to the diastereomer),
70.2 (CH), 72.6 (CH), 72.7 (CH) (due to the diastereomer), 74.4 (CH2), 77.8 (CH), 126.6 (CH)
(due to the diastereomer), 126.7 (CH), 127.39 (CH), 127.44 (CH) (due to the diastereomer),
128.65 (CH), 128.69 (CH) (due to the diastereomer), 142.8 (C), 168.0 (C).
IR (KBr): ν 2942, 2124, 1649, 1458, 1139 cm−1.
MS (EI, 70 eV): m/z(%) 445 (M+, 34), 402 (100), 285 (20).
[α]D
25 +34.4 (c 0.61, CHCl3).
HRMS for C25H31FeNOSi: calcd. 445.1524, found 445.1524.
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4.3.6 Synthesis of (S,Rp)-2-(α-diphenylsilane)ferrocenyl-5-phenyloxazoline -
[(S,Rp)-152e]
O
N
PhFe Si H
Ph Ph
It was synthesized according to general procedure B, starting from ferrocenyl-5-phenyloxa-
zoline and diphenylchlorosilane; 68% yield as dark orange solid. Eluent: pentane/diethyl ether
= 85/15.
mp. 141− 142 ◦C.
1H NMR (400 MHz, CDCl3): δ 3.65-3.72 (m, 1H, -CH2O), 4.10 (m, 1H, -C5H3), 4.21 (s,
5H, C5H5), 4.50 (bs, 1H, -C5H3), 4.54–4.62 (m, 1H, -CH2O), 5.09 (bs, 2H, -C5H3, -CHN), 5.76
(s, 1H, -SiHPh2), 7.00–7.71 (m, 15H, -Ph, -SiHPh2).
13C NMR (100 MHz, CDCl3): δ 66.7 (C), 70.2 (CH), 70.5 (CH), 73.0 (CH), 73.2 (CH), 74.4
(CH2), 75.1 (C), 79.2 (CH), 126.9 (CH), 127.4 (CH), 127.6 (CH), 127.9 (CH) 129.1 (CH), 129.5
(CH), 135.1 (CH), 135.3 (C), 135.5 (C), 135.6 (CH), 142.3 (C), 167.3 (C).
IR (KBr): ν 3064, 2146, 1642, 1151 cm−1.
MS (EI, 70 eV): m/z(%) 513 (M+, 100), 436 (39), 409 (28).
[α]D
25 +77.0 (c 0.5, CHCl3).
HRMS for C31H27FeNOSi: calcd. 513.1211, found 513.1211.
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4.3.7 Synthesis of (S,Rp)-2-(α-diisopropylsilane)ferrocenyl-5-iso-propyloxazo-
line [(S,Rp)-152f]
O
N
Fe Si H
It was synthesized according to general procedure B, starting from ferrocenyl-5-iso-propyl-
oxazoline and diisopropylchlorosilane, in 81% yield as dark orange oil. Eluent: pentane/diethyl
ether = 80/20.
1H NMR (300 MHz, CDCl3): δ 0.90–1.04 (m, 13H, -CH(CH3)2, -Si(CH(CH3)2)2, -Si(CH-
(CH3)2)2), 1.19 (d, J = 6.4 Hz, 3H, -Si(CH(CH3)2)2), 1.22–1.38 (m, 4H, -Si(CH(CH3)2)2, -
Si(CH(CH3)2)2), 1.73–1.86 (m, 1H, -CH(CH3)2), 3.93 (dd, J = 5.9 Hz, 7.9 Hz, 1H, -CHN-),
3.96 (m, 1H, -CH2O), 4.16 (s, 5H, -C5H5), 4.26 (t, J = 2.0 Hz, 1H, -SiH(CH(CH3)2)2), 4.32–
4.35 (m, 1H, -CH2O), 4.49 (t, J = 2.5 Hz, 1H, -C5H3), 4.96 (dd, J = 1.2 Hz, 2.2 Hz, 1H, -C5H3).
13C NMR (75 MHz, CDCl3): δ 11.8 (CH), 12.3 (CH), 18.2 (CH3), 18.9 (CH3), 19.0 (CH3),
19.4 (CH3), 19.5 (CH3), 20.5 (CH3), 32.7 (CH), 68.1 (C), 69.5 (CH2), 70.1 (CH), 72.3 (CH),
72.4 (CH), 72.5 (CH), 72.9 (C), 77.5 (CH).
IR (KBr): ν 3098, 2953, 2126, 1657, 1140 cm−1.
MS (EI, 70 eV): m/z(%) 411 (M+, 28), 368 (100), 282 (14).
[α]D
25 +78.8 (c 0.5, CHCl3).
HRMS for C22H33FeNOSi: calcd. 411.1681, found 411.1681.
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4.3.8 Synthesis of (S,Rp)-2-(α-diphenylsilane)ferrocenyl-5-iso-propyloxazoline
[(S,Rp)-152g]
O
N
Fe Si H
Ph Ph
It was synthesized according to general procedure B, starting from ferrocenyl-5-iso-propyl-
oxazoline and diphenylchlorosilane, in 85% yield as dark orange solid. Eluent: pentane/diethyl
ether = 85/15.
mp. 89− 91 ◦C.
1H NMR (400 MHz, CDCl3): δ 0.76 (d, J = 6.9 Hz, 3H, -CH(CH3)2), 0.89 (d, J = 6.9 Hz,
3H, -CH(CH3)2), 1.59–1.72 (m, 1H, -CH(CH3)2), 3.57 (t, J = 8.3 Hz, 1H, -CH2O), 3.82 (dt, J
= 6.0 Hz, 8.8 Hz, 1H, -CHN), 4.03–4.06 (m, 1H, -C5H3), 4.15 (s, 5H, C5H5), 4.16–4.22 (m, 1H,
-CH2O), 4.45 (t, J = 2.2 Hz, 1H, -C5H3), 5.02 (bs, 1H, -C5H3), 5.71 (s, 1H, -SiHPh2), 7.25-7.70
(m, 10H, -SiHPh2).
13C NMR (100 MHz, CDCl3): δ 18.1 (CH3), 19.0 (CH3), 32.5 (CH), 66.2 (C), 69.6 (CH2),
70.3 (CH), 72.5 (CH), 72.7 (CH), 72.9 (CH), 75.8 (C), 78.9 (CH), 127.5 (CH), 127.8 (CH), 128.9
(CH), 129.3 (CH), 135.0 (CH), 135.6 (CH), 135.70 (C), 135.74 (C), 165.5 (C).
IR (KBr): ν 2958, 2139, 1658, 1117 cm−1.
MS (EI, 70 eV): m/z(%) 479 (M+, 100), 408 (54), 402 (83).
[α]D
25 +35.6 (c 0.5, CHCl3).
HRMS for C28H29FeNOSi: calcd. 479.1368, found 479.1268.
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4.3.9 Synthesis of (S,Rp)-2-(α-diisopropylsilane)ferrocenyl-5-benzyloxazoline
[(S,Rp)-152h]
O
N
CH2PhFe Si H
It was synthesized according to general procedure B, starting from ferrocenyl-5-benzyloxazo-
line and diisopropylchlorosilane, in 82% yield as dark orange oil. Eluent: pentane/diethyl ether
= 80/20.
1H NMR (400 MHz, CDCl3): δ 0.95 (d, J = 7.4 Hz, 3H, -Si(CH(CH3)2)2), 0.96 (d, J = 7.4
Hz, 3H, -Si(CH(CH3)2)2), 1.17 (d, J = 6.6 Hz, 3H, -Si(CH(CH3)2)2), 1.21 (d, J = 6.6 Hz, 3H,
-Si(CH(CH3)2)2), 1.23–1.32 (m, 1H, -Si(CH(CH3)2)2), 2.66–2.73 (m, 1H, -CH2Ph), 3.15–3.21
(m, 1H, -CH2Ph), 3.94–3.99 (m, 1H, -CH2O), 4.11 (s, 5H, C5H5) (due to the diastereomer), 4.14
(s, 5H, C5H5), 4.15–4.30 (m, 3H, -SiH(CH(CH3)2)2, -C5H3, -CH2O), 4.37–4.46 (m, 1H, -CHN,
4.48–4.50 (m, 1H, -C5H3), 4.99 (dd, J = 1.4 Hz, 2.4 Hz, 1H, -C5H3), 7.17–7.34 (m, 5H, -Ph).
13C NMR (100 MHz, CDCl3): δ 11.8 (CH) (due to diastereomer), 11.9 (CH), 12.5 (CH),
19.1 (CH3) (due to diastereomer), 19.2 (CH3), 19.6 (CH3), 19.7 (CH3), 20.6 (CH3), 41.9 (CH2)
(due to diastereomer), 42.0 (CH2), 67.7 (CH) (due to diastereomer), 67.8 (CH), 68.3 (C), 70.3
(CH), 71.2(CH2), 71.4 (CH2), 72.5 (CH), 72.6 (CH), 74.7 (C), 77.8 (CH), 126.4 (CH), 128.5
(CH), 129.4 (CH), 129.5 (CH) (due to diastereomer), 138.1 (C), 167.1 (C).
The compound was found to be rather unstable and no analytically pure samples were
obtained. The product was directly converted into its oxidized counterpart (silanol 153h).
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4.3.10 Synthesis of (S,Rp)-2-(α-diphenylsilane)ferrocenyl-5-benzyloxazoline -
[(S,Rp)-152i]
O
N
CH2PhFe Si H
Ph Ph
It was synthesized according to general procedure B, starting from ferrocenyl-5-benzyloxa-
zoline and diphenylchlorosilane, in 60% yield as dark orange oil. Eluent: pentane/diethyl ether
= 85/15.
1H NMR (300 MHz, CDCl3): δ 2.37 (dd, J = 8.9 Hz, 13.6 Hz, 1H, -CH2Ph), 2.52 (dd, J = 8.6
Hz, 13.8 Hz, 1H, -CH2Ph) (due to diastereomer), 2.94 (dd, J = 4.7 Hz, 13.5 Hz, 1H, -CH2Ph)
(due to diastereomer), 3.08 (dd, J = 4.8 Hz, 13.7 Hz, 1H, -CH2Ph), 3.95 (dd, J = 6.2 Hz, 8.2
Hz, 1H, -CH2O-), 4.03–4.11 (m, 2H, -C5H3, -CH2O-), 4.12 (s, 5H, C5H5) (due to diastereomer),
4.14 (s, 5H, C5H5), 4.17-4.35 (m, 1H, -CHN), 4.48 (t, J = 2.5Hz, 1H, -C5H3), 5.02-5.08 (m, 1H,
-C5H3), 5.69 (s, 1H, -SiHPh2), 7.08–7.77 (m, 8H, -CH2Ph, -SiPh2).
13C NMR (75 MHz, CDCl3): δ 41.3 (CH2) (due to diastereomer), 41.8 (CH2), 67.4 (CH)
(due to diastereomer), 67.8 (CH), 70.4 (CH), 70.5 (CH) (due to diastereomer), 71.1 (CH2) (due
to diastereomer), 71.5 (CH2), 72.7 (CH), 73.0 (CH) (due to diastereomer), 73.2 (CH), 75.3 (C),
79.1 (CH), 79.2 (CH) (due to diastereomer), 126.5 (CH), 127.7 (CH), 127.9 (CH), 128.5 (CH),
129.1 (CH), 129.3 (CH), 129.5 (CH), 135.2 (CH), 135.5 (C), 135.7 (CH), 138.1 (C), 138.2 (C),
166.9 (C).
The compound was found to be rather unstable and no analytically pure samples were
obtained. The product was directly converted into its oxidized counterpart (silanol 153i).
98
4.4 Synthesis of ferrocenyl silanols 153
Organosilanols 153 were synthesized according to the following general procedure C, which is a
slightly modified version of the published protocol [130] for the conversion of silanes to silanols.
To a solution of silane 152 (1 mmol) in acetonitrile (3 mL) was added [IrCl(C8H12)]2 (7
mg, 0.01 mmol) and water (36 mg, 2.0 mmol). The reaction mixture was stirred in air at room
temperature or at 60 ◦C, and the conversion was monitored by TLC. Column chromatography
or preparative TLC plates using pentane/diethyl ether mixture as eluent were utilized for the
purification of the diastereomerically and enantiomerically pure organosilanols.
4.4.1 Synthesis of (S,Rp)-2-(α-dimethylsilanol)ferrocenyl-5-tert-butyloxazo-
line [(S,Rp)-153a]
O
N
Fe Si OH
MeMe
It was synthesized according to general procedure C, starting from (S,Rp)-152a, in 91% yield
as an orange solid. Eluent: pentane/diethyl ether = 90/10.
mp. 104− 105 ◦C.
1H NMR (400 MHz, CDCl3): δ 0.21 (s, 3H, -Si(CH3)2), 0.49 (s, 3H, -Si(CH3)2), 1.01 (s,
9H, -C(CH3)3), 3.93 (dd, 1H, J = 9.4 Hz, 9.9 Hz, -CHN), 4.14 (t, J = 8.8 Hz, 1H, -CH2O), 4.23
(s, 5H, -C5H5), 4.26 (dd, J = 1.4 Hz, 2.4 Hz, 1H, -C5H3), 4.29 (dd, J = 8.8 Hz, 9.9 Hz, 1H,
-CH2O), 4.48 (t, J = 2.5 Hz, 1H, -C5H3), 4.82 (dd, J = 1.4 Hz, 2.5 Hz, 1H, -C5H3), 7.83 (bs,
1H, -OH).
13C NMR (100 MHz, CDCl3): δ 0.0 (CH3), 2.91 (CH3), 25.98 (CH3), 33.0 (C), 68.4 (CH2),
69.8 (CH), 72.1 (CH), 72.5 (CH), 72.8 (C), 73.9 (C), 75.2 (CH), 76.3 (CH), 168.7 (C).
IR (KBr): ν 3441, 2858, 1643, 1149 cm−1.
MS (EI, 70 eV): m/z(%) 385 (M+, 100), 328 (27).
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[α]D
25 –309.6 (c 0.5, CHCl3).
Anal. Calcd. for C19H27FeNO2Si: C, 59.22; H, 7.06; N, 3.63; found C, 58.90; H, 7.41; N,
3.55.
4.4.2 Synthesis of (S,Rp)-2-(α-diisopropylsilanol)ferrocenyl-5-tert-butyloxa-
zoline [(S,Rp)-153b]
O
N
Fe Si OH
It was synthesized according to general procedure C, starting from (S,Rp)-152b, in 77%
yield as a dark orange oil. Eluent: pentane/diethyl ether = 90/10.
1H NMR (400 MHz, CDCl3): δ 0.78 (d, J = 7.14 Hz, 3H, -Si(CH(CH3)2)2), 0.88 (d, J
= 7.14 Hz, 3H, -Si(CH(CH3)2)2), 0.93–1.01 (m, 1H, -Si(CH(CH3)2)2), 1.02 (s, 9H, -C(CH3)3),
1.25–1.36 (m, 7H, -Si(CH(CH3)2)2), -Si(CH(CH3)2)2), 3.87-3.93 (m, 1H, -CHN-), 4.05-4.11 (m,
1H, -CH2O), 4.22 (s, 5H, C5H5), 4.29 (dd, J = 8.5 Hz, 9.9 Hz, -CH2O), 4.30–4.32 (m, 1H,
-C5H3), 4.50 (t, J = 2.5 Hz, 1H, -C5H3), 4.84 (dd, J = 1.1 Hz, 2.5 Hz, 1H, -C5H3), 7.65 (bs,
1H, -OH).
13C NMR (100 MHz, CDCl3): δ 13.9 (CH), 14.9 (CH), 17.86 (CH3), 17.94 (CH3), 18.51
(CH3), 18.53 (CH3), 26.5 (CH3), 33.1 (C), 68.6 (CH2), 70.3 (CH), 72.0 (C), 72.2 (CH), 72.3
(CH), 73.1 (C), 75.7 (CH), 76.8 (CH), 169.0 (C).
IR (KBr): ν 3444, 2863, 1642, 1149 cm−1.
MS (EI, 70 eV): m/z(%) 441 (M+, 57), 398 (100), 298 (37).
[α]D
25 –165.3 (c 0.88, CHCl3).
HRMS for C23H35FeNO2Si: calcd. 441.1786, found 441.1786.
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4.4.3 Synthesis of (S,Rp)-2-(α-diphenylsilanol)ferrocenyl-5-tert-butyloxazoli-
ne [(S,Rp)-153c]
O
N
Fe Si OH
Ph Ph
It was synthesized according to general procedure C, starting from (S,Rp)-152c; 91% yield
as an orange solid. Eluent: pentane/diethyl ether = 95/5.
mp. 104− 105 ◦C.
1H NMR (400 MHz, CDCl3): δ 1.04 (s, 9H, -C(CH3)3), 3.88 (dd, 1H, J = 9.3 Hz, 10.1 Hz,
-CHN), 4.02 (s, 5H, -C5H5), 4.14 (t, J = 8.8 Hz, 1H, -CH2O), 4.24–4.30 (m, 2H, -CH2O, -C5H3),
4.51 (t, J = 2.5 Hz, 1H, -C5H3), 4.89 (dd, J = 1.4 Hz, 2.5 Hz, 1H, -C5H3), 7.24–7.34 (m, 3H, -
Ph), 7.41–7.46 (m, 3H, -Ph), 7.49–7.52 (m, 2H, -Ph), 7.86–7.92 (m, 2H, -Ph), 8.60 (bs, 1H, -OH).
13C NMR (100 MHz, CDCl3): δ 26.2 (CH3), 33.1 (C), 68.6 (CH2), 70.1 (CH), 70.5 (C), 72.9
(CH), 72.9 (C), 75.1 (CH), 78.1 (CH), 127.3 (CH), 127.4 (CH), 129.0 (CH), 129.5 (CH), 134.4
(CH), 134.7 (CH), 136.0 (C), 138.6 (C), 168.8 (C).
IR (KBr): ν 2955, 1638, 1150, 1113 cm−1.
MS (EI, 70 eV): m/z(%) 509 (M+, 100).
[α]D
25 –446.8 (c 0.5, CDCl3).
Anal. Calcd. for C29H31FeNO2Si: C, 68.36; H, 6.13; N, 2.75; found C, 68.23; H, 6.34; N,
2.56.
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4.4.4 Synthesis of (S,Rp)-2-(α-diisopropylsilanol)ferrocenyl-5-phenyloxazoline
[(S,Rp)-153d]
O
N
PhFe Si OH
It was synthesized according to general procedure C, starting from (S,Rp)-152d, in 57%
yield as an orange solid. Eluent: pentane/diethyl ether = 80/20.
mp. 99− 100 ◦C.
1H NMR (400 MHz, CDCl3): δ 0.81 (d, J = 7.1 Hz, 3H, -Si(CH(CH3)2)2), 0.89 (d,
J = 7.1 Hz, 3H, -Si(CH(CH3)2)2), 0.93–1.04 (m, 2H, -Si(CH(CH3)2)2), 1.26–1.30 (m, 3H, -
Si(CH(CH3)2)2), 1.32–1.35 (m, 3H, -Si(CH(CH3)2)2), 4.20 (t, J = 8.5 Hz, 1H, -CH2O), 4.26 (s,
5H, -C5H5), 4.37 (dd, J = 1.4 Hz, 2.5 Hz, 1H, -C5H3), 4.55 (t, J = 2.5 Hz, 1H, -C5H3), 4.72
(dd, J = 8.5 Hz, 10.0 Hz, 1H, -CH2O), 4.92 (dd, J = 1.4 Hz, 2.5 Hz, 1H, -C5H3), 5.20–5.28 (m,
1H, -CHN), 7.25–7.42 (m, 5H, -Ph), 7.44 (bs, 1H, -OH).
13C NMR (100 MHz, CDCl3): δ 13.6 (CH), 14.8 (CH), 17.7 (CH3), 18.28 (CH3), 18.33
(CH3), 68.9 (CH), 70.3 (CH), 72.2 (C), 72.3 (C), 72.4 (CH), 74.4 (CH2), 77.4 (CH), 126.1 (CH),
127.5 (CH), 128.8 (CH), 141.6 (C), 170.3 (C).
IR (KBr): ν 2940, 2860, 1633, 1148 cm−1.
MS (EI, 70 eV): m/z(%) 461 (M+, 59), 418 (100).
[α]D
25 –227.2 (c 0.5, CDCl3).
Anal. Calcd. for C25H31FeNO2Si: C, 65.07; H, 6.77; N, 3.04; found C, 64.80; H, 6.44; N,
2.86.
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4.4.5 Synthesis of (S,Rp)-2-(α-diphenylsilanol)ferrocenyl-5-phenyloxazoline -
[(S,Rp)-153e]
O
N
PhFe Si OH
Ph Ph
It was synthesized according to general procedure C, starting from (S,Rp)-152e, in 91% yield
as an orange solid. Eluent: pentane/diethyl ether = 95/5.
mp. ≤150 ◦C (decomp).
1H NMR (300 MHz, CDCl3): δ 4.11 (s, 5H, -C5H5), 4.18–4.25 (m, 1H, -CH2O), 4.28–4-30
(m, 1H, -C5H3), 4.56 (t, J = 2.5 Hz, 1H, -C5H3), 4.62–4.71 (m, 1H, -CH2O), 4.99–5.01 (m, 1H,
-C5H3), 5.14–5.24 (m, 1H, -CHN-) 7.25–7.55 (m, 13H, -Ph), 7.82–7.90 (m, 2H, -Ph), 8.26 (bs,
1H, -OH).
13C NMR (75 MHz, CDCl3): δ 68.9 (CH), 70.5 (CH), 71.1 (C), 72.6 (C), 73.3 (CH), 73.4
(CH), 74.8 (CH2), 78.8 (CH), 126.3 (CH), 127.6 (CH), 127.7 (CH), 127.8 (CH) 129.1 (CH), 129.4
(CH), 129.8 (CH), 134.7 (CH), 135.0 (CH), 136.0 (C), 138.6 (C), 142.0 (C), 170.5 (C).
IR (KBr): ν 1626, 1157, 1115 cm−1.
MS (EI, 70 eV): m/z(%) 529 (M+, 100), 452 (30), 344 (27).
[α]D
25 –307.2 (c 0.5, CDCl3).
Anal. Calcd. for C31H27FeNO2Si: C, 70.32; H, 5.14; N, 2.65; found C, 70.09; H, 5.18; N,
2.65.
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4.4.6 Synthesis of (S,Rp)-2-(α-diisopropylsilanol)ferrocenyl-5-iso-propyloxa-
zoline [(S,Rp)-153f]
O
N
Fe Si OH
It was synthesized according to general procedure C, starting from (S,Rp)-152f, in 65% yield
as an orange oil. Eluent: pentane/diethyl ether = 85/15.
1H NMR (400 MHz, CDCl3): δ 0.79 (d, J = 7.1 Hz, 3H, -Si(CH(CH3)2)2), 0.88 (d, J
= 7.1 Hz, 3H, Si(CH(CH3)2)2), 0.93–0.99 (m, 1H, -Si(CH(CH3)2)2), 1.00 (d, J = 6.6 Hz, 3H,
CH(CH3)2), 1.19 (d, J = 6.6 Hz, 3H, -CH(CH3)2), 1.26–1.30 (m, 3H, -Si(CH(CH3)2)2), 1.32–
1.36 (m, 4H, -Si(CH(CH3)2)2, -Si(CH(CH3)2)2), 1.76–1.88 (m, 1H, -CH(CH3)2), 3.90 (dt, J =
6.9 Hz, 9.3 Hz, 1H, -CHN-), 4.03 (t, J =8.5 Hz, 1H, -CH2O), 4.20 (s, 5H, -C5H5), 4.30–4.36 (m,
2H, -C5H3, -CH2O), 4.55 (t, J = 2.5 Hz, 1H, -C5H3), 4.84 (dd, J = 1.4 Hz, 2.5 Hz, 1H, -C5H3),
7.73 (bs, 1H, -OH).
13C NMR (100 MHz, CDCl3): δ 13.8 (CH), 14.9 (CH), 17.8 (CH3), 17.9 (CH3), 18.50 (CH3),
18.53 (CH3), 19.1 (CH3), 19.3 (CH3), 32.90 (CH), 70.4 (CH2), 70.5 (CH), 72.0 (CH), 72.28 (CH),
72.30 (CH), 72.9 (C), 77.5 (CH), 168.9 (C).
IR (KBr): ν 3098, 2957, 2865, 1643, 1151 cm−1.
MS (EI, 70 eV): m/z(%) 427 (M+, 47), 384 (100), 298 (25).
[α]D
25 –312.1 (c 0.95, CDCl3).
Anal. Calcd. for C22H33FeNO2Si: C, 61.82; H, 7.78; N, 3.28; found C, 61.83; H, 7.92; N,
3.56.
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4.4.7 Synthesis of (S,Rp)-2-(α-diphenylsilanol)ferrocenyl-5-iso-propyloxazo-
line [(S,Rp)-153g]
O
N
Fe Si OH
Ph Ph
It was synthesized according to general procedure C, starting from (S,Rp)-152g, in 82% yield
as an orange solid. Eluent: pentane/diethyl ether = 95/5.
mp. 138− 139 ◦C.
1H NMR (300 MHz, CDCl3): δ 1.03 (d, J = 6.7 Hz, 3H, -CH(CH3)2), 1.15 (d, J = 6.9 Hz,
3H, -CH(CH3)2), 1.77–1.90 (m, 1H, -CH(CH3)2), 3.92 (ddd, J = 6.2 Hz, 8.2 Hz, 9.8 Hz, 1 H,
-NCH), 4.03 (s, 5H, -C5H5), 4.09 (dd, J = 8.2 Hz, 8.4 Hz, 1H, -CH2O), 4.28 (dd, J = 1.5 Hz,
2.5 Hz, 1H, -C5H3), 4.51 (t, J = 2.5 Hz, 1H, -C5H3), 4.90 (dd, J = 1.2 Hz, 2.2 Hz, 1H, -C5H3),
7.20–7.35 (m, 3H, -Ph), 7.40–7.55 (m, 3H, -Ph), 7.80–7.85 (m, 2H, -Ph), 8.88 (bs, 1H, -OH).
13C NMR (75 MHz, CDCl3): δ 18.8 (CH3), 18.9 (CH3), 32.6 (CH), 70.3 (CH2), 70.4 (CH),
70.7 (C), 71.4 (CH), 73.0 (CH), 73.1 (CH), 78.3 (CH), 127.5 (CH), 127.6 (CH), 129.3 (CH),
129.7 (CH), 134.6 (CH), 134.9 (CH), 136.1 (C), 138.8 (C), 169.1 (C).
IR (KBr): ν 3048, 2961, 1641, 1155, 1114 cm−1.
MS (EI, 70 eV): m/z(%) 495 (M+, 100).
[α]D
25 –393.6 (c 0.5, CDCl3).
Anal. Calcd. for C28H29FeNO2Si: C, 67.88; H, 5.90; N, 2.83; found C, 67.83; H, 6.12; N,
2.60.
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4.4.8 Synthesis of (S,Rp)-2-(α-diisopropylsilanol)ferrocenyl-5-benzyloxazoline
[(S,Rp)-153h]
O
N
CH2PhFe Si OH
It was synthesized according to general procedure C, starting from (S,Rp)-152h, in 45%
yield as a orange oil. Eluent: pentane/diethyl ether = 95/5.
1H NMR (400 MHz, CDCl3): δ 0.81 (d, J = 6.9 Hz, 3H, -Si(CH(CH3)2)2), 0.90 (d,
J = 6.9 Hz, 3H, -Si(CH(CH3)2)2), 0.94–1.04 (m, 1H, -Si(CH(CH3)2)2), 1.26–1.38 (m, 7H, -
Si(CH(CH3)2)2, -Si(CH(CH3)2)2), 2.79 (dd, J = 9.1 Hz, 13.7 Hz, 1H, -CH2Ph), 3.24 (dd, J =
4.0 Hz, 13.9 Hz, 1H, -CH2Ph), 4.08 (t, J = 8.2 Hz, 1H, -CH2O), 4.15 (s, 5H, -C5H5), 4.21–4.28
(m, 1H, -CH2O), 4.30–4.33 (m, 1H, -C5H3), 4.38–4.47 (m, 1H, -CHN), 4.48–4.52 (m, 1H, -C5H3),
4.80–4.84 (m, 1H, -C5H3), 7.20–7.36 (m, 5H, -Ph), 7.73 (bs, 1H, -OH).
13C NMR (100 MHz, CDCl3): δ 14.0. (CH), 15.0 (CH), 17.8 (CH3), 17.9 (CH3), 18.49
(CH3), 18.53 (CH3), 41.5 (CH2), 66.8 (CH), 70.6 (CH), 71.3 (CH2), 72.0 (C), 72.4 (CH), 72.5
(CH), 126. 7 (CH), 128.7 (CH), 129.5 (CH), 137.3 (C), 169.6 (C).
IR (KBr): ν 3090, 2940, 2863, 1640, 1147 cm−1.
MS (EI, 70 eV): m/z(%) 495 (M+, 54), 432 (100).
[α]D
25 –80.8 (c 0.5, CDCl3).
Anal. Calcd. for C26H33FeNO2Si: C, 65.08; H, 7.00; N, 2.95; found C, 64.94; H, 7.08; N,
3.11.
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4.4.9 Synthesis of (S,Rp)-2-(α-diphenylsilanol)ferrocenyl-5-benzyloxazoline -
[(S,Rp)-153i]
O
N
CH2PhFe Si OH
Ph Ph
It was synthesized according to general procedure C, starting from (S,Rp)-152i, in 43% yield
as an orange oil. Eluent: pentane/diethyl ether = 95/5.
1H NMR (300 MHz, CDCl3): δ 2.85 (dd, J = 8.7 Hz, 13.9 Hz, 1H, -CH2Ph), 3.21 (dd, J =
4.5 Hz, 13.9 Hz, 1H, -CH2Ph), 3.97 (s, 5H, -C5H5), 4.11 (t, J = 8.2 Hz, 1H, -CH2O), 4.21–4.28
(m, 2H, -CH2O, -C5H3), 4.35–4.45 (m, 1H, -CHN-), 4.48–4.52 (m, 1H, -C5H3), 4.88 (dd, J =
1.2 Hz, 2.2 Hz, 1H, -C5H3), 7.20–7.39 (m, 8H, -Ph), 7.41–7.53 (m, 5H, -Ph), 7.86–7.90 (m, 2H,
-Ph) 8.62 (bs, 1H, -OH).
13C NMR (75 MHz, CDCl3): δ 41.4 (CH2), 66.5 (CH), 70.5 (CH), 71.4 (CH2), 72.6 (C),
73.1 (CH), 73.2 (CH), 78.6 (CH), 126.8 (CH), 127.6 (CH), 127.7 (CH), 128.8 (CH), 129.4 (CH),
129.7 (CH), 129.8 (CH), 134.7 (CH), 135.0 (CH), 136.1 (C), 137.3 (C), 138.8 (C), 169.7 (C).
IR (KBr): ν 3008, 2923, 1638, 1151, 1114 cm−1.
MS (EI, 70 eV): m/z(%) 543 (M+, 100), 466 (28), 344 (24).
[α]D
25 –378.0 (c 0.25, CDCl3).
HRMS for C32H29FeNO2Si: calcd. 543.1317, found 543.1317.
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4.4.10 Synthesis of 1,1’-bis(dimethylsilyl)ferrocene (158)
Si
Fe
H
MeMe
Si
Me
H
Me
To a solution of TMEDA (4.6 mL, 30 mmol) in hexane (20 mL), n-BuLi (23 mL, 15% in
hexane, 30 mmol) was added dropwise and stirred for 10 min. The resulted mixture was added
slowly to a solution of ferrocene (2.5 g, 13.5 mmol) in hexane (100 mL), and stirred at room
temperature for 5 h. An orange precipitation formed, and the reaction mixture was cooled
to −78 ◦C on a dry ice/acetone bath, and dimethylchlorosilane (3.3 mL, 30 mmol) was added
dropwise. The reaction mixture was stirred for 1 h at the same temperature and after removal
of dry ice/acetone bath, the temperature was slowly raised to room temperature, and stirred
overnight. Saturated NH4Cl solution was added and two phase were separated in a separation
funnel. Water phase was extracted with CH2Cl2 (3 x 25 mL), and the combined organic phases
was washed with brine (25 mL), dried over MgSO4 and concentrated under vacuum. The crude
product mixture was separated with flash chromatography using pentan as eluent to separate
ferrocene, and to afford desired disilane 158 (2.01 g, 50% yield) as an orange liquid. Eluent:
pentane.
1H NMR (400 MHz, CDCl3): δ 0.31 (d, J = 3.9 Hz, 12H, -Si(CH3)2), 4.19–4.12 (m, 4H,
-C5H4), 4.31–4.51 (m, 4H, -C5H4), 4.31–4.45 (m, 2H, -SiH).
13C NMR (100 MHz, CDCl3): δ 2.9 (CH3), 68.2 (C), 71.6 (CH), 73.7 (CH).
MS (EI, 70 eV): m/z(%) 302 (M+, 100), 285 (60), 243 (32).
Anal. Calcd. for C14H22FeSi2: C, 55.62; H, 7.33. Found: C, 55.62; H, 7.38.
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4.4.11 Synthesis of 1,1’-bis(tetramethylsiloxane)ferrocene (159)
Si
Fe
MeMe
Si
MeMe
O
To a solution of disilane 158 (122 mg, 0.40 mmol) in acetonitrile (1.5 mL) was added
[RuCl2(η
6-benzene)]2 (4 mg, 0.008 mmol) and distilled water (1 drop, ≈ 18 mg, 1 mmol). The re-
action mixture was stirred under air for 4 h, and without any work-up, separated with flash chro-
matography using pentane as eluent to afford disiloxane (60 mg, 48%) and ferrocenyldimethyl-
silanol (156) (52 mg, 47%) as orange crystalline substances. Eluent: pentane/diethyl ether =
90/10.
mp. 88− 89 ◦C.
1H NMR (400 MHz, CDCl3): δ 0.30 (s, 12H, -Si(CH3)2), 4.23–4.25 (m, 4H, -C5H4), 4.33–
4.53 (m, 4H, -C5H4).
13C NMR (100 MHz, CDCl3): δ 2.5 (CH3), 73.0 (C), 73.4 (CH), 75.5 (CH).
MS (EI, 70 eV): m/z(%) 316 (M+, 100), 281 (52), 237 (12).
Anal. Calcd. for C14H22FeSi2O: C, 53.16; H, 6.37. Found: C, 53.28; H, 6.38.
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4.4.12 Synthesis of ferrocenyldimethylsilanol (156)
Si
Fe
OH
MeMe
n-BuLi (0.8 mL of 15% in hexane, 1.3 mmol) was added dropwise to a solution ferrocenyl-
tributyltin (0.48 g, 1.0 mmol) in dry THF (10 mL) at −78 ◦C. The reaction mixture was stirred
for 1.5 h at this temperature and a solution of hexamethyltrisiloxane (70 mg, 0.33 mmol) in
THF (6 mL). After removal of dry ice/acetone bath, the temperature was slowly raised to room
temperature, and it was stirred overnight, water (15 mL) was added, extracted with diethyl
ether (3 x 15 mL), dried over MgSO4, concentrated under vacuum, separated by column chro-
matography using pentane/diethyl ether (95/5) as eluent to afford silanol 156 (0.131 g, 44%)
as an orange solid. Eluent: pentane/diethyl ether = 85/15.
mp. 63− 65 ◦C. Lit [207]: 62− 63 ◦C.
1H NMR (300 MHz, CDCl3): δ 0.39 (s, 6H, -Si(CH3)2), 1.79 (bs, 1H, -OH), 4.15 (s, 5H,
-C5H5), 4.16–4.18 (m, 2H, -C5H3), 4.37–4.39 (m, 2H, -C5H3).
13C NMR (75 MHz, CDCl3): δ 0.5 (CH3), 67.9 (CH), 69.8 (C), 70.8 (CH), 72.4 (CH).
MS (EI, 70 eV): m/z(%) 260 (M+, 100), 245 (71), 179 (14).
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4.4.13 Synthesis of 1,1’-bis(dimethylsilanol)ferrocene (160)
Si
Fe
OH
MeMe
Si
Me
OH
Me
via 1’-Lithiation of ferrocenyldimethylsilanol (156)
To a solution of ferrocenyldimethylsilanol (156) (65 mg, 0.25 mmol) in dry THF (0.4 mL) under
inert atmosphere at room temperature, t-BuLi (0.4 mL of 15% in hexane, 0.6 mmol) was added
dropwise. The resultion solution was refluxed for 18 hours and after cooling to room temperature,
DMF (0.04 mL, 0.6 mmol) was added. After 24 hours stirring at room temperature, water was
added (1 mL) and extracted with diethyl ether (3 x 2 mL). Organic phases were collected, dried
over MgSO4 and concentrated under vacuum. The crude product mixture was purified by flash
chromatography using pentan/diethylether (85/15) as eluent to afford disilanol 160 (16 mg, 19%
yield) as an orange liquid.
via 1,1’-Dilithiation of ferrocene
To a solution of TMEDA (4.6 mL, 30 mmol) in hexane (20 mL), n-BuLi (23 mL, 15% in hexane,
30 mmol) was added dropwise and stirred for 10 min. The resulted mixture was added slowly to
a solution of ferrocene (2.5 g, 13.5 mmol) in hexane (100 mL), and stirred at room temperature
for 5 h. An orange precipitate formed, and the reaction mixture was cooled to −78 ◦C on a dry
ice/acetone bath, and hexamethyltrisiloxane (2.0 g, 9.0 mmol) was added dropwise. The reac-
tion mixture was stirred for 1 h at the same temperature and after removal of dry ice/acetone
bath, the temperature was slowly raised to room temperature, and stirred overnight. Saturated
NH4Cl solution was added and two phase were separated in a separation funnel. Water phase
was extracted with CH2Cl2 (3 x 25 mL), and the combined organic phases were washed with
brine (25 mL), dried over MgSO4 and concentrated under vacuum. The crude product mixture
was separated with flash chromatography using pentan as eluent to separate ferrocene, and to
afford desired disilanol 156 (1.06 g, 23% yield) as an orange solid.
mp. 130− 131 ◦C.
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1H NMR (300 MHz, CDCl3): δ 0.32 (s, 12H, -Si(CH3)2), 4.22 (t, J = 1.7 Hz, 4H, -C5H4),
4.37 (t, J = 1.7 Hz, 4H, -C5H4), 5.54 (bs, 2H, -SiOH).
13C NMR (75 MHz, CDCl3): δ 1.8 (CH3), 70.5 (C), 71.0 (CH), 73.4 (CH).
MS (EI, 70 eV): m/z(%) 334 (M+, 100), 317 (25), 149 (20).
Anal. Calcd. for C14H22FeO2Si2: C, 50.29; H, 6.63. Found: C, 50.45; H, 6.62.
4.4.14 Synthesis of rac-1,1’-bis(phenylmethylsilanol)ferrocene (161)
Si
Fe
OH
PhMe
Si
Ph
OH
Me
It was synthesized applying the same procedure as for the synthesis of disilanol 160, starting
from the same amount of ferrocene (2.5g, 13.5 mmol) and using triphenyl-trimethyl-trisilaxone
(3.7 mL, 9 mmol) as an electrophile to afford chiral disilanol 161 (1.03 g, 16% yield) as an
orange solid.
mp. 127− 129 ◦C.
1H NMR (300 MHz, CDCl3): δ 0.55 (s, 6H, -SiCH3), 4.13–4.21 (m, 4H, -C5H4), 4.30–4.37
(m, 4H, -C5H4), 6.29 (bs, 2H, -SiOH), 7.26–7.40 (m, 6H, -Ph), 7.57–7.63 (m, 4H, -Ph).
13C NMR (75 MHz, CDCl3): δ 1.3 (CH3), 69.9 (C), 72.2 (CH), 72.4 (CH), 74.6 (CH), 75.2
(CH), 128.7 (CH), 130.4 (CH), 134.4 (CH), 139.2 (C).
MS (EI, 70 eV): m/z(%) 458 (M+, 100), 440 (27), 322 (18).
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IR (KBr): ν 3067, 2957, 1425, 1254, 1166, 1036 cm−1.
Anal. Calcd. for C24H26FeO2Si2: C, 62.87; H, 5.72. Found: C, 63.14; H, 6.06.
4.5 Synthesis of N -Substituted Ferrocenes
4.5.1 Synthesis of Iodoferrocene (193)
I
Fe
It has been synthesized according to following slightly modified Kagan’s procedure. [156]
Iodine (1.4 g, 5.5 mmol) was added to the solution of ferrocenyltributyltin1(2.38 g, 5.0 mmol)
in 20 mL of CH2Cl2 at room temperature under inert atmosphere. The reaction mixture was
stirred at room temperature for 24 h. Excess iodine was removed by washing with saturated
Na2S2O3 solution, and filtered through neutral Al2O3, and the solvent was evaporated. The
crude product mixture was dissolved in MeOH (10 mL), KF (1 g) was added to precipicate the
stannylated byproducts which were removed by filtration through neutral Al2O3. The product
was diluted with diethylether (15ml) and washed with water (15 mL), and dried over MgSO4,
and concentrated under vakuum. Finally, it is one more filtrated, this time through silica gel
using pentan as eluent and after recrystallisation with hexane, product (0.66 g, 42% yield) was
obtained as red-brown crystals. which can be stored in dark at low temperature (−24 ◦C) for a
long time without decomposition.
1H NMR (400 MHz, CDCl3): δ 4.15–4.16 (m, 2H, -C5H4), 4.15 (s, 5H, -C5H5), 4.40–4.42
(m, 2H, -C5H4).
13C NMR (100 MHz, CDCl3): δ 68.9 (CH), 71.1 (CH), 74.5 (CH).
MS (EI, 70 eV): m/z(%) 312 (M+, 100), 184 (27), 129 (21).
1It is prepared according to the Kagan’s procedure [156]
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4.5.2 Synthesis of 1,1’-diiodoferrocene (196)
I
Fe
I
To a solution of TMEDA (4.6 mL, 30 mmol) in hexane (20 mL), n-BuLi (23 mL of 15% in
hexane, 30 mmol) was added slowly and stirred for 10 min. The resulted mixture was added
slowly to a solution of ferrocene (2.5 g, 13.5 mmol) in hexane (100 mL), and stirred at room tem-
perature for 5 h. An orange precipitate formed, and the reaction mixture was cooled to −78 ◦C
on a dry ice/acetone bath, and a solution of iodine (10.6 g, 30 mmol) in diethylether (75 mL)
was added slowly within 15 min. The reaction mixture stirred for 1 h at the same temperature
and after removal of dry ice/acetone bath, the temperature was slowly raised to 0 ◦C, and water
(25 mL) was added. After stirring for 15 min, the mixture was filtrated and the two phase were
separated in a separation funnel. The organic phase was washed with saturated Na2S2O3 solu-
tion (25 mL) and water (2 x 50 mL), dried over MgSO4 and concentrated under vacuum. The
crude product mixture was first separated over a short column filled with neutral Al2O3 using
pentane as eluent and then with a very long column filled with silica gel2 using pentane as eluent
to separate iodoferrocene, and to afford diiodoferrocene (0.64 g, 11% yield) as a dark-orange oil.3
1H NMR (300 MHz, CDCl3): δ 4.18–4.21 (m, 4H, -C5H4), 4.38–4.41 (m, 4H, -C5H4).
13C NMR (75 MHz, CDCl3): δ 72.3 (CH), 77.6 (CH).
MS (EI, 70 eV): m/z(%) 438 (M+, 100), 311 (9), 183 (11), 128 (31).
2It was found that silica gel gave a better separation than alumina
3Spectroscopical data is consistent with literature data: [208]
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4.5.3 Synthesis of (S,Rp)-α-iodo-ferrocenyl-5-benzyloxazoline [(S,Rp)-211]
O
N
Fe I
To a solution of ferrocenyl oxazoline 74 (0.311 g, 1.0 mmol) in dry THF (20 mL) at −78 ◦C
under inert atmosphere, sec-BuLi (1.0 mL of 1.3 M in cyclohexane, 1.3 mmol) was added slowly,
and resulting red solution was stirred for 2 h. Solid iodine (0.354 g, 1.0 mmol) was added at once
to the solution, and it was stirred overnight. Excess amount of iodine was removed by washing
with saturated Na2S2O3 solution (20 mL) and extracted with diethylether (2 x 20 mL). The
organic phase was dried over MgSO4 and concentrated under vacuum to obtain crude product.
It was, then, separated with flash chromatography to obtain iodooxazoline 211(0.381 g, 87%)
as a dark orange solid.4
1H NMR (300 MHz, CDCl3): δ 1.02 (s, 9H, -C((CH3)3), 3.98 (dd, J = 7.3 Hz, 8.5 Hz, 1H,
-CHN), 4.18–4.26 (m, 2H, -CH2O), 4.20 (s, 5H, -C5H5), 4.36 (t, J = 2.5 Hz, 1H, -C5H3), 4.62
(dd, J = 1.4 Hz, 2.5 Hz, 1H, -C5H3), 4.69 (bs, 1H, -C5H3).
13C NMR (75 MHz, CDCl3): δ 26.0 (CH3), 34.0 (C), 38.7 (C), 68.1 (CH2), 69.6 (CH), 70.9
(CH), 72.6 (CH), 76.5 (CH), 78.4 (CH).
4It is a slightly modified version of Bolm’s procedures and spectroscopical data is consistent with literature
data: [200]
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4.5.4 Synthesis of N -substituted ferrocenes; General Procedure D
Iodoferrocene (62.5 mg, 0.20 mmol), the nitrogen-containing coupling partner (R-[N]-H, 0.22
mmol), copper(I) iodide (38 mg, 0.2 mmol) and the base (0.4 mmol) were added into dry DMSO
(0.4 mL) under Ar atmosphere. A slurry mixture was formed, which was heated to 90 ◦C for
18 h. After cooling to room temperature, water (2.0 mL) and diethyl ether (2 mL) were added.
Then, the organic phase was separated and the aqueous phase extracted with diethyl ether until
no colorful organic phase was visible anymore. The combined organic phases were dried over
MgSO4, filtered and the solvent evaporated to give the crude product. Purification by flash
column chromatography (pentane/diethyl ether = 1/9) afforded the product.
4.5.5 Synthesis of N -ferrocenyl pyrazole (93)
Fe
N
N
It was synthesized (42 mg, 84%) according to general procedure D, using pyrazole (15 mg,
0.22 mmol) as coupling component and K2CO3 (56 mg, 0.40 mmol) as base in 84% yield as an
orange crystalline substance (42 mg).
mp. 119− 120 ◦C.
1H NMR (400 MHz, CDCl3): δ 4.17 (s, 5H, -C5H5), 4.16–4.17 (m, 2H, -C5H4) 4.76 (t, J =
1.9 Hz, 2H, -C5H4), 6.32–6.33 (m, 1H, -CH), 7.62 (d, J = 1.4 Hz, 1H, -NCH), 7.67 (d, J = 2.5
Hz, 1H, -NCH) ppm.
13C NMR (100 MHz, CDCl3): δ 60.8 (CH), 65.8 (CH), 69.8 (CH), 98.2 (C), 106.5 (CH),
128.1 (CH), 140.0 (CH) ppm.
IR (KBr): ν 3090, 1529, 1393, 1004, 873, 825, 759, 499 cm−1.
MS (EI, 70 eV): m/z(%) 252 (M+, 100), 187 (14), 131 (19), 56 (8).
Anal. Calcd. for C13H12FeN2: C, 61.94; H, 4.80; N, 11.11. Found: C, 61.67; H, 4.97; N,
11.04.
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4.5.6 Synthesis ofN -ferrocenyl-(4S,7R)-7,8,8-trimethyl-4,5,6,7-tetrahydro-4,7-
methano-2-indazole (95)
Fe
N N
It was synthesized according to general procedure D, using chiralpyrazole (194 mg, 1.1 mmol)
as coupling component and K2CO3 (560 mg, 4.0 mmol) as base in 71% yield as an orange solid
(254 mg).
mp. 136− 138 ◦C.
1H NMR (300 MHz, CDCl3): δ 0.72 (s, 3H, -C(CH3)2), 0.97 (s, 3H, -C(CH3)2), 1.15–1.24
(m, 1H, -CH2), 1.33 (s, 3H, -CH3) 1.34–1.42 (m, 1H, -CH2), 1.85 (ddd, J = 4.0 Hz, 10.1 Hz,
12.1 Hz, 1H, -CH2), 2.08 (ddt, J = 4.0 Hz, 9.9 Hz, 11.9 Hz, 1H, -CH2), 2.76 (d, J = 4.0 Hz, 1H,
-CH), 4.07–4.10 (m, 2H, –C5H4), 4.13 (s, 5H, -C5H5), 4.64 (dt, J = 1.5 Hz, 2.2 Hz, 1H, -C5H4),
4.71 (dt, J = 1.5 Hz, 2.2 Hz, 1H, -C5H4), 7.21 (s, 1H, -NCH).
13C NMR (75 MHz, CDCl3): δ 10.8 (CH3), 19.1 (CH3), 20.6 (CH3), 27.7 (CH2), 33.7 (CH2),
47.2 (CH), 50.4 (C), 59.9 (CH), 60.2 (CH), 60.4 (C) 65.0 (CH), 65.1 (CH), 69.5 (CH), 120.2 (CH),
128.1 (C), 167.1 (C).
MS (EI, 70 eV): m/z(%) 360 (M+, 100), 358 (7), 345 (5), 317 (19), 251 (6), 195 (4), 121 (4).
Anal. Calcd. for C21H24FeN2: C, 70.01; H, 6.71; N, 7.78. Found: C, 70.00; H, 6.60; N, 7.72.
[α]D
25 –13.6 (c 0.43, CDCl3).
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4.5.7 Synthesis of N -ferrocenyl indole (199)
Fe
N
It was synthesized according to general procedure D, using indole (15 mg, 0.22 mmol) as cou-
pling component and K2CO3 (56 mg, 0.40 mmol) as base in 73% yield as an orange solid (44 mg).
mp. 89− 91 ◦C. Lit [209]: 89− 90 ◦C.
1H NMR (300 MHz, CDCl3): δ 4.20-4.22 (m, 2H, -C5H4), 4.23 (s, 5H, -C5H5), 4.62–4.64
(m, 2H, -C5H4), 6.57 (d, J = 3.2 Hz, 1H, -NCH), 7.10–7.17 (m, 1H, -C6H4), 7.20–7.27 (m, 1H,
-C6H4), 7.40 (d, J = 3.2 Hz, 1H, -CH), 7.63 (dd, J = 0.7 Hz, 7.7 Hz, 1H, -C6H4), 7.73 (dd, J
= 0.7 Hz, 8.2 Hz, 1H, -C6H4).
13C NMR (75 MHz, CDCl3): δ 62.8 (CH), 65.4 (CH), 69.4 (CH), 97.4 (C), 102.8 (CH),
111.3 (CH), 120.1 (CH), 121.1 (CH), 122.0 (CH), 129.3 (C), 136.7 (C).
IR (KBr): ν 1521, 1446, 1311, 1234, 1141, 1103, 815, 740, 499 cm−1.
MS (EI, 70 eV): m/z(%) 301 (M+, 100), 235 (5), 180 (5), 150 (3).
4.5.8 Synthesis of N -ferrocenyl pyrrole (200)
Fe
N
It was synthesized according to general procedure D, using pyrrole (15 mg, 0.22 mmol) as
coupling component and K2CO3 (56 mg, 0.40 mmol) as base in 62% yield as an orange solid (31
mg).
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mp. 80− 81 ◦C.
1H NMR (300 MHz, CDCl3): δ 4.03 (t, J = 2.0 Hz, 2H, -C5H4), 4.10 (s, 5H, -C5H5), 4.44
(t, J = 2.0 Hz, 2H, -C5H4), 6.12–6.14 (m, 2H, -NCH), 6.85–6.87 (m, 2H, -CH).
13C NMR (75 MHz, CDCl3): δ 61.1 (CH), 65.3 (CH), 69.6 (CH), 63.8 (CH), 109.1 (CH),
120.8 (CH).
IR (KBr): ν 3106, 1527, 1302, 1080 cm−1.
MS (EI, 70 eV): m/z(%) 251 (M+, 100), 185 (9), 130 (5).
Anal. Calcd. for C14H13FeN: C, 66.96; H, 5.22; N, 5.58. Found: C, 66.95; H, 5.26; N, 5.34
4.5.9 Synthsis of N -ferrocenyl imidazole
Fe
N N
It was synthesized according to general procedure D, using imidazole (15 mg, 0.22 mmol) as
coupling component and K2CO3 (56 mg, 0.40 mmol) as base, with a longer reaction time (36
h), in 33% yield as an orange crystalline substance (20 mg).
mp. 100− 101 ◦C.
1H NMR (400 MHz, CDCl3): δ 4.19 (t, J = 1.9 Hz, 2H, -C5H4), 4.21 (s, 5H, -C5H5), 4.54
(t, J = 1.9 Hz, 2H, -C5H4), 7.10 (bs, 1H, -NCH), 7.17 (bs, 1H, -NCH), 7.74 (bs, 1H, -NCHN).
13C NMR (100 MHz, CDCl3): δ 62.1 (CH), 66.1 (CH), 69.9 (CH).
IR (KBr): ν 3083, 1528, 1247, 1104, 1034 cm−1.
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MS (EI, 70 eV): m/z(%) 252 (M+, 100), 187 (34), 121 (8), 56 (6).
HRMS for C13H12FeN2: calcd. 252.0349, found 252.0349.
4.5.10 Synthesis of 1-ferrocenyl-1,2,4-triazole (202)
Fe
N
N
N
It was synthesized according to general procedure D, using triazole (15 mg, 0.22 mmol) as
coupling component and KOt-Bu (45 mg, 0.40 mmol) as base in 30% yield as an orange crys-
talline substance (15 mg).
mp. 107− 109 ◦C.
1H NMR (400 MHz, CDCl3): δ 4.23 (s, 5H, -C5H5), 4.25 (t, J = 1.9 Hz, 2H, -C5H4), 4.76
(t, J = 2.0 Hz, 2H, -C5H4), 8.01 (s, 1H, -NCH), 8.32 (s, 1H, -NCH).
13C NMR (75 MHz, CDCl3): δ 61.6 (CH), 66.3 (CH), 69.9 (CH), 77.1 (C), 151.9 (CH).
IR (KBr): ν 3872, 3425, 1632, 1529, 1273, 1100, 1018 cm−1.
MS (EI, 70 eV): m/z(%) 253 (M+, 100), 199 (19), 121 (11).
HRMS for C12H11FeN3: cald. 253.0302, found 253.0302.
4.5.11 Synthesis of N -ferrocenyl-methyl phenyl sulfoximine (203)
N
Fe
S
O
Ph
Me
It was synthesized according to general procedure D using sulfoximine 191 (34 mg, 0.22
120
mmol) as coupling component and K2CO3 (56 mg, 0.40 mmol) as base in 80% yield as an or-
ange crystalline substance (54 mg).
mp. 92− 94 ◦C.
1H NMR (300 MHz, CDCl3): δ 3.17 (s, 3H, -CH3), 3.77–3.80 (m, 1H, C5H4), 3.80–3.85 (m,
1H, -C5H4), 3.88–3.91 (m, 1H, -C5H4), 4.03–4.07 (m, 1H, -C5H4), 4.11 (s, 5H, -C5H5), 7.51–7.65
(m, 3H, -Ph), 7.91–7.96 (m, 2H, -Ph).
13C NMR (75 MHz, CDCl3): δ 46.0 (CH3), 61.5 (CH), 62.6 (CH), 63.8 (CH), 69.3 (CH),
128.5 (CH), 129.6 (CH), 133.2 (CH), 140.0 (C).
MS (EI, 70 eV): m/z(%) 339 (M+, 100), 199 (35), 133 (11).
Anal. Calcd. for C17H17FeNOS: C, 60.19; H, 5.05; N, 4.13. Found: C, 59.84; H, 5.12; N,
4.06.
4.5.12 Synthesis of N -ferrocenyl-benzamide (205)
H
N
Fe O
It was synthesized according to general procedure D, using benzamide (27 mg, 0.22 mmol)
as coupling component and KOt-Bu (45 mg, 0.40 mmol) as base in 57% yield as an orange solid
(35 mg).
mp. 179− 181 ◦C.
1H NMR (400 MHz, CDCl3): δ 4.09 (bs, 2H, -C5H4), 4.21 (s, 5H, -C5H5), 4.77 (bs, 2H,
-C5H4), 7.30 (bs, 1H, -NH), 7.43–7.55 (m, 3H, -C6H5), 7.80–7.82 (m, 2H, -C6H5).
13C NMR (100 MHz, CDCl3): δ 61.7 (CH), 64.9 (CH), 69.5 (CH), 126.8 (CH), 128.7 (CH),
131.6 (CH), 134.7 (C), 165.4 (C).
4. Experimental Section 121
IR (KBr): ν 3304, 3091, 1643, 1556, 1281, 1000 cm−1.
MS (EI, 70 eV): m/z (%) 305 (M+, 100), 240 (43), 202 (7), 185 (7), 121 (9).
Anal. Calcd. for C17H15FeNO: C, 66.91; H, 4.95; N, 4.59. Found: C, 67.24; H, 5.21; N,
4.59.
4.5.13 Synthesis of 1,1’-bis(N -pyrazolyl) ferrocene (208)
Fe
N
N
N
N
It was synthesized according to general procedure D, using pyrazole (30 mg, 0.44 mmol) as
coupling component and K2CO3 (56 mg, 0.40 mmol) as base in 50% yield as an orange solid (40
mg).
mp. 154− 156 ◦C.
1H NMR (300 MHz, CDCl3): δ 4.19 (t, J = 1.7 Hz, 4H, -C5H4), 4.71 (t, J = 1.7 Hz, 4H,
-C5H4), 6.26 (t, J = 1.7 Hz, 2H, -CH), 7.49 (d, J = 2.2 Hz, 2H, -NCH), 7.55 (d, J = 2.2 Hz,
2H, -NCH).
13C NMR (75 MHz, CDCl3): δ 61.9 (CH), 67.1 (CH), 99.2 (C), 106.6 (CH), 128.1 (CH),
140.2 (CH).
IR (KBr): ν 1534, 1393, 869, 811, 742, 511 cm−1.
MS (EI, 70 eV): m/z (%) 318 (M+, 100), 187 (7), 159 (4), 131 (6).
HRMS calcd for C16H14FeN4: calcd. 318.0568, found 318.0568.
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4.5.14 Synthesis of 1,1’-bis[(4S,7R)-7,8,8-trimethyl-4,5,6,7-tetrahydro-4,7-methano-
2-indazolyl] ferrocene (209)
Fe
N N
N N
It was synthesized according to general procedure D, using chiral pyrazole 197 (77 mg, 0.44
mmol) as coupling component and K2CO3 (56 mg, 0.40 mmol) as base in 30% yield as an orange
solid (33 mg).
mp. decomp ≤ 160 ◦C
1H NMR (400 MHz, CDCl3): δ 0.73 (s, 6H, -C(CH3)2), 0.97 (s, 6H, -(CH3)2), 1.17–1.28
(m, 4H, -CH2), 1.33 (s, 6H, -CH3), 1.34–1.41 (m, 2H, -CH2), 1.86 (ddd, J = 3.8 Hz, 10.2 Hz,
12.2 Hz, 2H, -CH2), 2.09 (ddt, J = 3.8 Hz, 10.1 Hz, 12.1 Hz, 2H, -CH2), 2.75 (d, J =3.8 Hz,
2H, -CH), 4.08 (dt, J = 1.4 Hz, 2.5 Hz, 2H, -C5H4), 4.10 (dt, J = 1.4 Hz, 2.5 Hz, 2H, -C5H4),
4.49–4.52 (m, 2H, -C5H4), 4.53–4.56 (m, 2H, -C5H4), 7.13 (s, 2H, -NCH).
13C NMR (100 MHz, CDCl3): δ 11.0 (CH3), 19.3 (CH3), 20.7 (CH3), 27.8 (CH2), 33.8
(CH2), 47.3 (CH), 50.5 (C), 60.4 (C), 61.6 (CH), 62.0 (CH), 66.6 (CH), 100.4 (C), 120.6 (CH),
128.1 (C), 167.2 (C).
IR (KBr): ν 1591, 1525, 1405, 1382, 1286, 499 cm−1.
MS (EI, 70 eV): m/z (%) 534 (M+, 100).
HRMS for C32H38FeN4: calcd. 534.2446, found 534.2447.
[α]D
25 +63.1 (c 0.65, CDCl3).
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4.5.15 Synthesis of 2,6-bis(N -pyrazolyl)pyridine (220)
NN N
NN
It was synthesized according to general procedure D, using 2,6-dibromopyridine (47 mg, 0.20
mmol), pyrazole (30 mg, 0.44 mmol) as coupling component and K2CO3 (56 mg, 0.40 mmol) as
base in 72% yield as a white crystalline compound (33 mg). Spectroscopical data is consistent
with literature data. [201]
1H NMR (400 MHz, CDCl3): δ 6.48 (dd, J = 1.6 Hz, 2.5 Hz, 2H, -CHC), 7.75–7.77 (m,
2H, -CHN), 7.83–7.86 (m, 2H, -CHC), 7.91–7.95 (m, 1H, -CHC), 8.57 (d, J = 2.8 Hz, -CHN).
13C NMR (100 MHz, CDCl3): δ 108.0 (CH), 109.4 (CH), 127.0 (CH), 141.4 (CH), 142.3
(CH), 150.0 (C).
4.5.16 Synthesis of 2,6-bis[(4S,7R)-7,8,8-trimethyl-4,5,6,7-tetrahydro-4,7-me-
thano-2-indazolyl]pyridine (221)
N
N
N
N
N
It was synthesized according to general procedure D, using 2,6-dibromopyridine (47 mg, 0.20
mmol), chiral pyrazole 197 (77 mg, 0.44 mmol) as coupling component and K2CO3 (56 mg, 0.40
mmol) as base in 47% yield as a white crystalline compound (49 mg). Spectroscopical data is
consistent with literature data. [203]
1H NMR (400 MHz, CDCl3): δ 0.74 (s, 6H, -C(CH3)2)), 1.00 (s, 6H, -C(CH3)2)), 1.20–
1.31 (m, 2H, -CH2), 1.34 (s, 6H, -C(CH3)2)), 1.38–1.48 (m, 2H, -CH2), 1.90 (ddd, J = 3.7 Hz,
10.1 Hz, 12.2 Hz, 2H, -CH2), 2.12 (ddt, J = 4.0 Hz, 9.9 Hz, 11.9 Hz, 2H, -CH2), 2.82 (d, J =
4.0 Hz, -CH), 7.55–7.58 (m, 2H, -CH), 7.74 (dd, J = 7.4 Hz, 8.8 Hz, 1H, -CH), 8.10 (s, 2H, -CH).
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13C NMR (100 MHz, CDCl3): δ 10.6 (CH3), 19.0 (CH3), 20.7 (CH3), 27.6 (CH2), 33.7
(CH2), 47.0 (CH), 50.3 (C), 60.0 (C), 106.8 (CH), 118.5 (CH), 129.2 (C), 140.5 (C), 150.8 (CH),
169.9 (CH).
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